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SUMMARY
A GvHR in nonirradiated (C57B1/6JxDBA/2 ) BDF^ mice
manifests systemically in an acute immunostimulatory phase
followed by immunosuppression, often progressing to a
chronic immunostimulatory form. An intestinal GvHR can
occur due to the presence of activated T cells in the
mucosa. The aim of this thesis was to study the effects of
GvHR-induced T cell activation on mucosal structure and
humoral immunity.
The GvHR produced an intestinal inflammatory response which
resulted in an evolution of changes to the mucosal
architecture, correlating with the progression of the
systemic reaction. The lesion progressed from crypt
hyperplasia, and increased intraepithelial cells (IEL) to
crypt hyperplasia followed by crypt atrophy, villus atrophy
and decreased IEL counts. The animals remained healthy and
the mucosa recovered from this destructive lesion.
Total immunoglobulin concentrations were analysed in the
gut washings of mice with GvHR, using a newly developed
technique. An increase in IgA (day 12) and IgM (days 11-14)
levels in gut washings accompanied by increased plasma cell
counts in the lamina propria was observed. No changes in
IgG plasma cell counts were detected. The effects on
mucosal Ig levels were confined to the gut, and no
dissemination to distant mucosal sites was observed. A
pattern of increased serum IgA, IgM and IgG emerged,
reflecting the systemic GvHR. Increased total cell numbers
were observed in PP, MLN and SP, which although transient
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in the mucosal-associated lymph nodes, remained high in the
SP, with a dramatic increase on day 32. Similarly on day
32, Ig levels in the spleen and gut washings were
dramatically increased, as was the spleen index, which
possibly reflected the onset of the chronic GvHR. After
18mths, mice with chronic GvHR developed an autoimmune-type
reaction, which did not affect mucosal Ig levels. The
effect of a GvHR on mucosal Ig production was not
exaggerated in young immunologically immature mice or aged
mice with altered immune function.
I suggest that the effects of the GvHR on both the mucosal
structure and Ig levels are the result of cytokines
released from activated T cell subsets.
Oral tolerance studies revealed that in normal mice 50mgs
betalactoglobulin (BLG) was required to suppress the
systemic humoral and CMI responses. Preliminary studies
using a transgenic mouse colony, which carries a cloned
sheep BLG gene and expresses sheep BLG in milk during
lactation, suggested that possession and expression of the
gene are important in determining the antibody response to
BLG, presented in the milk during the first weeks of life,
in the transgenic offspring.
Finally, the mucosal immune response to the dietary
proteins, ovalbumin (OVA) and BLG were investigated, using
the GvHR as a model of mucosal cell activation. Initial
studies revealed that feeding OVA during the initial phase
of GvHR produced IgA antibodies to OVA in gut washings,
comparable to the IgA anti-OVA antibody response observed
when OVA was fed with the IgA immunopotentiating agent,
cholera toxin, and which was not observed in mice fed OVA
alone. However further studies revealed that an IgA
antibody response to OVA or BLG was dependent on the number
of feeds the animals received. Interestingly, systemic
hyporesponsiveness and mucosal immunity occurred
simultaneously in normal animals fed dietary antigen.
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The mucosal surface of the gastrointestinal tract shows a
fascinating dichotomy of functional roles. Physiologically,
this is the site of absorption of dietary nutrients; it is
also an immunological barrier against environmental
antigens.
The mucosal immune responses and the regulation of immunity
are totally different from the rest of the body.
The predominant immunoglobulin secreted from the mucosae is
IgA, and regulation of the mucosal IgA response is T cell
dependent.
Presentation of certain antigens at the mucosal surface is
believed to produce oral tolerance, recognised as a
suppression of the systemic humoral and cell-mediated
immune responses. This systemic hyporesponsiveness is also
under T cell regulation, and T cell reactions at the gut
level can alter oral tolerance induction.
The phenomenon of oral tolerance is thought to protect the
body from harmful systemic immune reactions, and is
believed to be the normal immunological response to
innocent dietary proteins.
The relationship between mucosal immunity and oral
tolerance is as yet uncertain, but there is evidence to
suggest a potential reciprocal balance, in that "switching
on" of a secretory IgA response effectively abrogates oral
tolerance.
The purpose of my work was to explore the effects of T cell
activation within the gut mucosa.
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Specifically I aimed to measure
i) The production and isotype distribution of
mucosal immunoglobulins and antibodies.
ii) Having observed striking changes in immunoglobulin
production the work was extended to study where, in the
mucosal B cell maturation pathway, T cells were exerting
their effect. Several areas of possible influence exist
such as isotype-switching and proliferation in the Peyer's
patches, migration, and at terminal differentiation in the
lamina propria.
iii) Finally the influences of antigen presentation and
mucosal T cell activation on oral tolerance induction were
to be examined.
The murine Graft-versus-host reaction (GvHR) model was used
in these studies. The injection of parental,
immunocompetent cells into nonirradiated F-j_ hybrid animals
produces a GvHR, during which class II-restricted,
activated T cells present in the mucosa. There is an
extensive amount of literature describing T cell-mediated
hypersensitivity reactions and cytotoxic T cell and NK cell
activity during the GvHR. However, apart from the findings
of Gold, Kosek, Wanek and Baur (1976), in which an
immunodeficiency of IgA- and IgM-containing plasma cells in
the gut was observed in neonatal mice, very little is known
about mucosal immunoglobulin production during a GvHR.
To answer the questions on intestinal immunoglobulin
production it was first necessary to develop a method for
measuring secretory immunity. A gut lavage technique was
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used. To allow analysis of T cell influences on B cell
development an ELISPOT assay was developed.
In the studies of antigen and mucosal influences on oral
tolerance I selected ovalbumin, which has been extensively
studied, and betalactoglobulin, an important dietary
protein implicated in milk allergy. In addition,
betalactoglobulin was selected as I had the unique source
of a transgenic mouse strain, which expresses sheep
betalactoglobulin in milk during lactation.
In this thesis I shall first review the literature on the
induction and immunoregulation of the mucosal immune
response (chapter 1), and the murine GvHR model (chapter
2).
In chapter 4 are described the different phases that occur
during the GvHR, with specific attention to the effects on
the histological architecture of the gut.
Chapter 5 explains the development of the gut lavage method
for the collection of gut luminal contents.
Having established this technique, a definitive,
descriptive study of the effect of the GvHR on the
concentrations of mucosal immunoglobulins was performed,
and is documented in chapter 6.
Significant changes were observed and attempts to address
the possible regulatory mechanisms were undertaken.
Experiments investigating the possible dissemination of
immunity to other sites of immune expression are detailed
in chapter 7. The influences of the GvHR at the extremes of
life, in neonates with potential immunodeficiency and
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possible accentuated gut damage, and in aged animals, 18
months after the initial GvHR when an autoimmune-type
disease occurs, are analysed in chapter 8. The last
chapter, dealing with studies on regulation (chapter 9),
describes the experiments undertaken to determine at what
stage in mucosal B cell differentiation the GvHR exerts its
effect.
The final two chapters concentrate on the mucosal and
systemic immune responses to . clinically relevant dietary
proteins both in normal mice, and mice with a GvHR.
-4-
CHAPTER ONE




The mucosal surface of the gastrointestinal tract is
involved in the absorption of dietary nutrients, but
perhaps more important, is its function as a barrier
against the constant pervasion of potentially antigenic
material . A wide range of antigens may be encountered
within the gut; these include ingested proteins, commensal
microorganisms and visiting pathogens such as bacteria,
viruses, protozoa and helminths.
While maintaining a tolerance to dietary proteins and
commensal microorganisms, and allowing absorption of
essential nutrients, the gut must be able to mount a rapid,
isolated and efficient immune response to the invading
pathogen. This ability lies in the close association
between the mucosa and the gut-associated lymphoid tissue
(GALT) and the range of mucosal immune responses that can
occur within the GALT.
The intestinal mucosa is composed of an inner epithelial
layer in direct contact with the gut lumen, an outer layer
of connective tissue (the lamina propria), and finally the
muscularis mucosae which separates the mucosa from the
submucosa (reviewed in Trier and Madara, 1981).
The GALT, the largest immune compartment in the body, is
composed of lymphoreticular cells within the epithelial
layer, the lamina propria, the organised lymphoid
aggregates (Peyer's patches) situated along the length of
the intestine, and the draining mesenteric lymph node
(MLN).
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This chapter will concentrate on the induction and
immunoregulation of the mucosal immune response within the
GALT, oral tolerance induction to enterically presented
antigens, and the relationship between mucosal immunity and
oral tolerance.
INDUCTION OF A MUCOSAL IMMUNE RESPONSE
The induction of the mucosal immune response requires the
initial uptake of antigen across the gut wall, and
subsequent presentation to mucosal effector cells.
Peyer's patches (PP) are generally believed to be the main
sites of engagement of antigens with the lymphoid system of
the gut, and of induction of the immune response. However
recent evidence suggests that the villus enterocyte may be
an important site of antigen presentation and
immunoregulation. Both theories will be reviewed.
ANTIGEN PRESENTATION WITHIN THE PEYER'S PATCH
PP, present in all mammals, are organised lymphoid
follicles distributed along the length of the small
intestine, with the greater number positioned distally.
Lymphoid aggregates, similar to PP but without an organised
structure, are also found the length of the intestine
including the large bowel.
In man, approximately 240 PP are present at puberty, and
this number declines with age (Cornes, 1965). In mice and
rats 8-10 PP can usually be determined in each animal.
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The structure of the Peyer's patch
The structure of the PP is comparable to that of other
lymph nodes, however, the PP is not encased in a capsule
and does not have an afferent lymph system.
Each patch is composed of a dome region, lymphoid follicles
(B cell zone) and a parafollicular region (T cell zone).
The dome region consists largely of T and B lymphocytes and
macrophage (Carlson and Owen, 1987). Enzymatic treatment of
PP releases equal numbers of T and B cells. 85-92% of B
cells are surface (s) sIgM+, the remainder being sIgA+
(Frangakis et al, 1982; Kiyono et al, 1982a). The mature T
cells are predominantly T helper cells bearing the Lyt-1+
(40-50%) and the L3T4 + (57-63%) surface markers, however
15-20% of PP T cells bear the T suppressor/cytotoxic, Lyt-
2+ surface marker (reviewed Mestecky and McGhee, 1987).
The germinal centres of the follicles are the sites of
antigen induced T-dependent B cell differentiation.
Follicle-associated epithelium
The important feature of the PP is the specialized
epithelium overlying the dome region. The columnar
follicle-associated epithelium (FAE) is derived from the
same crypt stem cells as the adjacent patch-associated
villi (PAV), however it possesses important characteristics
which enable it to transport antigen. For example, mature
goblet cell numbers are reduced in FAE as compared to the
adjacent epithelium (Bockman and Cooper, 1973) and there is
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greater contact between antigen and epithelial cells due to
the relative absence of mucus. The most important feature
is the presence of specialized antigen transport cells, M
cells, which are interspersed among the columnar epithelial
cells of the FAE (Owen and Jones, 1974).
M cells have microfolds or irregular shaped microvilli on
their surface (Owen and Jones, 1974; Carlson and Owen,
1987), and lymphocytes, accessory cells and PMN within the
central, basal indentation (Owen, 1977). There is
substantial evidence to suggest that M cells are the cells
through which luminal antigens are sampled and introduced
to the PP effector cell environment. Horseradish peroxidase
(HRP) (Owen, 1977) and the lectins, Ricinus communis
agglutinin II and wheat germ agglutinin (Neutra et al,
1982) have all been shown to adhere to M cells and be
transported into the PP. Similarly M cell transport of
viruses such as reovirus II (Wolf et al , 1983 ), and
bacteria such as Vibrio cholerae (Owen et al, 1986) has
been demonstrated.
It is unknown however if M cells are capable of antigen
presentation.
Antigen presentation in the Peyer's patch
Before their recognition by T lymphocytes, soluble antigens
reguire processing by antigen-presenting cells (ie.
macrophages or dendritic cells), and re-expression on the
cell surface in association with the MHC gene products
(Shimonkevitz et al, 1983).
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Macrophages are present in the PP, however their low
expression of all types of Fc receptors (FcR), and la
antigens (Vetvicka et al, 1987), and their inability to
effectively present antigen (Barr et al, 1985) suggests
they are not directly involved in presentation of antigen.
They do however appear to have a phagocytic role and
phagocytosis of ferritin (Lause and Bockman, 1981), latex
particles (Vetvicka et al, 1987 ), and Giardia trophozites
(Owen, Allen and Stevens, 1981) have been demonstrated.
A non-adherent accessory cell population, dendritic cells
(DC), has been extracted from PP (Mayrhofer, Pugh and
Barclay, 1983; Barr et al, 1985). DC are found in the skin
(Langerhan's cells) and there they play an important role
in antigen presentation. In the PP, cells with a dendritic
morphology occur in very low numbers (Barr et al, 1985).
Nevertheless, a non-adherent population extracted from PP
are capable of presenting ovalbumin (OVA), human gamma¬
globulin (HGG) and purified protein derivative (PPD) to
sensitized lymph node cells and to antigen-specific T cell
clones (Barr et al, 1985). PP DC are Ia+ indicating their
state of activation (Mayrhofer et al, 1983). In culture,
the interaction between both PP and splenic B cells with a
PP DC-T cell mixture produces a significant polyclonal
secretion of IgA, which may indicate the importance of DC
in the induction of a mucosal immune response.
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IMMUNOREGULATION OF THE MUCOSAL IMMUNE RESPONSE
The PP is widely recognised as the preferential source of
IgA+ B cells, and the site of induction and differentiation
of B cells after enteric antigen stimulation (Craig and
Cebra, 1971). There are two prominent theories as to why
the GALT is so rich in IgA+ B cells.
One theory suggests that the persistent presentation of
antigen, occurring at the PP surface, drives a continuous
cell division of PP B cells which in turn leads to a
vectorial deletion of heavy-chain C-region-encoding genes.
A B cell population is thus arrived at with the ultimate
heavy-chain C-region (Calpha) characteristic of IgA B
cells. The theory of antigen dependent B cell
differentiation is at odds however with the current
understanding of IgA B cell differentiation. In particular,
are the aspects concerned with the molecular biology of
immunoglobulin (Ig) genes. Although the gene encoding alpha
heavy-chain C-region is the ultimate in the murine system,
in humans one alpha heavy-chain C-region is in the middle
of the gene sequence and one at the end, hence in the human
model, continuous gene deletion would not lead inevitably
to IgA expression. Similarly, the theory predicts that
during some stage in the development of an IgA response, B
cells would express IgG and then switch to IgA production.
However cells bearing slgG and slgA have never been
observed (reviewed in Strober and Jacobs, 1985).
The second theory, and the one more readily accepted,
suggests that the differentiation of B cells into IgA
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producing plasma cells is completely under T cell
regulation.
T CELL REGULATION OF IGA B CELL DIFFERENTIATION.
There is now guite substantial evidence supporting T cell
regulation of IgA B cell differentiation and two important
stages have been defined.
The initial stage involves isotype-switching of sIgM+ PP B
cells to sIgA+ B cells and the second stage is the terminal
differentiation of sIgA+ PP B cells into IgA-producing
plasma cells (Fig 1:1).
Isotype-switching during IqA B cell differentiation
The definition of an IgA-specific isotype-switch T cell
came largely from Kawanishi and co-workers studying
Concanavalin A (Con A) stimulated cloned T cells, and their
effect on lipopolysaccharide (LPS)-driven B cells.
The co-culture of purified PP sIgM+ B cells with cloned PP
T cells has been shown to produce an increase in PP B cells
expressing slgA, with a simultaneous decrease in slgM4" B
cells. This isotype-switch did not occur in the presence of
cloned SP T cells, or when PP sIgG+ B cells were used
(Kawanishi, Saltzman and Strober, 1983a). The co-culture of
cloned PP T cells with SP sIgM+ B cells also produced an
isotype-switch to slgA expression, although to a lesser
extent. In addition the co-culture of sIgM+ B cells and
cloned T cells, both derived from the SP, resulted in an
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increase in slgG expression concomitant with a decrease in
sIgM+ B cells (Kawanishi, Saltzman and Strober, 1983a;
Kawanishi and Strober, 1983).
These results suggest that isotype-switching is T cell
dependent and that the origin of the T cell, not the B
cell, determines the expression of an isotype. Thus T cells
resident in the PP direct sIgM+ B cells to express slgA,
whereas splenic T cells direct sIgM+ B cells to express
slgG. The switch T cells do not act by causing
proliferation of cells which have reached the level of IgA
differentiation by random processes, but rather by acting
on B cells in such a way as to affect the course of DNA
rearrangement.
Importantly, the isotype-switch T cell does not induce
terminal differentiation of sIgA+ B cells, and thus no
increase in IgA synthesis occurs (Kawanishi, Saltzman and
Strober, 1983a).
Post-switch IqA B cell differentiation.
After PP B cells have undergone isotype-switching from
sIgM+ to become committed IgA+ B cells, they finally
undergo terminal differentiation to become IgA-producing
plasma cells.
Initial studies by Elson, Heck and Strober (1979) had shown
that Con A stimulated PP T cells were able to induce IgA
synthesis while suppressing both IgG and IgM, indicating
that despite the absence of plasma cells within the PP, the
regulatory-effector cells were present.
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Further studies by Kawanishi and co-workers have shown that
after isotype-switching of PP B cells from slgA- to sIgA+,
in the presence of cloned PP T cells, the addition of MLN
or SP T cells or Lyt-2+-depleted T cell subsets or soluble
T cell products, induces IgA synthesis (Kawanishi, Saltzman
and Strober, 1983b; Kawanishi and Strober, 1983).
From these observations it would appear that the terminal
differentiation of IgA-committed PP B cells is either
activated in the PP or during the migration of the B cells
from the PP to the draining MLN and SP. The post-switch T
cell is a T helper cell but its mode of regulation is as
yet unclear.
T cell clones from human GALT (appendix) mediate both an
isotype-switch and terminal differentiation of IgA B cells,
whereas T cell clones from peripheral blood direct terminal
differentiation only (Benson and Strober, 1988); both
mechanisms were mediated by soluble factors.
FcalvhaR and IqA B cell terminal differentiation
Quite separate studies performed by Kiyono and co-workers,
again using cloned PP T cells, have demonstrated the
existence of a PP T helper cell bearing the FcalphaR which
selectively promotes terminal differentiation of slgA4" B
cells (Kiyono et al, 1982b; 1984).
T cells bearing the FcalphaR have been described in both
mice and humans (Strober et al, 1978; Lum et al, 1979).
In addition, the FcalphaR can be released as an IgA binding
factor (IBFalpha) which has been shown to both suppress
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(Yodoi et al, 1983), and enhance (Endoh et al, 1981; Suga
et al, 1985) IgA synthesis in pokeweed mitogen (PWM)-driven
SP B cell cultures. More detailed studies of free IBFalpha
have demonstrated that higher concentrations of this factor
suppress, while lower concentrations enhance, IgA responses
(Kiyono et al, 1985).
These findings suggest that the terminal differentiation of
sIgA+ B cells is regulated by T helper cells in an isotype-
specific manner, rather than by non-specific regulation as
indicated by Kawanishi and Strober (1983).
The IgA response to T cell-dependent antigens may further
be regulated, either upwards or downwards, by the presence
of IBFalpha.
Lymphokine mediated terminal differentiation
The initial work by Kawanishi and Strober (1983),
demonstrated that IgA synthesis can be promoted by the
addition of B cell differentiation factor (BCDF). BCDF is
now recognised as IL-6, a lymphokine involved in the
terminal differentiation of B cells into immunoglobulin-
secreting cells (Kishimoto and Hirano, 1988). Recent
studies of lymphokine production and IgA synthesis have
produced reasonable evidence that IL-5 is a "mucosal
lymphokine" (Harriman and Strober, 1987), in that it
preferentially enhances IgA synthesis from sIgA+ B cells
but not slgA- B cells, and is therefore important in IgA B
cell terminal differentiation (Harriman et al , 1988;
Matsumoto et al, 1989). IL-4 appears to enhance the action
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of IL-5 by two-three fold (Murray et al, 1987).
Recently, Mosmann et al (1986) described the existence of
two subsets of T helper cell clones that differ in their
pattern of lymphokine secretion. One type, Tjji/ secretes
IL-2, IL-3 and IFN-gamma, whereas the second type, TH2/
secretes IL-4 and IL-5. It is possible that the population
of T helper cells within the mucosa are predominantly of
the TH2 phenotype, which on activation release IL-4 and IL-
5 causing a predominantly IgA response.
The influences of T cell activation and lymphokine
secretion on immunoglobulin production within the mucosa
will be discussed in greater detail in the discussion
chapter of this thesis.
ANTIGEN PRESENTATION BY VILLUS ENTEROCYTES
The intestinal epithelium represents the barrier between
the gut lumen and the lymphoid system of the gut. The
position of the enterocyte, its absorptive function, MHC-
class II (la) expression, and close association with
intraepithelial (IEL) and lamina propria (LP) lymphocytes
indicates a pertinent role of the gut enterocyte in antigen
presentation and immunoregulation of a mucosal immune
response.
Intraepithelial lymphocytes
Approximately 15-20% of cells in the epithelium are
lymphocytes. The IEL are a heterogeneous population, and
although sharing surface antigens with T lymphocytes, no T
lymphocyte marker encompasses the whole IEL population in
any species (reviewed Mayrhofer, 1984). There are no B
cells, plasma cells or macrophages found within the
epithelium.
The IEL population are located in the basal one-third of
the epithelium at the basement membrane of the enterocyte,
and can be found crossing this membrane in either direction
(Toner and Ferguson, 1971).
The majority of IEL carry the T suppressor/cytotoxic (CD8+)
surface marker, with less than 15% possessing the T cell
helper/inducer (CD4+) surface marker (Dobbins, 1986; Mowat,
1987a) . In the mouse, a population of IEL bear the CD3-
associated gamma-delta T cell receptor, as opposed to the
alpha-beta T cell receptor. The function of this
phenotypically diverse population is as yet unclear.
Interestingly, approximately half of the CD8+ IEL do not
express Thy 1 on their cell surface which is unprecedented
for murine T cells (Bonneville et al, 1988; Goodman and
Lefrancois, 1988).
In vitro studies have shown that rodent IEL have cytotoxic
T lymphocyte (CTL) activity (Davies and Parrott, 1981) and
natural killer (NK) cell activity (reviewed in chapter 2).
They can secrete minimal amounts of IL-2, and intermediate
amounts of IFN-gamma and IL-3 on in vitro stimulation with
Con A (Dillon, Dalton and MacDonald, 1986). Other in vitro
studies have demonstrated a poor proliferating capacity of
murine IEL in response to phorbol esters and calcium
ionophores, both powerful stimulators of cell proliferation
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(Mowat, Mclnnes and Parrott, 1989). The authors suggested
that IEL are IL-2 unresponsive and their poor proliferative
response is because the cells are fully activated in situ.
Certainly, murine IEL have been shown to express markers
associated with T cell activation, such as CTl (Klein,
1986; Lefrancois, 1987) and human IEL have an activated
morphology in situ (Marsh, 1975a). It is possible that a
significant proportion of IEL are recently derived from a
rapidly dividing precursor pool (Marsh, 1975b; Ropke and
Everett, 1976) most probably from the LP. In this respect,
Monk et al, (1988) have shown that in situ activation of LP
T cells in human foetal intestine culture, using the T cell
activator anti-CD3 antibody, produced an increase in IEL
numbers/100 epithelial cells 1-3 days after culture. Only
LP T cells were found to be activated, as determined by the
presence of the CD25 surface marker, and the authors
suggested that the IEL were activated T cells which had
migrated from the LP.
The in vivo cell effector function of IEL has not yet been
elucidated. However, raised IEL counts are found in
experimental cell-mediated immune (CMI) responses such as
in graft-versus-host reactions (GvHR) (see chapter 2) and
allograft rejection (MacDonald and Ferguson, 1976) and in
clinical disorders associated with intestinal inflammation
such as coeliac disease (Ferguson, 1974) and cow's milk
protein intolerance (CMPI) (Phillips et al, 1979).
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Class II expression on intestinal epithelium
Expression of MHC class II molecules on intestinal
epithelium has been described in guinea pigs (Wilman et al,
1978), mice (Parr and MacKensie, 1979), rats (Mason,
Dallman and Barclay, 1981) and humans (Scott et al, 1981).
This constitutive expression is confined to the small
intestine, and is not normally displayed in the large
bowel. In rat intestinal epithelium, as with other species,
the class II (la) molecules are expressed on the mature
enterocyte in the distal two-thirds of the villi, with no
constitutive expression on the crypt stem cells (Mayrhofer
et al, 1983). The molecule is restricted to the basolateral
membrane (Bland and Warren, 1986).
An increased expression of la on villus enterocytes occurs
during intestinal inflammation both in experimental animals
and clinical disease (see chapter 2).
The association of IEL with the la molecule has raised the
interesting possibility that epithelial cells may perform
class II-dependent genetically restricted transport and
presentation of luminal antigens to IEL.
Antigen presentation by villus enterocytes
Presentation of OVA by villus enterocytes, to primed lymph
node T cells has been shown to induce proliferation of the
T cells after 18hrs in co-culture. This accessory function
of the enterocytes was la-restricted as determined by
blocking with monoclonal anti-sera (Bland and Warren,
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1986). Similarly class II-restricted presentation of
tetanus toxoid to primed peripheral blood T cells by human
enterocytes has been demonstrated (Mayer and Shlien, 1987).
In both reports the authors demonstrated that T cells of
the suppressor/cytotoxic phenotype (MRC OX8+/CD8+) were
activated when antigen was presented in such a manner.
Using a class II negative cell line, Cerf-Bensussan et al,
(1984) showed that class II expression could be induced in
this cell line when cultured with Con A supernatants of
spleen cells or IEL. In vivo, the expression of la antigens
was associated with an increased IEL count. As with class
II induction in other cell types, the la-inducing factor is
most likely to be IFN-gamma.
The preferential induction/activation of CD8+ T cells
either in the LP or epithelium (IEL) may explain the
suppressive nature of the response to enterically presented
antigens. However a recent publication has described the
class II-restricted presentation of Keyhole limpet
haemocyanin (KLH), by mouse enterocytes, to a specific
class II-restricted (L3T4+) T cell hybridoma. This
presentation resulted in a production of IL-2 (Kaiserlain,
Vidal and Revillard, 1989).
There still remain many unanswered guestions as to the
ability of the villus enterocyte to present antigen and
influence the outcome of the immune response. The
hypothesis proposed by Bland (1985; 1988) is that the
enterocyte selectively absorbs luminal antigens in
endocytic vesicles, whereby antigenic fragments (epitopes)
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would become complexed to locally synthesized la molecules.
The complex would then be re-expressed on the lateral
epithelial cell membrane, and be presented to an adjacent
IEL. The IEL would then migrate into the LP where it would
exert a regulatory signal directing terminal
differentiation of immunoglobulin-secreting cells. The
regulatory T cells for IgA terminal differentiation are
autoreactive and may be activated by antigen in association
with MHC class II (la) molecules to release lymphokines
such as IL-4, IL-5 or IL-6 in situ.
Aicher et al (1989), have recently demonstrated IEL in
Balb/c mice which express mRNA for IL-5 in relatively high
amounts compared to SP T cells. This IEL population also
possessed IgA FcalphaR. Binding of IgA to this receptor
down-regulated the production of IL-5, which in turn down-
regulated the synthesis of IgA in an antigen-specific
manner.
Intra-PP (IPP) immunisation of rats with KLH results in a
population of antigen-specific T helper cells for IgA
(Dunkley and Husband, 1987). Interestingly, KLH-specific
IgA helper T cells were subsequently detected within the
IEL and LP populations. Unlike other forms of oral antigen
presentation, no SP suppressor cells were formed which
again suggests that enterocytic presentation of antigen is
involved in systemic suppression, while PP antigen




Intra-gastric presentation of antigen can result in a down-
regulation of both the systemic humoral and cell mediated
immune responses; a phenomenon recognised as oral
tolerance. Oral tolerance can be induced to a variety of
soluble proteins such as OVA (Hanson et al, 1977 ), gamma¬
globulins (Chiller, Habicht and Weigle, 1970), to
particulate antigens, such as sheep red blood cells (SRBC)
(Mattingly and Waksman, 1978), and to contact-sensitizing
agents (Asherson et al, 1977).
The degree of suppression depends on the dose of antigen
given, the freguency of administration, and the timing of
feeding relative to challenge with the antigen (Bienenstock
and Befus, 1980). In addition, the genetic background of
the animal is critical (Stokes, Swarbrick and Soothill,
1983; Mowat, Lamont and Bruce, 1987), as is the age of the
animal at the time of feeding. Neonatal mice fed OVA in the
first days of life are primed rather than tolerized
(Strobel and Ferguson, 1984), similarly aged mice are more
difficult to tolerize (Szewczuk and Wade, 1983).
Many different mechanisms have been implicated in the
induction and maintenance of oral tolerance. Serum factors
(which on transfer to naive recipients induce oral
tolerance) such as circulating immune complexes (Andre et
al , 1975 ), anti-idiotypic antibodies (Kagnoff, 1978 ),
tolerogenic forms of antigen (Strobel et al, 1983 ) which
have been intestinally processed (Bruce and Ferguson,
1986), have been reported.
Cellular control mechanisms have been extensively studied,
and although direct clonal anergy of T helper cells has
been demonstrated (Vives et al, 1980; Titus and Chiller,
1981), T cell mediated suppression seems to be the
predominant mechanism (Mattingly and Waksman, 1978; Miller
and Hanson, 1979; Mowat, 1985). Adoptive transfer of cells
from antigen fed animals into naive syngeneic recipients
demonstrates, in vivo, that T suppressor cells act on both
arms of the systemic immune response, and the cells act on
the afferent phase of the CMI response, as they are
effective only when transferred before or shortly after the
time of sensitization (Miller and Hanson, 1979).
The suppressor cells appear to be first stimulated within
the GALT, and are found within PP 3 days after feeding
antigen. By 7 days post-feed they have migrated to the SP
(Richman et al, 1981). However, oral tolerance to SRBC can
be induced in rats after surgical removal of PP (Enders,
Gottwald and Brendel, 1986). Although this procedure does
not eliminate the role of unorganised lymphoid aggregates
in oral tolerance induction, it does suggest, once again, a
possible role of enterocytic antigen presentation in oral
tolerance induction.
A number of mechanisms therefore are implicated in the
induction and maintenance of systemic hyporesponsiveness,
and within each experimental situation different mechanisms
may be in play.
In this final section the relationship between the systemic
and mucosal responses to orally presented antigens will be
discussed.
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SYSTEMIC TOLERANCE AND MUCOSAL IMMUNITY
There are conflicting reports as to the relationship
between mucosal immunity and oral tolerance. Prior feeding
of a tolerizing dose of OVA has been shown to reduce
subsequent absorption of that antigen, presumably a
function of local immunity, as well as induce systemic
hyporesponsiveness (Swarbrick, Stokes and Soothill, 1979).
In a more specific study, Challacombe and Tomasi (1980),
found that feeding OVA, or the particulate antigen Strep,
mutans, produced both a suppression of the systemic
response to either antigen and significant salivary
antibodies. The demonstration of antigen-specific T helper
cell activity for IgA anti-OVA and antigen-specific T
suppressor cell activity for IgG anti-OVA in PP after
feeding (Richman et al, 1981) explained the co-existence of
both responses.
It has been suggested by Green and Martin (1983), that the
maintenance of a mucosal immune response and oral tolerance
is under the regulation of the contrasuppressor T cell
(Tcs) network.
There are three cell types involved in the contrasuppressor
circuit, Tcs inducer (Lyt-1~2+,I-J+), Tcs transducer (Lyt-
l+2+, I-J+) and Tcs effector (Lyt-l+2~, I-J+) cells. The
Tcs effector cell can be positively selected on the basis
of its adherence to plastic dishes coated with the Vicia
villosa lectin (Gershon et al, 1981).
Murine PP are enriched in T cell subsets with helper
activity and with contrasuppressor activity (Green and
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Martin, 1983). The Tcs effector cell is believed to render
T helper cells resistant to suppressor signals (Green and
Martin, 1983), and when adoptively transferred to mice the
previously induced oral tolerance to SRBC can be abrogated
(Suzuki et al, 1986; Kitamura et al, 1987 ). An IgA response
is potentiated as the Tcs cells bear FcalphaR with which
they bind to isotype-specific T helper cells (Suzuki et al,
1986) .
These findings suggest that the contrasuppressor T cell
network preferentially protects the mucosal IgA response
from suppressor signals, but not the systemic IgG and IgM
responses. In this way orally encountered antigens can
induce protective immunity and systemic tolerance.
In complete contrast, Elson and co-workers have provided
substantial evidence that mucosal immunity and oral
tolerance do not occur simultaneously, but exist in a
reciprocal relationship.
Using a method for sampling intestinal contents and
directly measuring secretory antibody responses (Elson,
Ealding and Lefkowitz, 1984) these workers found that while
KLH induced systemic hyporesponsiveness when given orally,
there was no detectable IgA response in the gut contents
(Elson and Ealding, 1984ab). However when KLH was fed
concomitantly with Cholera Toxin (CT), a recognised
immunopotentiator of an IgA response, the oral tolerance to
KLH was abrogated and an IgA response, both to CT and KLH,
was stimulated (Elson and Ealding, 1984b). Further in vitro
studies of both SP anti-CT and PP anti-CT antibody
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production demonstrated that the induction of both the
mucosal IgA response and the systemic IgG response
originated in the GALT and then disseminated to other
tissues.
CT is a potent immunogen of both the systemic and mucosal
immune responses (Elson and Ealding, 1984ab; Lycke and
Holmgren, 1986), however the way in which CT affects the
immunoregulatory network of the immune response is as yet
unclear. In vitro studies have shown that CT induces IL-1
production from antigen presenting cells, but not
expression of la antigens, increased B cell proliferation
and production of IgG and IgA from activated B cells, and
either inhibition or stimulation of T cells (Lycke et al,
1989 ) .
This combination of effects of CT on the important cells
within the mucosal immunoregulatory network may favour an
up-regulation of T helper cells and down-regulation of
systemic T cell-mediated suppre s sion; abrogation of
systemic hyporesponsiveness and the induction of a
secretory response would thus be the end result and
unrelated antigen presented to the GALT at this time, would
produce the same response. CT however is an atypical
antigen and one must be careful in drawing analogies
between its effects on the mucosal response and that of
other proteins.
A breakdown in oral tolerance is an important factor in the
immunology of food hypersensitivities such as coeliac
disease and CMPI, and although an increase in secretory
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antibody does occur, the important clinical manifestation
is an antigen-specific delayed-type hypersensitivity (DTH)
response in the gut. In this respect animal studies have
shown that feeding of OVA, after the abrogation of oral
tolerance, can lead to a DTH response in the gut
manifesting in crypt hyperplasia and IEL infiltration.
This reaction only occurs when T suppressor cells are
depleted or APC are activated (Mowat, 1987b), or after
challenging mice whose first encounter with OVA was during
the neonatal period (Strobel, 1983).
The intestinal GvHR is an animal model of a DTH response in
the gut (reviewed in chapter 2), and although not specific
to a dietary protein, the manifestations are similar to
those found in clinical enteropathy.
The effects of the local DTH response and T cell activation
on the mucosal immune response is the subject of this
thesis.
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IgA synthesis at Mucosal sites
FIGURE 1:1 T cell regulation of IgA B cell differentiation
in GALT.
(adapted from Mestecky and McGhee, 1987)
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CHAPTER TWO
THE GRAFT-VERSUS-HOST REACTION MODEL
In this chapter I shall review the literature on the Graft-
versus-host reaction (GvHR). The review will be
predominantly concerned with the reaction in animals.
However, the GvHR is clinically important and where
appropriate the consequences of the reaction in humans will
be described. The first section will detail the general
consequences of a systemic GvHR, and the cellular and
genetic basis of the reaction. In the second section I
shall review the intestinal GvHR.
INTRODUCTION
The demonstration and description of the GvHR came in the
1950s and 1960s from studies of transplantation immunology
and immunological tolerance. While studying tolerance
induction in mice, Billingham and Brent (1957) found that
in certain strain combinations the injection of spleen
cells from one strain into newborn mice of another produced
alarming mortality rates. In some animals the attack was
acute, whereas in others, the disease manifested in a
chronic form, and mice became undersized runts with
retarded growth and development before eventual death.
With the discovery of the immunologically competent
lymphocyte and its recirculation properties (Simonsen,
1960 ; Gowans, 1962 ), it was soon recognised that this
"runting disease" was the end result of introducing graft
lymphocytes which had the ability to react against the
foreign antigens of the host: hence the Graft-versus-host
reaction (Simonsen, 1962).
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The mature T cell is responsible for the induction of a
GvHR (Cantor, 1972) and stimulation of the donor T cells by
the differing host MHC antigens, and/or non-MHC antigens
results in a complex series of events affecting both
lymphoid and parenchymal organs.
While the GvHR in animals provides an excellent model for
investigating MHC-restricted cellular reactions, Graft-
versus-host disease (GvHD) is a serious clinical problem in
bone marrow transplant (BMT) patients, and in 5-10% of
cases GvHD is associated with fatal complications (Tsoi,
1982 ) .
GRAFT-VERSUS-HOST DISEASE IN MAN
There are two forms of GvHD in bone marrow transplant
patients; acute and chronic. Acute GvHD occurs in 30-50%
of BMT patients within 3 months of transplantation
(Renkonen, 1987) and is a primary or contributory cause of
death in 15-40% of patients (Gale, 1985). The target organs
are the skin, liver, gastrointestinal tract and lymphoid
tissue. Chronic GvHD can affect 15-50% of patients who have
survived 180 days post-transplantation, and is often a
transition from the acute form (Graze and Gale, 1979).
However in 20-30% of cases chronic GvHD may develop without
a previous acute reaction (Gale, 1985). Effects are seen
in skin (Siimes, Johansson and Rapola, 1977), mouth,
oesophagus, (McDonald et al, 1981) and liver (Sullivan et
al, 1981).
A spectrum of immunological disorders have been described;
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these include B cell hyperplasia, hypergammaglobulinaemia,
immune complex deposition and autoantibody production
(Shulman et al, 1980), and are suggestive of an autoimmune-
type disease. In contrast to the autoimmune-type
reactivity, a decreased ability to produce an immune
response to exogenous antigens occurs, resulting in
recurrent and often fatal bacterial infections (Atkinson et
al, 1979).
EXPERIMENTAL GRAFT-VERSUS-HOST REACTIONS IN ANIMALS
The outcome of an experimental GvHR in animals depends on
the strain combinations used and the immune status of the
host.
The reaction can be divided into a proliferative phase and
an effector phase (Klein, 1976), and the evolution of
either phase depends on the animal model under
investigation.
In irradiated hosts there is an initial proliferative phase
during which the donor cells are induced to proliferate
after stimulation by differing host cell membrane antigens.
This is followed by an effector phase characterised by the
generation of donor derived effector lymphocytes that can
attack and destroy host tissue.
During the proliferative phase in the semi-allogeneic GvHR
in F-^ hybrid hosts, alloactivation of donor cells occurs,
followed by a non-specific activation of host cells. The
consequences of this activation depend on the genetic
differences between the donor cells and the recipients.
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In both cases the proliferative phase leads to an
enlargement of spleen and lymph nodes and the progression
of the reaction can be monitored by the splenomegaly assay
(Simonsen, 1962).
The severity of the effector phase is usually monitored by
changes in body weight, mortality rate or cumulative
mortality (Bril and Benner, 1985).
The animals most commonly used in experimental GvHR are
mice and rats .
The two models most widely studied are:-
i) reconstitution of irradiated hosts with semi-allogeneic
or allogeneic donor cells (referred to in the text as GvHR
in irradiated hosts), and,
ii) a semi-allogeneic GvHR produced by injection of parent
cells into hybrid hosts, (referred to as a semi-
allogeneic GvHR in hybrids).
Both models produce a distinctive pathology. The systemic
effects in each model will be discussed separately below.
Due to the nature of the intestinal GvHR, both models will
be discussed in conjunction in that section.
General consequences of a GvHR in irradiated hosts.
The reconstitution of irradiated hosts by a graft
containing high numbers of T cells results in death within
30 days (reviewed Bril and Benner, 1985). This acute
reaction affects the skin, liver, gastrointestinal tract
and lymphoid system. The skin is the initial target and
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lesions range in severity from a mild rash and epidermal
necrolysis, to a loss of epidermis. Liver damage can
result in hepatocellular necrosis or bile duct injury. The
intestinal lesions will be discussed in full below.
A delayed form of GvHR can occur when bone marrow grafts,
considered T cell depleted, are contaminated with either
relatively low numbers of mature T cells (Lowenberg et al,
1977), or immature T cells and haemopoietic stem cells
which mature under the influence of the host thymus
(Goedbloed and Vos, 1965 ; Wolters et al, 1979 ). The
clinical features of delayed GvHR are not well documented,
but it is reported to have an almost 100% mortality rate
(Bril and Benner, 1985).
General consequences of a semi-alloqeneic GvHR in F1
hybrids.
The semi-allogeneic GvHR induced in the parent to F-^ hybrid
model can produce an acute and a chronic form.
The acute form of the reaction is characterised by
pancytopenia, aplastic anaemia and hypogammaglobulinaemia.
This phase of suppressive pathology is often preceded by a
brief phase of stimulation depending on the strain
combinations used (Rolink, Pals and Gleichmann, 1983;
Rolink and Gleichmann, 1983; Pals, Radaszkiewicz and
Gleichmann, 1984a; Pals, Gleichmann and Gleichmann, 1984).
Specific lesions are detectable in the gut and these will
be described in full below.
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The chronic phase of this GvHR produces a stimulatory
pathology with B lymphocyte hyperplasia leading to
hypergammaglobulinaemia and the formation of
autoantibodies. Characteristics of systemic lupus
erythematosus (SLE) such as antibodies against nuclear
antigens, double-stranded DNA, erythrocytes and thymocytes
have been described (Gleichmann, Van Elven, and Van der
Veen, 1982). Symptoms often include severe immune complex
glomerulonephritis and deposition of immunoglobulins along
the basement membrane of the skin, suggestive of collagen
vascular disease. Injury to the liver is also observed.
(Gleichmann et al , 1984 ). In certain parent to
combinations the acute form may precede the chronic form.
GENETIC BACKGROUND TO THE GRAFT-VERSUS-HOST REACTION
Major histocompatability complex antigens and GvHR.
The strongest proliferative response, as measured by the
splenomegaly assay, occurs when the donor and host cells
differ at the class II, H-2I region of the MHC (Klein and
Park, 1973 ). The main loci of stimulation is the I-A
subregion (Klein, 1976). Disparities at the H-2K/D region
produce a weak proliferative response, whereas mutations in
the H-2K or H-2D region have a strong proliferation-
inducing capacity (Klein and Egorov, 1973).
With regard to the effector phase, the most severe
reactions, as measured by 100% cumulative mortality, occur
across an entire H-2 disparity or H-2K plus H-2I (I-A)
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disparity. A less severe mortality rate occurs in H-2K, I
or D singular disparities (Klein, 1976).
In man the strongest GvHR occurs across an HLA-D/DR
incompatability which is analogous to the class II
disparity in animals.
Class III products do not participate in the GvHR.
Non-Major histocompatabilitv complex antigens and GvHR.
A lethal GvHR can occur across an H-2 identical, non-H-2
disparity in irradiated recipients (Korngold and Sprent,
1983). This type of GvHR is obviously clinically important
in BMT patients receiving HLA-matched bone marrow cells.
The outcome of non-H-2 incompatable GvHR depends on where
the incompatability lies, and on there being at least three
minor H antigen differences (Korngold and Sprent, 1987).
Non-MHC antigen products of the MLS locus in mice, MLSa,
MLSd and MLSe, are strongly stimulatory in the mixed
lymphocyte culture assay, whereas MLSc is intermediate and
MLSb not at all (Festenstein, 1973; Coutinho et al, 1977).
In the vast majority of H-2 compatable, non-H-2
incompatible strain combinations, the GvHR is directed by




T cells can be divided into two distinct subsets according
to differences in phenotypic expression and function, and
in using monoclonal antibodies directed against surface
markers, individual T cell subsets can be isolated for
investigation.
T helper cells are now recognised as CD4+ and T
suppressor/cytotoxic cells as CD8+. However in past
research other antibody markers were used, and T helper
cells were recognised as Lyt-l+2~ and T
suppressor/cytotoxic cells as Lyt-1~2+ (Shiku, Kisielow,
Bean, 1975; Cantor and Boyse, 1975). More recently the Lyt-
1 surface marker was found to be present on all mouse T
cells (Ledbetter et al, 1980), and the monoclonal antibody
to the L3T4 molecule (Dialynas et al, 1983) has facilitated
the separation of T cells into two non-overlapping
populations; L3T4+ and Lyt-2+. Except for isolated T cell
clones (Fink, Rammensee and Bevan, 1984) expression of both
molecules by peripheral T cells is rare.
Lyt-l+2~/L3T4+/CD4+ T cells are helper cells for B cell and
DTH reactions. They are class II (I-A, I-E) MHC-
restricted, both in recognising antigens and alloantigens.
Lyt-1~2+/CD8+ T cells are predominantly cytotoxic cells
and are class I (H-2K/D) MHC-restricted.
The induction of GvHR is caused by mature T cells (Cantor,
1972), and in the following section the role of individual
T cell subsets in GvHR will be discussed. The nomenclature
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of the T cell subsets will be that used by the authors
whose work is cited.
T cell subsets and GvHR in irradiated hosts.
The original studies analysing the role of Lyt-1+ and Lyt-
2+ T cells in GvHR in irradiated mice produced conflicting
results. Vallera, Soderling and Kersey (1982) found Lyt 1+
T cells to be responsible for a lethal GvHR across a
complete H-2 complex disparity, while Jadus and Peck
(1983), described cytotoxic T cells as the predominant
subset. Using the L3T4+ and Lyt-2+ T cell markers, Korngold
and Sprent ( 1985), found that a GvHR in irradiated mice
directed against the complete H-2 complex was induced by
L3T4+ T cells, confirming the original findings of Vallera
et al, (1982) .
In the class I (H-2K or D) mismatched GvHR, Piguet (1985),
detected only Lyt-2+ T cells in the recipient. Conversely,
in the class II (I-A or I-E) mismatched GvHR, Jadus and
Peck (1983), found that Lyt-2+ T cells were not involved.
However both Lyt-1+ and Lyt-2+ T cells have been isolated
from recipients with a class II disparate GvHR (Piguet,
1985). Using the L3T4+ T cell marker, Sprent et al, (1986)
showed that L3T4+ T cells are able to mediate a class II
mismatched GvHR, with no detectable effect by Lyt 2+ T
cells. Similarly, in rats, T helper cells with the W3/25
surface marker are very potent inducers of GvHR (Mason,
1981).
Lyt-2+ T cells are also fully capable of mediating GvHR
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independently but only across an allelic or bml mutant H-2
K/D difference (Korngold and Sprent, 1985).
This MHC-restricted function of both L3T4+ and Lyt-2+ T
cells has also been demonstrated in in vitro assays
(Sprent and Schaefer, 1985).
T cell subsets and GvHR in F1 hybrid hosts.
The parent into hybrid GvHR mouse model provides more
evidence regarding the role of each T cell subset in the
eventual outcome of the GvHR.
The persistent B cell hyperplasia and autoantibody
production as described in the chronic form of this GvHR
model is produced by Lyt-1+ T cells activated by a class II
(I-A) disparity (Van Rappard Van der Veen, Rolink and
Gleichmann, 1982; Rolink et al, 1983).
The induction of the suppressive acute GvHR reguires both
Lyt-1+ and Lyt-2+ T cells with a difference at both class I
and class II MHC regions in the F-^ recipient (Rolink et al,
1983) .
Interestingly, in the (C57B1/10 x DBA/2) BDF^ mouse strain,
introduction of C57B1/10 parental cells into the BDF
recipients produces a suppressive-type GvHR which is
preceded by a brief initial stimulatory phase of
alloactivation. This occurs in the first 2 weeks. The
alloactivation of Lyt-1+ donor cells produces a transient
proliferation with B cell activation. This phase is
followed by alloactivation of donor Lyt-2+ T cells and the
suppressive pathology (Rolink et al, 1983; Pals et al,
1984ab).
The induction of a GvHR with DBA/2 parental cells, produces
a stimulatory reaction. Only donor T helper cells are
recovered from the recipients and no or only a few F
specific donor T suppressor/cytotoxic cells (Gleichmann et
al, 1984). The lack of Lyt-2+ T cells in the DBA/2 induced
GvHR has been attributed to an inadequate number of
functioning Lyt-2+ T cells in the donor inoculum (Via,
Sharrow and Shearer, 1987).
This information suggests that the L3T4+ T cells are
involved in the proliferative and stimulatory reactions
occurring during the GvHR, while Lyt-2+ T cells are
involved in the effector mechanisms, such as suppression of
the host immune system and damage of the host tissue.
MECHANISMS OCCURRING DURING THE GRAFT-VERSUS-HOST REACTION
There are a range of anti-host reactions that occur during
the GvHR depending on the animal model under investigation.
Cytotoxic T cell activity, helper T cell activity,
suppressor T cell activity, DTH responses, effects on
immunoglobulin and antibody production, NK cell activity
and enhanced class II (la) expression have all been
described, and are detailed below. Those activities
important in the intestinal GvHR will be discussed in the
second section of this chapter, while the effects on
systemic T and B cells will be discussed below.
-38-
Anti-host delayed-type hypersensitivity responses in the
irradiated host.
During the GvHR in irradiated mice a DTH response, directed
against host histocompatability antigens, may occur.
The degree of anti-host DTH reactivity can be determined in
an in vivo assay by transferring lymphoid cells from the
irradiated recipient with GvHR into a nonirradiated naive
host, syngeneic to the original GvHR donor. This animal is
then challenged in the right hind footpad with spleen cells
syngeneic with the original irradiated recipients. The
anti-host DTH response to the challenge cells is measured
as the difference in thickness of the footpad 24hrs later.
The early proliferation of mature donor T cells is reguired
for the anti-host DTH response to occur (Wolters and
Benner, 1978). The response is detectable, in irradiated
recipients, 1 day after the transplantation of spleen
cells, and peaks on day 4 (Wolters and Benner, 1973). It
is class II MHC-restricted, the I region antigens providing
the proliferative stimulus (Wolters and Benner, 1981). For
a maximum anti-host DTH response, H-2I alloantigens must be
presented with syngeneic H-2K/D molecules (Benner et al,
1985). In H-2 compatible and non H-2 incompatible strain
combinations no consistent anti-host DTH responses occur
unless the recipient has a disparity at a stimulatory MLS-
locus such as MLSa, MLSd or MLSe (Bril et al, 1984).
A long-lived recirculating population of T DTH effector
precursor cells (Bril et al, 1984), which are Lyt-l+2~, and
designated T2 cells (Cantor and Asofsky, 1972), are
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believed to be responsible for the anti-host DTH response.
A second population of short-lived, sessile spleen cells of
the Lyt-l"t"2+ phenotype and designated T1 cells are believed
to "amplify" the T2 response, although they are unable to
mediate an anti-host DTH response alone (Wolters and
Benner, 1981). T2 cells are activated by an H-2I region
disparity and T1 cells require H-2K/D antigens to elicit
their amplifier effect (reviewed Benner et al, 1985).
T cell synergism may not be dependent on direct cell
contact, but may be mediated by soluble factors released
from the activated cells.
Suppressor T cells, able to suppress both the induction of
the anti-host DTH response as well as already activated
anti-host T DTH effector cells, can be selectively induced
by intra-venous preimmunisation of spleen or bone marrow
cell donors with recipient type irradiated allogeneic
lymphoid cells (Bril and Benner, 1985). The suppressor
cells are long-lasting, are of the Lyt-2+ phenotype, and
require proliferation in order to display their effect.
Although H-2 identity between donor and host cells is
required to activate the T suppressor cells, they are able
to mediate both alloantigen specific and alloantigen non¬
specific suppression (Benner et al, 1985).
Anti-host cytotoxic responses in irradiated hosts.
The sensitization of donor cells to host histocompatability
antigens during a GvHR in irradiated mice or rats has been
shown to activate cytotoxic T cells (CTL) (Cerottini,
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Nordin and Brunner, 1971; Singh, Sabbadini and Sehon, 1972;
Mowat et al, 1988). Anti-host CTL specifically lyse host
target cells, and this activity may contribute to the host
tissue damage that occurs during the GvHR.
The specific anti-host cytotoxic activity can be assessed,
C I
in vitro, by measuring the release of Cr from labelled
tumour target cells cultured with cells from the GvHR
recipient (Borland, Mowat and Parrott, 1983).
Lyt-2+ CTL are class I MHC-restricted and in a class I
directed GvHR or non H-2 incompatibility they are potent
mediators of the disease.
Lyt-2+ T cells and specific anti-host CTL are detectable in
the spleens of irradiated mice 4-6 days post¬
transplantation of donor cells (Cerottini et al, 1971;
Singh et al, 1972; Mowat et al, 1988). Donor-derived CTL-
precursors are also detectable in the thymus, and although
initially few in number their numbers start to increase
between 10-20 days after bone marrow transplantation
(Ceredig and MacDonald, 1982).
The ability of Lyt-2+ T cells to produce a lethal GvHR in
the absence of L3T4+ T cells suggests that in certain
strain combinations Lyt-2+ T cells are able to function
without exogenous help from L3T4+ T helper cells or
recombinant (r)IL-2 (Sprent et al, 1986).
A GvHR elicited across a class I MHC disparity appears in
a more chronic form (Piguet, 1985), and in mice
transplanted with donor-marrow and Lyt-2+ T cells,
mortality normally occurs 6-8 weeks post-transplantation
(Sprent and Korngold, 1987). If however, animals are
simultaneously injected with rIL-2 or L3T4+ T cells of the
donor type, death occurs more quickly. Transfer of L3T4+ T
cells with host type marrow produces a very acute mortality
due to the CTL activity against the host cells (Sprent and
Korngold, 1987).
Anti-host cytotoxic responses in F1 hydrid hosts
Kubota, Ishikawa and Saito (1983) described the presence of
CTL in nonirradiated GvHR in mice, however, Borland et
al (1983) were unable to detect CTL in their animal
model.
An immunostimulatory GvHR is characterised by a complete
absence of Lyt-2+ T cells, with donor cells almost entirely
of the T helper phenotype. Conversely in the suppressive
GvHR, Lyt-2+ T cells are the predominant phenotype (Rolink
and Gleichmann, 1983). The absence of anti-host CTL
activity allows the continuous presentation of antigen to
donor L3T4+ T cells thus resulting in non-specific help for
F-^ B cells, and the immunostimulatory features.
The anti-host CTL activity in certain mouse Fhybrid
combinations is believed to be under suppression. This has
been shown in vitro (Shearer and Polisson, 1980; Hurtenbach
and Shearer, 1983; Langlade Demoyen and Larsson, 1986) and
appears to be effective at an early stage of the CTL
differentiation pathway (Langlade Demoyen and Larsson,
1986 ) .
Non-specific cytotoxic activity, NK cell activity, has also
been described in both irradiated (Mowat et al, 1988) and
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nonirradiated hybrid mice with GvHR (Borland et al,
1983; Pattengale et al, 1983). Due to the importance of NK
cell activity in intestinal GvHR, this topic will be
discussed later in the chapter.
Effects on B cells during the GvHR in F1 hybrid hosts
An important immunological feature of both acute and
chronic stimulatory GvHD, in BMT patients and certain semi-
allogeneic F-^ hybrid murine models, is the phase of B cell
hyperplasia which may result in hypergammaglobulinaemia and
autoantibody production.
In the brief phase of alloactivation occurring in class I
plus class II MHC-restricted GvHR in mice, there is an
initial phase of lymphoproliferation (Gleichmann et al,
1984), and increased numbers of plasma cells in the
medullary areas of peripheral lymph nodes, and spleen have
been reported (Lindholm, Rydberg and Stannegard, 1973;
Rolink et al, 1982). By day 14, the plasma cells are still
present, but in lower numbers (Lindholm et al, 1973)
reflecting, possibly, the alloactivation of T suppressor
cells and the onset of a suppressive GvHR (Rolink and
Gleichmann, 1983).
An increase in host immunoglobulins has been reported in
the serum of nonirradiated F^ mice (Lindholm et al, 1973)
and in the liver of irradiated rats transplanted with
allogeneic bone marrow cells. In the latter case a
decrease in immunoglobulin-producing cells was observed
later in the GvHR (Renkonen, Wangel and Hayry, 1986).
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In acute GvHD in BMT patients there is a sharp, transient
increase in IgE levels in serum (Ringden, Persson and
Johansson, 1983). Similarly, increased IgG-, IgM- and IgA-
plaque-forming cells (PFC) have been reported in BMT
patients, within the first 4 weeks post-transplantation,
followed by a significant decrease, during weeks 6-12 post¬
transplantation, of IgM- and IgA-PFC. Long-term survivors
had significantly reduced IgM (Ringden et al, 1987).
In the chronic form of GvHR in mice there is an increase in
IgM- and IgG-secreting cells in the spleen, and although
the IgM-secreting cell numbers return to normal levels by
day 5, IgG-secreting cell numbers remain elevated (van
Rappard van der Veen et al, 1984).
During the acute GvHR the T-B cell collaborations are
between host B cells, and alloreactive donor T helper cells
(Gleichmann et al , 1984 ). The initial increase in
immunoglobulin production is attributed to polyclonal
activation of stimulated B cells, which under the influence
of alloreactive T helper cells, and their soluble
mediators, proliferate, mature and release antibodies
(Gleichmann et al, 1984; van Rappard van der Veen et al,
1984; Ringden et al, 1987).
The presence of foreign antigen at the onset of GvHR, can
provide an activation signal to B cells which are induced
to produce a specific IgG antibody response on receiving
help from alloreactive T helper cells. This is known as
the allogeneic effect (Osborne and Katz, 1972; Katz and
Osborne, 1972 ), and it only occurs when the antigen
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presented to the host, prior to the induction of GvHR, is a
hapten coupled to either linear molecules or cell
membranes. The production of these antibodies does not
require a challenge immunisation of antigen.
A common feature of the antigens which can produce the
allogeneic effect, is their repeating identical epitopes
presented in a linear fashion on molecules with a rigid
backbone (Osborne and Katz, 1973). This structural feature
is believed to allow multipoint high-avidity binding to,
and cross-linking of, the Ig-receptors on unprimed B
cells, thus activating them, and making them sensitive to
soluble mediators released by activated T cells.
The allogeneic effect is important in considering the
underlying mechanisms of autoantibody production in chronic
GvHR (Gleichmann et al, 1984). "Self-antigens" are believed
to activate autoreactive B cells while the long-lived
alloreactive donor T helper cells provide the second help
signal, possibly in the form of soluble mediators.
(Gleichmann et al, 1984; van Rappard van der Veen et al,
1984) .
The importance of T helper cells in the induction of
autoimmunity was shown using Cyclosporin A (CyA). CyA
suppresses the T helper cell population in lethally
irradiated rats reconstituted with syngeneic bone marrow.
The induction of CyA-induced autoimmunity in these animals
commences only on the cessation of CyA, when T helper cells
have regenerated (Bos et al, 1988).
The "self antigens" which induce autoantibodies share
similar molecular structures to those antigens capable of
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inducing the allogeneic effect (Gleichmann et al, 1982).
Thus, autoantibodies to double-stranded DNA and RBC are
detectable, but autoantibodies to organ-specific globular
proteins such as mouse thyroglobulin and insulin are not
(Gleichmann et al, 1982; van Rappard van der Veen et al,
1984 ) .
The binding of " self-antigen" to F-^ B cells may induce an
isotypic-switch from IgM to IgG, causing decreased levels
of IgM and hypergammaglobulinaemia. Autoantibodies to RBC
results in haemolytic anaemia. Both phenomena are
characteristic of the chronic disease.
Immunosuppression during GvHR in Fl hybrid hosts
As discussed, certain models of GvHR produce a suppressive
disease, resulting in profound immunosuppression of both T-
and B-cell functions.
The degree of suppression and the kinetics depend on the
murine strain combinations used and the donor cell dosage.
Maximal effects are seen between day 7 and day 14 after
GvHR induction (Lapp, Weschler and Kongshavn, 1974; Shand,
1975 ) and can persist for an indefinite period. A second
phase of immunosuppression was shown in mice 21 days after
GvHR induction although no effector cell was detected
(Shand, 1975).
The initial early suppression was previously attributed to
an increase in macrophage numbers in the spleen (Sjoberg,
1972), however other workers have shown the presence of a
parental-type T suppressor cell in host spleen that is
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capable of the immunosuppression of normal spleen cell
function (Shand, 1976; Pickel and Hoffman, 1977). Serum
from mice with GvHR has been shown to suppress normal
lymphoid function (McMaster and Levy, 1975), and the
production of soluble suppressor factors has been
demonstrated in vitro (Elie and Lapp, 1976). A depressed T
helper cell function has also been observed (Moser et al,
1987 ) .
Thymic dysplasia and atrophy have been reported after the
entry of mature lymphocytes during the GvHR (Seemayer, Lapp
and Bolande, 1977). The damage to the thymus is believed to
result in defects in T cell function thus preventing the
maturation of T cells into IL-2 secreting cells (Lapp et
al, 1985).
During the GvHR the humoral response to systemically
presented antigens is determined by, when in the
progression of the GvHR, the antigen is administered. A
potentiated antibody response to the thymus-independent
antigen SIII occurred when the antigen was given
immediately after the induction of the GvHR. In contrast,
when the antigen was given to the mice at a later stage of
the GvHR, a suppressed antibody response was observed
(Byfield, Christie and Howard, 1973).
An interesting finding by Treiber and Lapp (1976), was the
concomitant stimulation of a CMI response to SRBC and
suppression of a humoral response during a GvHR. The
authors suggested that two distinct T helper cells were
involved, and the recent discovery of two subsets of T
helper cell clones, T^l and T^2 cells, giving help for CMI
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and antibody responses respectively (Mosmann et al, 1986)
enhances their original hypothesis. It is feasible that
during the GvHR, different T cell subsets are stimulated,
and this possibility will be explored in the discussion of
my findings.
The role of suppressor mechanisms in the progression of
GvHR in both animals and humans is important, and in some
animal models of GvHR, suppressor cells were found to be
more important than CTL in mortality of the host (Rolink et
al, 1982).
The conseguences of the GvHR are diverse. The close
relationship between the lymphoid system and the
parenchymal organs, both targets during the GvHR, raises
interesting guestions relating to the mechanisms underlying
the damage found in the skin, liver and gastrointestinal
tract. Is there a direct attack on the host tissues by
anti-host cytotoxic cells, or is the damage a bystander
effect of the many and varied alloantigen-stimulated DTH
responses ?
This following section describes the intestinal GvHR, and
studies more closely the mechanisms of host tissue, cell
damage.
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GRAFT-VERSUS-HOST REACTION AND THE SMALL INTESTINE
The gastrointestinal tract is a major target organ in both
human and animal GvHD. The clinical features include
malabsorption, bloody diarrhoea and a protein-losing
enteropathy (Weisdorf et al, 1983 ). In the rodent GvHD,
this results in general wasting and the classic "runting"
syndrome as described by Billingham and Brent (1957).
Distribution of lesions
In man, the whole length of the gastrointestinal tract is
affected, with more severe lesions found in the distal
ileum and colon (Slavin and Woodruff, 1974). In animal
models, histological changes have also been observed in the
ileum and the colon (Reilly and Kirsner, 1965), but the
majority of information on GvHR and the intestine has been
gained from studies of the jejunum.
PATHOLOGICAL CONSEQUENCES OF THE GRAFT-VERSUS-HOST REACTION
The earliest studies of intestinal GvHR in irradiated mice
described destructive changes in the mucosal architecture,
characterised by crypt lengthening, increased crypt cell
mitosis, increase in cell numbers near the tips of villi,
villus atrophy and cellular debris in the intestinal lumen
(Reilly and Kirsner, 1965; Cornelius, 1970). In some
mice, crypts at various stages of necrosis were also
described (Cornelius, 1970). These studies were performed
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in irradiated animals and the conclusions made did not
allow for the damage occurring in the gut due to
irradiation alone.
The simultaneous occurrence of increased crypt cell mitotic
activity and villus atrophy during the GvHR was suggested,
by these early workers, to be the direct result of a
cytotoxic attack on the enterocytes. The increase in crypt
cell mitosis was thus an attempt to redress the balance and
produce normal functioning villi.
More detailed studies of the dynamic changes in intestinal
morphology during the GvHR were obtained using the
nonirradiated hybrid murine model.
Elson, Reilly and Rosenberg (1977), showed that 14 days
after the induction of GvHR in adult nonirradiated
(C57BL/6JxDBA/2) BDF^ mice the crypts were elongated but
there was no change in the villus length.
In nonirradiated neonatal Fhybrid mice, age 6-8 days at
the onset of GvHR, crypt hyperplasia and an increased crypt
cell production rate (CCPR) were observed 5-7 days after
the induction of the GvHR (MacDonald and Ferguson, 1977;
Mowat and Ferguson, 1982; Felstein and Mowat, 1988).
In very immature neonates, age 2-6 days at the onset of
GvHR, a more interesting evolution of morphological changes
has been described. After an initial distinct phase of
crypt hyperplasia and increased CCPR, the lesion evolved
into a severe, destructive lesion characterised by crypt
hyperplasia, increased CCPR and villus atrophy (MacDonald
and Ferguson, 1977; Felstein and Mowat, 1988).
This evolution of morphological changes has also been
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observed in irradiated recipients. 1-3 days after the
induction of GvHR in heavily irradiated (CBAxBALB/c)
mice, there is an increase in CCPR and crypt hyperplasia.
After 3 days, the CCPR falls to zero and the crypt and
villus lengths significantly shorten (Mowat et al, 1988).
The enteropathy occurring during the GvHR has been
suggested by Mowat and co-workers to present in two
distinct phases of morphological change.
It has been suggested that the initial increase in CCPR and
crypt hyperplasia is a proliferative form of enteropathy.
This then evolves to a destructive form of enteropathy
characterised by villus atrophy with or without crypt
hyperplasia.
The proliferative form predominates in mature
immunocompetent hosts, and can occur as an initial early
phase of enteropathy in severe models of GvHR. The
progression to the second, destructive form appears to be
the outcome in neonatal animals and immunocompromised hosts
(Mowat et al, 1988; Felstein and Mowat, 1988; Mowat and
Felstein, 1989 ) .
IMMUNOLOGICAL CONSEQUENCES
Alterations to the lymphoid cell populations in the mucosae
appear to fall into a similar pattern. An early
infiltration of mononuclear cells into the LP, with a later
destruction and ulceration of PP and depletion of mucosal
lymphoid cells, was described in early studies of
intestinal GvHR (Reilly and Kirsner, 1965; Cornelius,
1970) .
Influences on T cells, of both donor and host origin have
now been extensively studied, however the effects on B
cells, and non-lymphoid cell populations are less well
documented.
GvHR and mucosal T cells
Both donor and host T cells may infiltrate the mucosae,
depending on the animal model used. T cell infiltrates of
the small intestine of lethally irradiated mice, are
predominantly of donor origin, whereas a semi-allogeneic
GvHR in F^ hybrid mice produces a cell infiltrate generally
of host origin.
T cells have been shown to infiltrate the crypt area, both
LP and epithelium, an area in which T cells are not
normally found (Guy-Grand and Vassalli, 1987).
Alloantigenic activation of T cells has been reported in
PP, with subsequent migration to the gut (Guy-Grand,
Griscelli and Vassalli, 1978), suggesting that the
intestinal GvHR is a locally mediated response.
GvHR and Intraepithelial lymphocytes
In the initial proliferative form of enteropathy there is a
substantial increase in the IEL count per 100 epithelial
cells, making it a useful marker of the progression of the
GvHR. The increase in IEL count coincides with the
increased CCPR and crypt hyperplasia, and with the
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progression of the systemic GvHR, as measured by
splenomegaly (Mowat and Ferguson, 1982).
In the destructive form of enteropathy in irradiated hosts,
a striking decrease in IEL numbers coincides with the
decrease in CCPR, and crypt and villus length (Mowat et al,
1988) .
The origin of IEL is as yet unclear. Reports of donor IEL
and host IEL infiltration into the epithelium have been
documented (Guy-Grand and Vassalli, 1986). Their role
remains to be elucidated.
GvHR and mucosal B cells
A profound decrease in the numbers of IgA- and IgM-
containing plasma cells in the LP of nonirradiated neonatal
mice (Gold et al, 1976), and a secretory IgA deficiency in
BMT patients with chronic GvHD (Beschorner et al, 1981)
have been described. There is very little data on GvHR and
mucosal B cells; the findings of this thesis will hopefully
elucidate the effects of the GvHR on mucosal B cell
responses.
GvHR and Mucosal Mast cells
An increase in mucosal mast cells (MMC) has been reported
in both the mouse (Mowat and Ferguson, 1982 ) and rat
(Ferguson et al, 1987) during GvHR. The increase in cell
counts in the rat is paralleled by an increase in the MMC
specific protease - rat mast cell protease II in jejunal
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tissue and in serum (Ferguson et al, 1987; Cummins et al,
1988).
The induction of Class II expression on intestinal
epithelium during a GvHR.
During a GvHR in rats, the expression of class II (la)
molecules on villus enterocytes, is intensified and de
novo expression occurs on the crypt stem cells (Mason,
Dallman and Barclay, 1981; Barclay and Mason, 1982).
In human acute GvHD, HLA-DR (class II) expression has been
described on rectal crypts in association with the
characteristic histological appearance of GvHD, even in the
absence of intestinal symptoms (Sviland et al , 1988 ).
Interestingly, in other disorders of the gastrointestinal
immune system, such as coeliac disease and dermatitis
herpetiformis, where villus atrophy and crypt hyperplasia
are classic features, both residual immature enterocytes
and crypt cells express class II (Scott et al, 1981).
Using an in vitro organ culture of foetal small intestine,
MacDonald, Weinel and Spencer (1988), showed that
activation of T cells in situ using PWM, produced a cell-
mediated immune reaction with enhanced expression of HLA-DR
(class II) on villus and crypt epithelium. This effect was
neutralized with an antibody raised against recombinant
human IFN-gamma.
The la molecule is normally associated with the
presentation of antigen to activated T cells. During GvHR
in rats there is an increase in macrophages and dendritic
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cells - antigen presenting cells - expressing class II
molecules (Barclay and Mason, 1982 ; Mayrhofer et al ,
1983). A possible role of enterocytic presentation of
antigen either directly to T cells, or into the LP has been
hypothesized (Bland, 1988; reviewed in chapter 1), but not
proven.
During GvHR, the enhanced expression of la could feasibly
be induced by the release of IFN-gamma during the DTH
reaction, but the role it plays in the pathology of gut
enteropathy remains to be elucidated.
THE CELLULAR AND GENETIC BASIS OF THE INTESTINAL GRAFT-
VERSUS-HOST REACTION.
The intestinal GvHR is T cell dependent, and as with the
systemic GvHR, T cell activation depends on the MHC
disparity between donor and host.
Initial studies using the Lyt T cell markers suggested that
Lyt-l+2~ T cells alone induced the increase in IEL numbers,
and a degree of crypt hyperplasia in nonirradiated F-j_
hybrid mice, but the full crypt changes appeared to require
both Lyt-l+2~ and Lyt-1~2+ T cells. A disparity at the
class II I-A locus alone was sufficient for these changes.
Class I disparities did not produce the intestinal,
proliferative changes (Mowat, Borland and Parrott, 1986).
The intestinal lesions produced in irradiated mice have
been shown to occur solely across a class II disparity
(Piguet, 1985) .
More detailed information has evolved from the use of the T
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cell markers, Lyt-2+, and L3T4+. While both phenotypes are
able to migrate to the gut, Lyt-2+ T cells are five times
more efficient. Thus, even in a GvHR across a class II
difference alone, both cell types are detectable in the gut
(Guy-Grand and Vassalli, 1987). However, despite the
lesser ability of L3T4+ cells to migrate to the gut, they
are more efficient in creating gut damage and stimulating
host cells (Guy-Grand and Vassalli, 1986).
Despite these apparently clear-cut findings, other reports
have shown that Lyt-2+ cells are capable of causing
intestinal injury, however this depends on the
concentration of Lyt-2+ cells in the donor inoculum (Guy-
Grand and Vassalli, 1987).
The L3T4+ and Lyt-2+ T cells are able to function
independently (Sprent et al, 1986). It would appear that
both class I and class II MHC alloantigens can stimulate
intestinal GvHR, but that the L3T4+ class II-restricted T
cells may be more potent inducers of intestinal GvHR, and
that the Lyt-2+ class I-restricted T cells may be involved
at a different stage of the intestinal damage.
MECHANISMS OF GUT INJURY
The mechanisms underlying the intestinal GvHR are still
under investigation. There are two possible mechanisms. It
is feasible that the destruction of the mucosa is due to a
local, specific anti-host cytotoxic response against the
enterocytes. An alternative explanation is that a local DTH
response is occurring and either through direct cell
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contact or by the action of cytokines released during the
reaction, profound alterations are made to the homeostasis
of the villus/crypt unit.
The predominant involvement of class II MHC-restricted T
cells in the induction of intestinal GvHR, suggests that
the underlying mechanism is a class II MHC-restricted local
DTH reaction.
The class II (I-A) restricted proliferative form of
intestinal GvHR in both adult nonirradiated mice (Borland
et al, 1983) and 7 day old neonatal mice (Felstein and
Mowat, 1988) is not associated with CTL activity. However,
the destructive form, observed in irradiated mice (Mowat et
al, 1988) and in 1-2 day old neonatal mice (Felstein and
Mowat, 1988) is paralleled by a marked CTL activity. Yet,
CTL activity is not necessary for the destructive phase
because, in 5-6 day old mice, which can develop villus
atrophy, no CTL activity was detected (Felstein and Mowat,
1988) .
There is in fact detailed evidence to suggest that the
intestinal damage occurring during GvHR is a "bystander
phenomenon" reguiring no direct cellular attack on the
mucosa.
The implantation of parental-type foetal small intestine
under the kidney capsule of adult F^ hybrid mice produces a
graft which develops normal, parental intestine
architecture and contains host bone marrow derived cells
(Ferguson and Parrott, 1972). Induction of a GvHR in the
F-l hosts by injection of parental cells induces an increase
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in IEL numbers, CCPR and crypt length in the implanted
graft, similar to the host jejunum. (Elson et al, 1977;
Mowat and Ferguson, 1981). Similarly, implanted foetal
intestine in mice, irradiated prior to GvHR induction,
demonstrates the destructive pathology as seen in the host
jejunum (Mowat et al, 1988). Thus, both forms of intestinal
pathology can occur when the gut offers no allogeneic
stimulus for donor cells.
The evidence to date favours a local DTH response, over the
cytotoxic attack, as the underlying mechanism of intestinal
GvHR. And there is further evidence that locally produced
cytokines play a key role.
Lvmphokines and intestinal damage
The described forms of enteropathy are also observed in T
cell mediated allograft rejection of foetal small intestine
implants, and the damage has been attributed to lymphokines
- "enteropathic" lymphokines released during a DTH reaction
(Ferguson and Parrott, 1973; MacDonald and Ferguson, 1976;
1977 ) .
Mucosal lymphocytes isolated from mice with acute GvHR are
able to produce IFN-gamma, IL-2 and IL-3 (Guy-Grand and
Vassalli, 1986). The production of IFN-gamma is probably
responsible for the enhanced expression of class II (la)
molecules on intestinal epithelium and increased NK
activity (see below).
IFN-gamma is a potent stimulator of lymphocyte migration
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into the skin during DTH (Issekutz, Stoltz and Meide,
1988), and interestingly, treatment of mice during GvHR
with monoclonal antibodies to IFN-gamma prevents the
increase in IEL counts (Mowat, 1989).
Injection of anti-TNF-alpha antibodies during GvHR almost
entirely prevents intestinal lesions (Piguet et al, 1987),
as does the injection of anti-IFN-gamma antibodies (Mowat,
1989). TNF-alpha cannot be detected in the blood and is
most probably produced locally (Piguet et al, 1987).
The definitive role of lymphokines in intestinal GvHR is as
yet uncertain, however the characteristics of certain
soluble mediators would suggest that their production and
release at various times throughout the GvHR plays a major
part in the patterns of intestinal injury.
Natural Killer cell activity
Enhanced peripheral non-specific natural killer (NK) cell
activity has been demonstrated in early human GvHD
(Dokhelar et al, 1981), and in nonirradiated mice with GvHR
(Borland et al, 1983), and parallels the progression of the
systemic GvHR.
The IEL population in mouse small intestine exhibit NK
cell activity (Tagliabue et al, 1981; Tagliabue et al,
1982) which is under suppressive regulation (Mowat et al,
1983) .
During the proliferative form of intestinal GvHR, IEL
exhibit enhanced NK activity which coincides with the
-59-
increase in IEL numbers (Borland, Mowat and Parrott, 1983).
Depletion of resting NK activity by treatment of host mice
with anti-asialo (As ) antibody results in a less severe
systemic GvHR (Ghayur, Seemayer, and Lapp, 1988) with no
crypt hyperplasia, and reduced IEL numbers (Mowat and
Felstein, 1987) .
Both IL-2 and IFN-gamma can enhance NK cell activity
(Roder, Karre and Keissling, 1981), suggesting their
activity is part of the local DTH reaction.
In the destructive form of intestinal GvHR in irradiated
mice, the onset of villus atrophy is marked by a complete
loss of NK cell activity (Mowat et al, 1988).
The close proximity between these effector cells and the
epithelium is potentially important, and their role in the
intestinal GvHR obviously warrants further investigation.
Bacterial microflora and intestinal damage
Antibiotic decontamination of the intestinal tract, and the
use of laminar air flow isolation to provide protection
from exogenous microorganisms have been reported to reduce
the incidence and severity of acute GvHD in mice (van
Bekkum et al, 1974 ), and in BMT patients (Buckner, Clift
and Saunders, 1978). Nevertheless, it is not certain if
survival is improved. More specifically, the removal of
aerobic gut flora prevents much of the gut damage (van
Bekkum et al, 1974 ) and return to conventional conditions
induces tissue damage and mortality. Despite the suggested
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beneficial effects of a germ-free environment, the
intestinal damage does occur in antigen free, foetal, small
intestine implants in mice with GvHR (Elson et al, 1977;
Mowat and Ferguson, 1981).
Increased levels of circulating endotoxin have been
described in animals with GvHR (Walker, 1978). It is
possible that an increased absorption of antigens with
adjuvant properties such as LPS will exacerbate intestinal
GvHR.
The evidence discussed suggests that the intestinal GvHR
evolves from a proliferative form to a destructive form:
both of which produce distinct morphological and cellular
changes (Table 2:1).
The progression from the proliferative form to the
destructive form depends on the immune status of the host.
This suggests that the host mucosal lymphocytes play a
major role in determining the evolution of enteropathy.
A GvHR induced in athymic mice produces a severe,
destructive enteropathy (Mowat, Felstein and Baca, 1987),
as does a GvHR in irradiated and 1-5 day old neonatal mice.
These animals all lack normal, mature T cell function and
may thus be unable to suppress or regulate the ongoing DTH
reaction.
A continuous release of unregulated non-specific soluble
mediators during the DTH reaction may thus be responsible
for the development of the intestinal lesion.
Interestingly, the two distinct forms of enteropathy have
been described in coeliac disease (Marsh, 1988). This cell-
mediated hypersensitivity to gluten is characterised by the
simultaneous occurrence of villus atrophy and crypt
hyperplasia.
The local DTH reaction in the gut, irrespective of the
initial stimulus, appears to induce an initial
proliferative form of enteropathy. If this reaction
proceeds uncontrolled by the host, perhaps due to a lack of
suppressor mechanisms or some deficiency in
immunoregulation, the intestinal lesions progress to a
destructive pathology characteristic of gut enteropathy in
clinical disease.
There is evidence, which I have detailed, suggesting that
cytokines released locally, during the DTH response, have a
major influence on the mucosal architecture of the gut and
the infiltration of cells into the epithelium.
The close spatial relationship between the epithelium and
cells of the lymphoid system, and the effects observed
during the intestinal GvHR point to an important
immunoregulatory balance between the two.
The intestinal GvHR offers an excellent model for the study
of cell mediated immunity at the gut level, and may thus
aid and extend our understanding of similar types of
reactions occurring in clinical diseases.
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PROLIFERATIVE PHASE OF INTESTINAL GVHR







- Enhanced class II (la) expression on villus and crypt
epithelium.
- Increased NK cell activity
- No specific anti-host CTL activity
- Normal villus height.
DESTRUCTIVE PHASE OF INTESTINAL GVHR
Observed in immunocompromised hosts i.e. irradiated mice,
1-2 day old and some 5 day old mice.
FEATURES




- Loss of NK cell activity
- Appearance of specific anti-host CTL activity
TABLE 2:1 Morphological and cellular changes occurring





C57B1/6J (H-2^) mice, purchased from Bantam and Kingman,
(Hull, England), were mated with DBA/2 (H-2^) mice which
were bred continuously at the Animal Unit, Western General
Hospital, Edinburgh. The BDF^ (H-2 ^ ) F^ progeny were used
throughout this work.
The transgenic mice were a kind gift from J. Paul Simons,
Edinburgh Research Station, AFRC Institute of Animal
Physiology and Genetics Research, King's Buildings, West
main Road, Edinburgh. The female (C57B1/6JxCBA) F-^ progeny
were mated with (C57B1/6JxCBA) F-^ males. The progeny of
this cross were donated for this study.
The ages of the animals used are indicated in the relevant
chapters. All animals were kept on a 12/12 hour light/dark
cycle.
DIET
Animals were maintained on a standard small rodent diet,
CRM(x), (Labsure; Cambridge, England) which is known to be
free from both ovalbumin and betalactoglobulin. Water was
available ad libitum.
ANAESTHESIA
Ether (May & Baker Ltd; U.K.) anaesthesia was used for
procedures such as intra-gastric intubation, intra-
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peritoneal and intra-footpad injections, retro-orbital
plexus bleeds, and complete exsanguination.
Initial experiments in the development of a method for the
collection of gut contents (Chapter 5) were carried out
under barbital anaesthesia using Sagatal 60mg/ml (May &
Baker Ltd; U.K.) diluted 1:10 in sterile water. Mice were
injected intra-peritoneally with O.Olmg/g body weight.
BODY WEIGHTS
Mice were weighed using an Oertling TP40, top pan balance,
accurate to O.OOg.
ORGAN WEIGHTS
Organs were dissected free of surrounding tissue and
weighed using the Oertling TP40, top pan balance, accurate
to O.OOg.
ANTIGENS
Ovalbumin five times crystallized, and bovine
betalactoglobulin, three times crystallized, were obtained
from Sigma, (England, U.K.).
Cholera toxin was obtained from List Biological
Laboratories Inc., (California, U.S.A.).
Antigens were dissolved in sterile water or 0.15M saline




Experimental animals were not fasted unless otherwise
stated. Animals were fed antigen by gastric intubation
using a 19 gauge stainless steel dosing needle with a
spherical shaped blunted end.
Antigens were administered in either 0.2ml or 0.4ml volumes
depending on the concentration of antigen being
administered.
Parenteral immunisation
In studies of systemic immunity mice were immunised intra-
dermally (i.d.) in the right hind footpad. 200ug of
antigen, dissolved in 50ul saline, was suspended in an
egual volume of Complete Freund's Adjuvant (CFA) (H37 Ra;
Difco, England). Each animal received lOOug of antigen
suspended in 50ul of adjuvant.
When raising antisera to specific antigens, mice were given
lOOug of antigen in lOOul of CFA and injected intra-
peritoneally (i.p.).
COLLECTION OF BLOOD
In survival experiments 150ul of blood were obtained from
the retro-orbital plexus, under light ether anaesthesia,
using non-heparinised haematocrit capillary tubes
(Hawksley; England). Each capillary tube was sealed at one
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end with Cristaseal (Hawksley; England). Samples were
allowed to clot in the upright position and then spun down
in a micro-haematocrit centrifuge (Hawksley; England) for
2min at 12,000g. Serum was collected and then stored at
-2 0°C.
Larger guantities of blood were obtained by complete
exsanguination from the axillary vessels. Mice were kept
under continuous ether anaesthesia. Blood was kept in non-
heparinised blood tubes, or autoanalyser cups (Sterilin;
England), and centrifuged at 400g for lOmin in a Super
Minor MSE bench centrifuge. Serum was collected and stored
at -2 0°C.
COLLECTION OF SALIVA
Mice were given an i.p. injection of 200ug pilocarpine
(Sigma; U.K.) dissolved in 0.2ml sterile water. 10-15mins
later the animals would begin to salivate. Up to lOOul of
saliva could be collected in non-heparinised capillary
tubes, by holding the tips at the mouth of the mouse,
gently massaging the mouth area, and allowing the saliva to
be collected by capillary action. Animals were maintained
under light ether anaesthesia during this procedure. Saliva
was stored at -20°C.
COLLECTION OF MILK
Lactating mice were given an i.p. injection of 600ul (3U)
oxytocin (Syntocinon: Sandoz, England). 15-
20min later, milk was collected in capillary tubes by
gentle massage of the mammary gland area. Milk was stored
at -20°C. This procedure did not require anaesthesia, as
the oxytocin had a light anaesthetic effect. The mice
suffered no ill-effects from this procedure.
ASSESSMENT OF SYSTEMIC DELAYED-TYPE HYPERSENSITIVITY
Mice were tested for delayed-type hypersensitivity
responses by measuring the specific increment in footpad
thickness 24hrs after an i.d. challenge of lOOug of antigen
in 50ul saline into the non-immunised rear footpad.
The response is expressed as the difference in thickness
(in mm) between the pre- and post challenge footpad.
Initial experiments were performed using Pocotest A
microcalipers (Carobronze Ltd; U.K.). In the final year of
experimental work I used a set of Microstat calipers (Moore
& Wright, Microsystems Ltd; Sheffield, U.K.) which had been
specifically adjusted and refined to measure small rodent
footpads. A comparative study between the two types of
calipers showed that the latter gave a more sensitive and
reproducible measurement of the footpad thickness.
Control mice were immunised with antigen in CFA and tested
with 50ul saline.
SACRIFICE OF ANIMALS
Mice were killed by cervical dislocation.
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PREPARATION OF CELL SUSPENSIONS
Spleen, mesenteric lymph nodes, and Peyer's patches were
removed immediately after sacrifice and dissected free from
surrounding tissue. They were placed in medium and cut into
small segments. For the SP cell suspensions to be used in
the induction of GvHR, RPMI 1640 medium (Flow Labs; Irvine,
U.K.) was used. For SP, MLN and PP cell suspensions to be
analysed in the ELISPOT assay, RPMI 1640 containing 10%
foetal calf serum (FCS) (Gibco; U.K.) was used.
The segments of tissue were gently passed through a
stainless steel fine gauge wire mesh using the plunger of a
5ml syringe (Sterilin; U.K.). The suspensions were
transferred to sterile universals (Sterilin; U.K.). SP
cell suspensions to be used in GvHR experiments were passed
through a wide pore sterile gauze to remove debris. The
cell suspensions were then washed three times at 400g in a
MSE bench centrifuge.
After the final wash, the cells were counted in an improved
Neubauer haemocytometer using white cell diluting fluid.
Cell viability was determined by the trypan blue exclusion
test. Viability was generally 80-85%. The final cell pellet
was made up to the reguired concentration of viable cells
using the appropriate medium.
INDUCTION OF A GRAFT-VERSUS-HOST REACTION
A semi-allogeneic GvHR was induced in nonirradiated female
BDFmice by an i.p. injection of 10® adult female C57BL/6J
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spleen cells suspended in 0.2ml RPMI 1640. Control animals
received either the equivalent concentration of syngeneic
cells i.p. or medium alone.
In the experiments studying the effects of GvHR in neonatal
s
mice (chapter 8), BDF-^ mice aged 7 days old received 7x10
n
cells, mice aged 14 days received 5x10 cells, and mice age
O
21 days received the adult dose, 10 cells. Control animals
were given medium alone.
ASSESSMENT OF THE GRAFT-VERSUS-HOST REACTION
The progression of the GvHR was assessed using the Simonsen
spleen weight assay (Simonsen, 1962). Mice were weighed
prior to sacrifice, the spleen removed free of fat and
weighed. The relative spleen weight was expressed as mg
spleen/lOg body weight.
The splenic index (SI) was calculated using the formula:-
SI = mean relative spleen weight in GvHR mice
mean relative spleen weight in control mice
THE SOLID-PHASE ENZYME-LINKED IMMUNOSPOT (ELISPOT) ASSAY
FOR THE ENUMERATION OF IMMUNOGLOBULIN SECRETING CELLS
The ELISPOT assay, as described by Czerkinsky et al (1983),
and Sedgwick and Holt (1986), was set up in this laboratory
with the technical assistance of Mr N. Anderson. The assay
was modified to suit our requirements and reagents, and was
used for the detection of IgA-, IgM- and IgG-immunoglobulin
secreting cells in PP, MLN and SP from mice.
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Twenty-five well tissue culture plates (Repli-
dishes, Sterilin; U.K.) were coated with 500ul of the
isotype-specific antibody diluted in carbonate/bicarbonate
buffer pH 9.6. (See solutions and buffers).
Coating antibodies
For the detection of IgA-secreting cells: Goat anti-mouse
IgA affinity purified antibody (Sigma; U.K.) at a 1:500
dilution.
For the detection of IgM-secreting cells: Rabbit anti-mouse
IgM affinity purified antibody (Litton Bionetics; U.S.A.)
at a 1:250 dilution.
For the detection of IgG-secreting cells: Goat anti-mouse
IgG affinity purified antibody (Sigma; U.K.) at a 1:1000
dilution.
The plates were incubated overnight at 4°C in a "moist
box", and then washed twice with PBS (pH 7.2) containing
0.05% Tween 20 (BDH Ltd; U.K.), with a final wash with PBS
alone. The final SP, PP, MLN cell suspensions were made up
in 500ul of RPMI 1640 containing 10% FCS (Gibco; U.K.),
and 10^ cells were added to the first well. 3 subsequent
doubling dilutions were made. The plates were incubated at
37°C for 2hrs, then further washed with PBS/0.05% Tween 20.
500ul of the appropriate conjugate, detecting antibody
diluted in PBS/0.05% Tween 20/1% BSA at a 1:1000 dilution
for all three isotypes was added.
Conjugated antibodies
For the detection of IgA-secreting cells: Goat anti-mouse
IgA alkaline phosphatase conjugated antibody (Sigma; U.K.).
For the detection of IgM-secreting cells: Goat anti-mouse
IgM alkaline phosphatase conjugated antibody (Jackson Labs;
U.S.A.).
For the detection of IgG-secreting cells: Goat anti-mouse
IgG alkaline phosphatase conjugated antibody (Jackson Labs;
U.S.A.).
The plates were incubated for 5hrs at room temperature (RT)
in a "moist box". After a further three washes with
PBS/0.05% Tween 20 the plates were placed on a level
surface and 500ul of warm (45°C) agarose-substrate mixture
(containing lmg/ml of 5-bromo-4-chloro-3-indolyl phosphate
(5-BCIP: Sigma; U.K.) in 0.6% w/v agarose) added to each
well.
After about lmin the agarose-substrate mixture hardens.
Macroscopic blue spots became visible within 30mins at RT.
The spots were counted after l-2hrs. If the spots were
small or not clearly visible, the plates were left
overnight at RT in a "moist box" to allow further colour
development.
The substrate-enzyme reaction was stopped by adding
200ul/well of 3M NaOH (BDH Ltd; U.K.). The plates could
then be stored at 4°C.
The spots were studied under a dissecting microscope (x32
magnification: Zeiss Stereomicroscope 4B) and the visible
blue spots scored. By moving through the field of focus,
definite blue spots could be marked and blue stained debris
eliminated.
The results are expressed as spot-forming cells (SPC) per
106 cells.
REMOVAL OF TISSUES
Immediately after sacrifice, pieces of intestine
(approximately 5-10mm in length) were removed, free from
PP. They were opened, placed on card, villus surface
upwards and immersed in fixative.
FIXATIVES AND HISTOLOGY
For conventional histology, and for staining of plasma
cells of IgA, IgM and IgG isotypes, intestine specimens
were fixed in 4% buffered formalin (see solutions and
buffers) for 24hrs and subsequently stored in 70% ethanol.
The specimens were embedded in paraffin wax, and sections
3um thick were cut.
For conventional histology and counts of intraepithelial
lymphocytes, tissues were stained with haemotoxylin and
eosin (H&E).
INTRAEPITHELIAL LYMPHOCYTE COUNTS
Intraepithelial lymphocytes (IEL) were counted by the
method described by Ferguson and Murray (1971). Sections
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were examined under xlOOO (oil immersion) magnification,
and only sections with a single epithelial cell layer were
considered. Lymphoid cell nuclei, above ' the basement
membrane, were counted. A total of 600 epithelial cells
were counted per specimen and counts were expressed as
number of IEL/100 epithelial cells.
STAINING PROCEDURE FOR THE DETECTION OF IMMUNOGLOBULIN-
CONTAINING CELLS IN TISSUE SECTIONS
IgA-, IgM- and IgG-containing plasma cells were detected
separately using a peroxidase anti-peroxidase (PAP)
technique.
Cut sections 3um thick were placed on lysine (Sigma; U.K.)
coated slides, allowed to dry overnight at 37°C, and
dewaxed and rehydrated through histoclear and decreasing
strengths of alcohol.
After a 5mins wash in tap water followed by a rinse in
distilled water, the sections were treated with 1% periodic
acid (BDH Ltd; U.K.) for 5mins, rinsed in running tap water
for a further 5mins and treated with 0.2% potassium
borohydride (BDH Ltd; U.K.) for 5mins. This effectively
blocked endogenous peroxidase.
Sections were washed in running tap water for 5mins, rinsed
in Tris buffer saline (TBS) (pH 7.6), and treated with
normal donkey serum (SAPU; Scotland) in TBS (1:4 dilution)
for 30mins.
The relevant primary antibody was then added at the
appropriate dilution (in TBS) for 2hrs.
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Primary antibodies
For the detection of IgA: Rabbit anti-mouse IgA affinity-
purified antibody (Litton Bionetics; U.S.A) at a 1:600
dilution.
For the detection of IgG: Rabbit anti-mouse IgG affinity
purified antibody (Litton Bionetics; U.S.A.) at a 1:100
dilution.
For the detection of IgM: Rabbit anti-mouse IgM affinity
purified antibody (Litton Bionetics; U.S.A.) at a 1:100
dilution.
The sections were rinsed in two changes of TBS, 5mins each,
and the secondary antibody, a donkey anti-rabbit Ig (SAPU;
Scotland) diluted 1:40 in TBS was then added for a further
2hrs .
After a further two rinses in TBS the rabbit peroxidase
anti-peroxidase (PAP) complex, at a 1:80 dilution in TBS
was added, for lhr.
The sections were rinsed in TBS, washed in tap water for
5mins and treated with 3-amino-9-ethyl carbozole (Sigma;
U.K.) for 20-30mins.
After a further wash in tap water for 5mins the sections
were treated with haematoxylin to lightly stain the nuclei, \
the sections were washed and then "blued" with lithium
carbonate (BDH Ltd; U.K.) solution.
After a final wash the sections were mounted in glycerine
jelly.
All cells have dark blue nuclei. Positively stained cells
have a red, grainy cytoplasm. The other cells have light
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blue cytoplasms.
All sections were examined under a Leitz ortholux II or a
Leitz dialux EB20 microscope.
Histological processing was carried out by Mr J Bode.
PLASMA CELL COUNTS
Positively stained plasma cells within the lamina propria
were counted using a sguare-grid eyepiece, calibrated to
give the number of cells per mm of mucosa. The eyepiece
was aligned with the lower edge lying on the upper surface
of the muscularis mucosae close to the bottom of the
crypts. The tissue was examined under xlOOO magnification,
40 areas of each section were counted and the numbers
p
expressed as cells/mm mucosa. No correction was made for
the area containing epithelium.
TISSUE PROCESSING FOR MICRODISSECTION
Pieces of intestine were removed immediately after
sacrifice, opened, placed on card and immersed in Clarke's
fixative (see solutions and buffers) for 24hrs, then stored
in 70% ethanol. To allow for repeated examination, only one
half of the tissue was stained by the modified feulgen
reaction. Pieces of gut were immersed in 50% ethanol for
lOmins, followed by lOmins in tap water, and 7mins
hydrolysis in 0.IN HCL at 60°C. The tissue was then rinsed
three times in tap water, and stained with Schiff's reagent
(Difco Ltd; U.K.) for 30mins at room temperature. The
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specimens could then be stored in tap water for a maximum
of 48hrs before microdissection.
The tissue was examined under the dissecting microscope
(Zeiss Stereomicroscope 4B) and the muscularis mucosae
removed using fine forceps. Thin layers of mucosa
containing a few villi and the adjacent crypts were
dissected from the tissue using a cataract knife (Weiss
Ltd; U.K.). The pieces were placed on a microscope slide
with a drop of 45% acetic acid, covered with a coverslip
and examined under a Wild M20, Heerbrugg Microscope
(Switzerland) with a previously calibrated eyepiece
micrometer.
In each specimen the lengths of 10-15 complete villi (under
xlOO magnification) and crypts (under x400 magnification)
were measured and the means calculated for group
comparisons.
PRECIPITIN ASSAY FOR THE DETERMINATION OF THE CROSS-
REACTIVITY BETWEEN BOVINE AND OVINE BETALACTOGLOBULIN.
A standard precipitin assay based on the Ouchterlony double
diffusion method (Weir, 1973) was used to determine the
cross-reactivity between bovine and ovine BLG (chapter 10).
Antibodies to bovine BLG were raised in BDF-^ mice by an
i.p. injection of lOOug BLG in 50ul CFA followed three
weeks later by a booster dose of BLG in incomplete CFA. The
presence of IgG antibodies to BLG was determined by ELISA.
The precipitin assay was performed in an agarose medium.
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7mls of a 1% solution of pure agarose (Marine Colloids,
Inc.; U.K.) in PBS pH 7.2, containing 0.1% sodium azide
(BDH. Ltd; U.K.) were pipetted into a 5cm diameter plastic
petri dish (Sterilin; U.K.), and allowed to solidify-
overnight. Three wells were cut into the agarose using a
no. 2 cork borer, and sealed with a drop of molten agarose.
A range of concentrations of bovine BLG and ovine BLG,
(extracted from milk from the Dorset Horn sheep; a kind
gift from J. Paul Simons, Edinburgh Research Station, AFRC
Institute of Animal Physiology and Genetics Research.
Edinburgh), were added to wells 1 and 2 in a series of
plates and the detecting antisera against bovine BLG added
to the final well (well 3) in each plate. A positive
control was incorporated into the assay.
The plates were incubated in a "moist box" for 48hrs at RT
and then washed over a period of two days with PBS, which
was freguently changed.
The plates were allowed to dry, the precipitin lines were
examined over a light source, and the lines of identity
between the antisera to bovine BLG and the ovine BLG
determined.
DETERMINATION OF TOTAL PROTEIN CONTENT IN GUT LAVAGE FLUID
Measurment of total protein concentrations in gut
secretions from mice was performed using a diagnostic kit,
the BCA protein assay (Pierce Chemical Company; U.K.).
The protein concentration is determined by the reaction of
the protein, in the sample, with alkaline copper II to
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produce copper I. The bicinchoninic acid (BCA) reagent
reacts with the copper I to form an intense purple colour,
which can be detected spectrophotometrically (I used a Pye
Unicam PU 8610 spectrophotometer) at O.D. 562nm.
The concentrations of protein in the gut lavage fluid were
extrapolated from the standard curve which was produced
using a range of known concentrations of bovine serum
albumin (BSA: Sigma; U.K.)' plotted against their
corresponding absorbance values.
The standard curve (Fig 3:1) for this assay is extremely
accurate and reproducible.
THE GUT LAVAGE TECHNIQUE
(Elson, Ealding and Lefkowitz, 1984)
Materials
The lavage solution contained:-
25mM NaCl (BDH Ltd. U.K.)
40mM Na2S04 (BDH Ltd. U.K.)
lOmM KCl (BDH Ltd. U.K.)
20mM NaHC03 (BDH Ltd. U.K.)
48.5mM Polyethylene glycol (PEG) MW 3350 (Sigma; U.K.)
The solution was made up in 1 litre distilled water, with a
final osmolarity of 530 osmM.
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Protease Inhibitors
1. EDTA/Soybean trypsin inhibitor.
0.lmg/ml soybean trypsin inhibitor (Sigma; U.K.) in 50mM
ethylenediaminetetra-acetic acid (disodium salt) (EDTA: BDH
Ltd. U.K.).
2. lOOmM phenylmethyl sulphonyl fluoride (PMSF: Sigma;
U.K.) dissolved in 95% ethanol.
Method
Under anaesthesia, four doses of 0.5mls lavage solution
were given intra-gastrically at 15mins intervals. 30mins
after the last dose each animal was given lOOug of
pilocarpine (Sigma; U.K.) in lOOul saline, i.p. Each animal
was then placed on an animal cage lid, under which was
positioned, a 100mmxl5mm plastic petri dish (Sterilin;
U.K.) containing 3mls of the EDTA/soybean trypsin inhibitor
solution. A 500ml glass laboratory beaker was put over the
animal to keep it in position (Fig 3:2).
The desired action of the pilocarpine begins within 15-
20mins. The mice salivate, and defaecate, discharging
faecal pellets and some intestinal fluid into the petri
dish. Solid material not retained by the wire was
removed.
The fluid was transferred to 15ml glass, graduated, conical
centrifuge tubes and fibrous material fragmented using a
glass rod. The volume obtained was recorded and the samples
made up to 6mls with PBS (pH 7.2). Each sample was vortexed
and centrifuged in a MSE bench centrifuge at 650g for
15mins.
3mls of supernatant were transferred into round bottom
polycarbonate centrifuge tubes. 30ul of PMSF were added,
and the samples were further clarified by
ultracentrifugation at 27,000g in a MSE ultracentrifuge for
20mins at 4°C.
2, 1ml aliquots of the supernatant were transferred into
sterile bijoux bottles (Sterilin; U.K.) and a further 20ul
PMSF plus lOul sodium azide added to each.
After 15mins standing, 50ul FCS (Gibco; U.K.) were added to
each aliquot and the samples were stored at -20°C.
THE GUT WASHING TECHNIQUE
Mice were given 4x0.5ml doses of the lavage solution (as
described above). After 30mins each animal was sacrificed,
and the intestine from the duodenum up to and including the
caecum carefully removed, so as not to damage or puncture
the intestinal wall. The contents of the caecum were
collected, because after this length of time they do
contain a large volume of liquid (see chapter 5).
A 10ml syringe (Sterilin; U.K.), attached to a blunt ended
feeding tube, containing 3mls EDTA/soybean trypsin
inhibitor, plus 3mls of air was inserted into the proximal
duodenum. The caecum was placed into a graduated, conical
centrifuge tube, and the bottom snipped to allow the
contents to empty into the tube. The contents of the
syringe were gently flushed through the gut (Figure 3:3).
The collected samples were immediately placed on ice and
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processed using the method described for the lavage
technique. The samples were finally stored at -70°C.
ELISA METHODS
I developed the ELISA methods for the detection of total
IgA in serum, gut washings, milk and saliva, total IgM in
serum and gut washings, and total IgG in serum. This was
achieved by a checkerboard analysis of the optimum
concentrations of coating antibody, standard reference
serum and conjugated antibody for each isotype.
The materials and the methodology for all the ELISAs are
in the appendix to this chapter.
The initial studies of total IgA concentrations in the
lavage fluid were performed using an ELISA set up prior to
my arrival in the laboratory (Appendix A:l). In all
subsequent investigations, using the gut washing technique,
total IgA concentrations were determined using my own newly
developed ELISA (Appendix A:2).
The ELISAs for the detection of IgG and IgM antibodies to
OVA and BLG had been developed prior to my arrival in the
laboratory. Using the same principles of development I set
up an ELISA for the detection of IgA antibodies to OVA and
BLG in gut washings.
STATISTICAL EVALUATIONS
The results for body and spleen weights, villus and crypt
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lengths and IEL counts, are presented as mean+s.d., as
indicated in the graphs and tables. A student's t-test was
used to compare differences between groups.
Immunoglobulin concentrations, antibody responses and DTH
responses, are presented as mean + SEM, and as a non-
parametric distribution of this data was likely, a Wilcoxon
rank sum test was used to compare differences between
groups.
Where the analysis of variance within and between groups,
as determined by the MINITAB computer programme, is given
in the Tables, the Wilcoxon rank sum test significance
values are given in the text.
In all tests P>0.05 was taken as not significant, a value
of PC0.05 as significant, and P<0.01 as highly
significant.
Calculations were performed on a Casio fx-180P calculator,





1:20 dilution of stock carbonate/bicarbonate buffer diluted
in distilled water (Northeast Biomedicals; U.K.). The
solution was used at pH 9.6.
4% Buffered formalin:
40mls Formaldehyde, 960mls distilled water, 4g
NaH2P04.2H20, and 6.5g Na2HP04.
Clarke's fixative:





































FIGURE 3;2 Diagrammatic representation of the apparatus
used to collect lavage fluid using the gut lavage
technigue.
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I 10 mis syringe containing 3
mis EDTA/soybean Trypsin
Inhibitor and 3 mis air
Blunt ended feeding tube
Proximal duodenum
— Caecum
Graduated conical centrifuge tube
Gut washing fluid collected
and placed on Ice
FIGURE 3;3 Diagrammatic representation of the method used





To determine the optimum concentrations, of both coating
and conjugated antibodies, to be used in each isotype-
specific ELISA, a checkerboard analysis was performed.
Briefly, a 96 well microtitre ELISA plate (as described
below) was coated with one dilution of coating antibody
(125ul/well;diluted in carbonate/bicarbonate buffer (for
all solutions see below). The plate was incubated overnight
at 4°C in a "moist box", washed, and divided into 4
sections (each section 6 by 4 wells). Doubling dilutions of
standard normal mouse reference serum ( ICN
Immunobiologicals), from neat to near extinction (diluted
in serum diluent), were added to each section of the plate.
The plate was incubated overnight at 4°C, washed, and 4
different dilutions of the conjugate antibody (eg. 1:1000,
1:2000, 1:3000 or 1:4000) added;l dilution/section. The
plate was incubated at RT for 5hrs, washed and developed.
Readings were taken continuously until the OD values for
the doubling dilutions of reference serum gave a linear
curve. This type of analysis was repeated, using various
combinations of coating antibody and conjugated antibody
concentrations, until the optimum dilutions, giving the
most linear standard curve of reference serum, were
determined. The ELISAs for the detection of total IgA, IgM
and IgG were developed in this way.
The ELISA protocols described below are divided into two
sections. The first section describes the materials and
methods used for the detection of total immunoglobulins in
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murine serum, saliva, milk and intestinal contents. The
second section describes the materials and methods for the
detection of specific antibodies in serum and gut washings.
The ELISAs are grouped according to their method. The
materials used for each ELISA will be detailed first,
followed by the common method.
ELISA FOR THE DETECTION OF TOTAL IGA, IGM AND IGG
A. 1 ELISA FOR THE DETECTION OF TOTAL IGA IN MOUSE LAVAGE
FLUID
This ELISA was used in the initial experiments determining
the concentration of total IgA in intestinal fluid,
collected from mice using the lavage technique (as
described in chapters 3 and 5). The general method for this
ELISA is the same as the other ELISAs in this group.
However, some of the antibodies used in this ELISA
required different incubation times and temperatures, also
there is an additional step, that of adding the detecting
antibody prior to adding the conjugate. For this reason the





Rabbit anti-mouse IgA affinity purified antibody (Litton
Bionetics; U.S.A) used at a 1:1000 dilution. Incubation:
2hrs at 37°C.
Standard curve
The standard curve was produced using the following
dilutions of normal mouse reference serum (Miles; U.K.):-





Rabbit anti-mouse Ig affinity purified antibody (Northeast
Biomedicals; U.K.) used at a 1:500 dilution. Incubation:
5hrs at RT.
Conjugate antibody
Goat anti-rabbit globulin affinity purified antibody
conjugated to alkaline phosphatase (Northeast Biomedicals;
U.K.) used at a 1:1500 dilution. Incubation: overnight at
4°C.
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A.2 ELISA FOR THE DETECTION OF TOTAL IGA IN GUT WASHINGS,
SERUM, MILK AND SALIVA.
MATERIALS
Coating antibody
Goat anti-mouse IgA affinity purified antibody (Sigma; UK)
used at a 1:5000 dilution.
Standard Curve
The standard curve was produced using the following
dilutions of a normal mouse reference serum (ICN
Immunobiologicals; U.K.):-













Goat anti-mouse IgA affinity purified alkaline phosphatase
conjugated antibody (Sigma; UK), diluted 1:1000.
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Rabbit anti-mouse IgM (Litton Bionetics; U.S.A) affinity-
purified antibody, diluted 1:2000.
Standard Curve
The standard curve was produced using the following
dilutions of normal mouse reference serum ( ICN
Immunobiologicals; U.K.): lOOOng/ml, 500ng/ml, 250ng/ml,
125ng/ml, 62.5ng/ml, 31.25ng/ml and 15.62ng/ml. (Fig: A:3).
Sample Dilutions
Serum: 1:2000, 1:4000, 1:8000, 1:16000
Gut washings: Neat
Detecting Antibody
Goat anti-mouse IgM alkaline phosphatase conjugated
antibody (Jackson Labs Ltd. U.S.A) diluted 1:1000.
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A.4 ELISA FOR THE DETECTION OF TOTAL IGG IN SERUM-
MATERIALS
Coating Antibody
Goat anti-mouse IgG affinity purified antibody (Sigma;
U.K.) at a 1:2000 dilution.
Standard Curve
The following dilutions of normal mouse reference serum
(ICN Immunobiologicals; U.K.) were used to produce the
standard curve: 500ng/ml, 250ng/ml, 125ng/ml, 62.5ng/ml,
31.25ng/ml and 15.62ng/ml. (Fig: A:4).
Sample Dilutions
Serum: 1:80,000, 1:160,000, 1;320,000,
1:640,000.
Detecting Antibody
Goat anti-mouse IgG alkaline phosphatase conjugate antibody
(Jackson Labs Ltd. U.S.A) used at a 1:5000 dilution.
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ELISA METHOD
The ELISAs for the detection of all three isotypes were
performed on EIA microtitre plates, number 129A (Dynatech
Ltd. U.K.), and the working volume used throughout was
125ul.
The appropriate dilution of coating antibody was made in
carbonate/bicarbonate buffer (see solutions), and added to
each well. The plates were incubated overnight at 4°C in a
"moist box". The plates were washed three times with an
ELISA wash (see solutions), and blocked for 10-15mins with
serum diluent (solutions).
The correct dilutions, of both the samples and the
standards, were made up in serum diluent, and added to the
plates. The plates were incubated in a "moist box" at
either RT for 5hrs or overnight at 4°C.
After a further three washes, the conjugated antibody
diluted in serum diluent, was added and the plates
incubated in a "moist box" again at either RT for 5hrs or
overnight at 4°C.
The plates were washed three times and the substrate
solution, lmg/ml p-nitrophenyl phosphate (Sigma; U.K.) in
10% Diethanolamine buffer (see solutions), added to the
plates. The plates were kept uncovered at RT, in daylight,
until the reaction developed.
Each plate was read, using a MR580 Microelisa autoreader
(Dynatech Ltd. U.K.), at a wavelength of 405nm, when the
highest concentration of standard reference serum reached
an absorbance value of 1.00.
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The IgG ELISA developed within 10-15mins, the IgA and IgM
ELISAs took 40-45mins.
The standard concentrations were transformed into log
values, and these were plotted against the corresponding
absorbance values (Fig: A.l, A.2, A.3 and A.4).
The concentrations of total IgA, IgM and IgG
immunoglobulins, in each sample, were extrapolated from the
standard curves.
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ELISA METHOD FOR THE DETECTION OF IGG, IGM, AND IGA
ANTIBODIES TO OVA. AND BLG IN SERUM AND GUT WASHINGS.
A.5 ELISA FOR THE DETECTION OF IGG, IGM AND IGA ANTIBODIES
TO OVA AND BLG IN SERUM.
MATERIALS
Coating antigen concentrations
Ovalbumin (Sigma; U.K.) - lOug/ml
Betalactoglobulin (Sigma;U.K.) - 500ug/ml
Sample concentrations
Serum antibodies to Ovalbumin - IgG - 1:400
IgM - 1:50
IgA - 1:50




The positive reference serum for each ELISA was obtained by-
immunising BDF^ mice with lOOug of the appropriate antigen
in lOOul of CFA. Serum to be used in the IgM detecting
ELISA was collected from animals 10 days after
immunisation, while serum to be used in both the IgA and
IgG ELISAs was collected 21 days post-immunisation. Samples
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were pooled, and aliquots stored at -20°C.
A range of doubling dilutions of the positive serum,
starting at 1:400 for IgG, at 1:50 for IgM and 1:50 for IgA
were added to the desired plate. Dilutions were made in
serum diluent.
Detecting antibodies for IgG, IqM, and IaA antibodies to
OVA and BLG.
For the detection of IgG antibodies, a 1:5000 dilution of
Goat anti-mouse IgG antibody conjugated to alkaline
phosphatase (Jackson Labs Ltd. U.S.A.) was used.
Antibodies of the IgM isotype were detected using a 1:1000
dilution of Goat anti-mouse IgM alkaline phosphatase
conjugated antibody (Sigma; U.K.).
Antibodies of the IgA isotype were detected using a 1:1000
dilution of a Goat anti-mouse IgA alkaline phosphatase
conjugated antibody (Sigma; U.K.).
ELISA METHOD
The appropriate antigen was dissolved in
carbonate/bicarbonate buffer, and 125ul added to each well
of a 129B EIA 96 well microtitre plate (Dynatech Ltd.
U.K.). The plates were incubated overnight at 4°C in a
"moist box".
The plates were washed 3 times with ELISA wash (see
solutions), and blocked with serum diluent (see solutions);
15mins block for IgG, 30mins for IgM and 45-60mins for IgA.
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Serum samples, in the appropriate dilutions, and the
standard serum dilutions, again at 125ul, were added to the
plates, and the plates incubated at RT for 2.5hrs, in a
"moist box".
The plates were washed 3 times with ELISA wash, and the
appropriate dilution of conjugated antibody, dissolved in
serum diluent, added. Plates were incubated for either
3.5hrs at RT or overnight at 4°C.
After a further washing, 125ul of substrate solution
(lmg/ml p-nitrophenyl phosphate in 10% DEA buffer)(see
solutions), was added to each well. The plates were allowed
to develop, and were read when the first standard serum
dilution gave an absorbance reading of 1.00.
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A.6 ELISA METHOD FOR THE DETECTION OF IGA ANTIBODIES TO OVA
AND IGA AND IGM ANTIBODIES TO BLG IN GUT WASHINGS.
MATERIALS
Coating antigen concentrations
Ovalbumin (Sigma; U.K.) -
Betalactoglobulin (Sigma; U.K.)
Sample concentrations
Gut washings - Neat
Standard Curve
As described above. A 1:8 dilution of positive serum was
used as the starting dilution.
Detecting antibody
Antibodies of the IgA isotype were detected using a 1:1000
dilution of a Goat anti-mouse IgA alkaline phosphatase
conjugated antibody (Sigma; U.K.).
Antibodies of the IgM isotype were detected using a 1:1000
dilution of a Goat anti-mouse IgM alkaline phosphatase
conjugated antibody (Sigma; U.K.).
ELISA METHOD




carbonate/bicarbonate buffer (see solutions), added to the
plates and incubated overnight at 4°C. After washing 3
times with ELISA wash (see solutions) and blocking
(60mins), with serum diluent (see solutions), the samples
and standards were added, and the plates incubated at RT
for 5hrs. The plates were washed, the detecting antibody-
added and incubated overnight at 4°C.
After a further wash, 125ul of substrate solution (lmg/ml
p-nitrophenyl phosphate in 10% DEA buffer (see solutions)),
was added to each well. The plates were allowed to develop





1:20 dilution of stock carbonate/bicarbonate buffer
(Northeast Biomedicals; U.K.) diluted in distilled water.
Used at pH 9.6.
Elisa wash:
0.05% Tween 20 (BDH Ltd. U.K.) in physiological saline.
Serum diluent:
0.05% Tween 20, 0.02% sodium azide (BDH Ltd. U.K.) and 1%
adult bovine serum (SAPU. Scotland), in physiological
saline.
10% Diethanolamine buffer:
lOOmls DEA (Diethanolamine buffer: BDH Ltd. U.K.), 800mls
distilled water, 0.1015g MgCl2.H20 (BDH Ltd. U.K.), 0.2g






















100 Mg 10 ng 1 Jig 100 ng 10 ng
FIGURE A:1 Total IgA ELISA standard curve.
Both the OD 405nm values (solid line) and the best fitting
line (broken line), as determined by linear regression
analysis, are shown.
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IgA conc/ml 100 pg 10 pg 1 (.ig 100 ng 31.6 ng 10 ng 1 ng
FIGURE A:2 Total IgA ELISA standard curve.
Both the OD 405nm values (solid line) and the best fitting





















500 ng 250 ng 125 ng 62.5 ng 31.25 ng 15.62 ng
FIGURE A:3 Total IgM ELISA standard curve.
Both the OD 405nm values (solid line) and the best fitting























IgG conc/ml 125 ng 62.5 ng 31.25 ng 15.62 ng 7.81 ng
FIGURE A:4 Total IgG ELISA standard curve.
Both the OD 405nm values (solid line) and the best fitting




INTESTINAL GVHR; A STUDY OF THE MUCOSAL CHANGES OCCURRING
DURING A GVHR IN ADULT MICE
INTRODUCTION
Prior to studying the effects of a GvHR on the secretory
immune response, it was first necessary to establish the
changes in mucosal architecture that occur as a result of
this reaction.
The intestinal GvHR in nonirradiated (C57B1/6JxDBA/2) BDF ^
hybrid mice is known to produce alterations to the small
intestine which are indicative of a local DTH response. An
initial proliferative form of enteropathy, characterised by
crypt hyperplasia, increased CCPR and infiltration of IEL,
and a destructive form, characterised by villus atrophy,
crypt hyperplasia and decreased IEL numbers, have been
described (chapter 2).
A progression from the proliferative to the destructive
form of intestinal GvHR has been described in
immunocompromised mice such as neonates and irradiated
hosts. However, in mature, adult nonirradiated hybrid
mice, the evolution of the intestinal GvHR is not well
defined.
The first set of experiments was designed to describe and
define the morphology of the small intestine, during the
initial phase of immunostimulation, in the adult,
nonirradiated (C57B1/6J x DBA/2) BDF-^ murine GvHR model.
In the light of Mowat's definitions of the intestinal GvHR
(chapter 2), briefly outlined above, the second set of
experiments was designed to study, in the same animal
model, the possible progression of the initial
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proliferative form of intestinal GvHR, to a second
destructive form of enteropathy.
The experiments were designed to monitor changes in the
mucosal architecture up to 5 weeks after the induction of
the GvHR. In conjunction, the protocol was modified in that
a group of animals received a large donor cell inoculum, to
try to produce severe, destructive lesions in the
intestine.
The parameters used to study the changes in mucosal
architecture were villus and crypt lengths, and IEL
infiltration into epithelium.
A: MUCOSAL CHANGES DURING THE INITIAL PHASE OF GVHR.
Experimental protocol
8
Female BDF^ mice, aged 6-8 weeks, were injected with 10
C57B1/6J female spleen cells. Age-matched controls
O
received 10 spleen cells or medium alone. At various
time intervals between day 4 and day 14 after the induction
of GvHR, mice from control and experimental groups were
sacrificed. Body and spleen weights were measured and the
spleen index calculated. Sections of jejunum, taken from
the mid-gut region were fixed and processed for
microdissection.
Development of the GvHR
All animals remained healthy throughout the experiment.
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Those animals with GvHR did show a slight decrease in body-
weight, on days 12 and 14, as compared to controls, however
this did not reach statistical significance (Fig 4:1).
Splenic hypertrophy, as assessed by the spleen index, was
detectable as early as day 4, reaching a peak of 3.20 on
day 10, with a slow decline thereafter (Fig 4:1).
Mucosal architecture during GvHR
Microdissection analysis of jejunal samples revealed that
the villus length was unchanged during this phase of GvHR
(Table 4:1). The crypt length was significantly increased
on day 10 of the GvHR (P<0.05) as compared with controls,
and continued to rise until day 14 (PC0.001), the last day
studied.
Intraepithelial lymphocyte counts during GvHR
IEL counts (Table 4:1) showed a significant increase on day
10 (P<0.001), as compared to controls, reaching a peak on
day 12 (PC0.001). By day 14 the IEL counts were in
decline, but still significantly greater (PC0.001) than
controls.
Comments
The development of the GvHR was assessed by following the
increase in spleen weight. The peak of splenomegaly
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occurred on day 10, and from this time point the crypts
remained longer than controls. IEL counts were also
increased from day 10, however after reaching a peak on day
12 the counts began to decline. No change in villus length
was observed.
These findings are in accordance with data from other
researchers, and confirm the morphological changes
occurring in the initial phase of GvHR in this murine
model.
B: EVOLUTION OF MUCOSAL CHANGES DURING GVHR
Experimental protocol
The mucosa of the small intestine was studied at various
intervals up to 32 days after the induction of GvHR.
Architectural changes were monitored in mice receiving the
standard donor cell dose and in mice receiving a large
donor cell inoculum.
Group A and B animals were adult BDF-^ mice, aged 6-8 weeks
at the onset of the experiment. The donor cells were
C57B1/6J spleen cells. Group A, received the standard donor
O
cell dose, 10 spleen cells, while animals in group B
O
received 5x10 donor spleen cells. Age-matched controls
received medium alone.
On days 4, 7, 11, 13, 19, 24, 27 and 32 after the induction
of GvHR, 4 animals from each group were sacrificed, the
body and spleen weights measured, and sections of jejunum
fixed and processed for histological and microdissection
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analysis.
The experiment was duplicated, and the results detailed
below represent the findings.
Development of the GvHR
The animals remained well throughout the time of the
studies, with no change in body weights (Fig 4:2).
Figure 4:3 shows the spleen index for both Groups A and B.
O
The animals receiving 10 donor spleen cells (Group A)
exhibited a peak in spleen hypertrophy, with a spleen index
of 3.11 on day 11, followed by a decline reaching 1.7 on
day 19 and 1.5 on day 27. On day 32, however, there was a
substantial rise in spleen index to 4.70, much higher than
O
the initial peak. The animals receiving 5x10 spleen cells
(Group B) revealed a much greater spleen hypertrophy which
peaked at 4.90 on day 13, declined to 2.2 on day 19 and
then rose to a second, higher peak, of 5.30, on day 32.
Mucosal architecture during the GvHR
Fig 4:4 depicts the various phases of alterations to both
the villus and crypt lengths during the GvHR induced by the
injection of 10 donor spleen cells.
a. Villus and crypt lengths remained as controls until day
11.
b. On day 11 there was a brief point of reduced villus
length (P<0.05) coinciding with crypt hyperplasia
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(P<0.001).
c. Villus length returned to normal by day 13, although the
crypts remained hyperplastic (P<0.001).
d. By day 19, the crypts had returned to normal lengths but
the villi were significantly reduced in length (PC0.001).
e. Day 24 revealed the most severe changes to the mucosal
architecture, with very short villi (359um±31 vs 530um±32,
POD. 001) and once again crypt hyperplasia (P<0.001).
f. The crypts entered an atrophic stage on day 27
(P<0.001). The villi, although longer than on day 24, were
still shorter than controls.
g. While the crypts returned to normal length by day 32 the
villi still remained shorter than controls.
In Fig 4:5 the changes in villus and crypt lengths of
animals injected with 5x10® (Group B) donor spleen cells
are represented.
a. Villus and crypt lengths remained as controls until day
11.
b. On day 11 the villi were decreased in length (P<0.001)
and the crypts hyperplastic (P<0.001).
c. Both villi and crypt lengths returned to normal by day
13.
d. On day 19, the villi became atrophic (P<0.001) and the
crypts hyperplastic (PC0.001),
e. The villi reached their shortest length (353um±43 vs
530um+32, P<0.001) by day 24, although the crypt lengths
had returned to control levels.
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f. The crypts entered an atrophic phase on day 27 (P<0.02).
g. Both the villus and crypt lengths reached control length
by day 32.
In both groups A and B the evolution of changes in mucosal
architecture followed a similar pattern.
Intraepithelial lymphocyte counts during GvHR
IEL were counted on H&E stained sections of jejunum. Fig
O
4:6 shows that during GvHR, mice injected with 10 donor
spleen cells (Group A) had an increased IEL count from day
7 (P<0.02) reaching a peak on day 11 (P<0.001). Thereafter
there was a slow decline in IEL numbers, although the
counts were always significantly higher than controls
(P<0.001). On day 24, there was a striking decrease in IEL
numbers (P<0.001), however, by day 27 the IEL count was
higher than control values (P<0.05). This rise continued
until the end of the study, day 32 (P<0.001).
BDF^ mice receiving 5x10^ (Group B) donor spleen cells did
not show such dramatic changes in IEL numbers (Fig 4:7).
There was a significantly increased IEL count on day 7
(P<0.005), which after a slight decline, although still
remaining significantly higher than controls (PC0.005),
reached a peak on day 13 (P<0.001). The IEL count dropped,
and on days 19 and 24 there was no statistically
significant difference in IEL counts between mice with GvHR
and controls. A significant decrease did occur on day 27
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(P<0.02), with a return to control levels by day 32.
As with the changes in mucosal architecture, the
infiltration of IEL into the epithelium followed a very
similar pattern in both groups.
Histological examination of mouse jejunum during GvHR
Photographs of H&E stained sections of control jejunum (Fig
4:8) and jejunum taken on days 11 (Fig 4:9) and day 24 (Fig
4:10; 4:11) of the intestinal GvHR (Group A) are submitted.
The photographs show guite elegantly the changes in mucosal
architecture that occur during the GvHR, and reinforce the
findings using the microdissection technigue.
During the initial phase, at day 11, (Fig 4:9), the villi
are smaller in length, and of greater width as compared to
the controls (Fig 4:8). The crypts are visibly longer, and
an increase in IEL numbers is obvious.
Examination under x250 magnification of jejunum taken on
day 24 (Fig 4:10) of the GvHR, when more destructive
lesions were observed, reveals extreme damage to the villi,
and elongated crypts. Interestingly, the presence of a
large number of mitotic figures can be seen under x400
magnification (Fig 4:11), suggesting an increase in CCPR at
this time.
Comments
The results detailed in this chapter not only confirm the
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existence of two distinct forms of intestinal GvHR, but
further indicate an evolutionary pattern of changes to the
small intestine throughout the GvHR in adult mice.
A similar pattern in both the systemic progression (Fig
4:3), the mucosal alterations (Figs 4:4, 4:5) and the
infiltration of IEL (Fig 4:6, 4:7) was observed. The
pattern of changes did not appear to depend on the dose of
donor cells given to induce the GvHR.
In Fig 4:12 I have brought together, diagrammatically, the
evolution of effects both systemically and in the mucosa.
a. All parameters normal until day 7 when there was a rise
in spleen index, and an increase in IEL count. No change
observed in the gut.
b. By day 11 both the spleen index and the IEL count had
reached a peak. At this point a transient decrease in
villus length was observed and the crypts were
hyperplastic.
c. By day 13 the spleen index was on a decline, as were the
IEL counts. Although the villi had returned to normal
length, the crypts remained hyperplastic.
d. On day 19 the spleen index and IEL counts remained as
day 13. However subtle changes in the mucosae had produced
normal crypts but villus shortening.
e. On day 24 the spleen index remained as before, but a
dramatic decrease in IEL counts was observed accompanied by
villus atrophy and crypt hyperplasia.
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f. By day 27 the spleen index had increased and the IEL
count had risen dramatically above normal. The villi
remained atrophic and interestingly the crypts became
atrophic as well.
g. A striking increase in spleen index and IEL counts
occurred on day 32, even greater than had been observed on
day 11. The crypt lengths had returned to normal and the
villi were returning to normal, although they remained a
little shorter than controls.
In summary, the findings show that during the intestinal
GvHR, many changes occur in the mucosa. Several of the
pathological alterations are however transient such as the
shortening of villi on day 11, and the changes in crypt
length between days 19 and 27.
Although two distinct forms, a proliferative and a
destructive form, can be determined, the intestinal GvHR in
adult mice appears to affect the gut in such a way, as to
induce an evolution of changes to the mucosal architecture
producing a severe, destructive type of enteropathy during


















Time alter Induction ol GvHR (days)
FIGURE 4:1 Progression of the GvHR in adult BDF1 mice.
Measurements of body weights (mean+s.d.) of control (closed












Control 555 + 19 116 + 4 10 + 2
Day 6 GvHR 550 ± 19 110 + 10 11+2
Day 8 GvHR 550 ± 10 110 + 10 9 + 1
Day 10 GvHR 540 + 50 122 + 4 * 16 + 2 **
Day 12 GvHR 560 + 20 126 + 5 " 19 + 1**




TABLE—4 • 1 Changes in mucosal architecture during the
initial phase of GvHR.
Villus and crypt lengths (mean+s.d.) and intraepithelial
lymphocyte (IEL) counts (meanis.d).
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FIGURE 4:2 Measurement of body weights during GvHR in adult
BDF1 mice.
Body weights of controls (closed circle) and GvHR mice
having received 10 donor cells (Group A: closed triangle)













FIGURE 4:3 Progression of the GvHR in adult BDFl mice.
Spleen index of GvHR mice having received 10 donor cells














Time alter Induction ol GvHR (days)
Control
FIGURE 4;4 Changes in mucosal architecture during a GvHR.
Villus and crypt lengths (mean+s.d.) of jejunum taken from
mice injected with 108 donor cells (Group A). The group
means+s.d. of villus and crypt lengths for age-matched































Time alter Induction of GvHH (days)
FIGURE 4:5 Changes in mucosal architecture during a GvHR.
Villus and crypt lengths (mean+s.d.) of jejunum taken from
mice injected with 5x10 donor cells (Group B). The group
means+s.d. of villus and crypt lengths for age-matched





• p < 0 02
•' p < 0.05
... p < 0.001
Time alter Induction ot GvHR (days)
FIGURE 4;6 Cellular infiltration during a GvHR.
Intraepithelial cell (IEL) counts (mean+s.d.) of mice
injected with 10 donor cells (Group A: closed triangle),






















Time after Induction of GvHR (days)
FIGURE 4;7 Cellular infiltration during a GvHR.
Intraepithelial cell (IEL) counts (mean+s.d.) of mice
injected with 5x10 donor cells (Group B: closed triangle)
and age-matched controls (closed circle).
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FIGURE 4:8 H&E stained section of jejunum taken from
control mouse. (x250 magnification).
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FIGURE 4:9 H&E stained section of jejunum taken on day 11
the GvHR (Group A). (x250 magnification).
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FIGURE 4:10 H&E stained section of jejunum taken on day 24
of the GvHR (Group A). (x250 magnification).
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FIGURE 4:11 H&E stained section of jejunum taken on day 24
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Days after the Induction of GvHR
FIGURE 4:12 Diagrammatic representation of the evolution of
effects on the mucosa and spleen during a GvHR. (see text).
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CHAPTER 5
DEVELOPMENT OF A GUT WASHING TECHNIQUE FOR THE STUDY OF
MURINE INTESTINAL HUMORAL IMMUNE RESPONSES
INTRODUCTION
The study of the intestinal secretory immune response in
animals or humans, requires a specific technique for
directly measurinq the secretion of immunoqlobulins and
antibodies into the gut lumen.
Until the description by Elson, Ealding and Lefkowitz
(1984), of a repeatable lavage technique for measuring IgA
antibody in mouse intestinal secretions, most studies of
mucosal humoral immunity were performed using isolated
intestinal loops. Large animals such as rabbits (Hamilton
et al, 1981; Keren et al, 1982 ) and rats (Husband and
Gowans, 1978; Lightman, Sherman and Forstner, 1986) were
used. More recently, simple gut wash collections (Elson and
Ealding, 1984b; McKensie and Halsey, 1984) and gut
perfusions (Ebersole, Smith and Taubman, 1985), have been
described. Bile duct cannulations (Schmucker et al, 1988),
have often been used to study the concentrations of dimeric
IgA present in the bile, as a measure of the secretory
antibody response. However, concentrations of IgA in the
bile, are not representative of concentrations of IgA
secreted at the gut level.
The lavage technique (Elson et al 1984), was described as
an accurate and easily performed technique, allowing
temporal studies of IgA antibody secretion in individual
mice. The method consisted of feeding mice a lavage
solution containing non-absorbable polyethylene glycol
(PEG). Defaecation was induced by the cholinergic agent,
pilocarpine. The intestinal fluid and faecal pellets were
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collected, processed, the important proteins protected with
a variety of protease inhibitors, and antibody content
measured by ELISA.
The ability to measure accurately the immunoglobulin and
antibody concentrations in intestinal contents of mice, was
central to my work. This chapter describes my findings
using the Elson method (1984), the problems I encountered,
and the final method I developed to collect and analyse
murine gut washings.
The gut washing technigue was used in all of my studies of
the intestinal, humoral immune responses.
THE LAVAGE TECHNIQUE. (Elson et al 1984)
Experimental Protocol
Initial studies were performed to assess the
reproducibility of this technigue.
On 4 separate occasions the same group of adult BDF^ mice
were given 4x0.5ml of the lavage solution. 30mins after the
last dose, they were injected with pilocarpine and the
intestinal contents collected. The complete method is
described in chapter 3. The volume recovered was recorded,
the concentrations of total IgA were determined by ELISA
(chapter 3; Appendix:A.1) , and the concentrations of total
protein were determined using the Pierce BCA protein assay
(chapter 3). The anaesthesia used, and the general methods
of feeding are also described in chapter 3.
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Results
The results for the volumes (mis), total IgA (Ug/ml)
concentrations and total protein (mg/ml) concentrations for
each experiment are given in Table 5:1.
Volume of gut contents collected.
The collections from these animals contained both faecal
/
pellets and lavage fluid. The volume of lavage fluid
recovered varied significantly from day to day (P=0.001)
and there was a wide range within each group.
Concentrations of total IqA in intestinal contents.
Table 5:1 also shows the striking variation of total IgA
concentrations (ug/ml) between days (P=0.014), and the wide
range within each group.
Total protein concentrations in intestinal contents.
The concentrations of total protein (mg/ml) in the
intestinal contents were not significantly altered between
experiments. Total protein concentrations were not
determined in samples collected from experiment 4.
Comments
The volumes and total IgA concentrations, of intestinal
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contents collected from these mice, were extremely variable
both between animals and between days. Although the
concentrations of protein appear to remain constant from
day to day of the study, the significant variation in the
IgA concentrations still remained when the results were
expressed as ug total IgA/mg protein (Figures not shown).
There have been many reports describing the effects of
pilocarpine on IgA concentrations (Wilson et al, 1982;
Smith et ai, 1982) and volume of fluid collected from mice
(Elson et al, 1984), rats (Wilson et al, 1982) and hamsters
(Smith et al, 1982).
The cholinergic activity of this agent increases the volume
of fluid secreted, both in salivary glands and intestine,
and subsequently produces a net decrease in IgA
concentrations.
It is possible that the cumulative effect of the
pilocarpine in these animals, altered the recoverable
volume and thus the concentrations of total IgA.
The data shown in Table 5:1, is evidence that this
technique is unreliable as a method for obtaining fluid for
subsequent analysis of IgA concentrations in gut luminal
contents.
A study of the movement of lavage fluid along the gut.
The volume of lavage fluid fed to the mice was 2mls,
however, despite the large variation, the volume of lavage
fluid recovered was on only one occasion 2mls. The average
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amount collected was approximately 1ml.
In a further experiment, I fed adult BDF-j_ mice the 4x0.5ml
dose of lavage fluid containing 2 drops of Evans blue dye
(Sigma; U.K.).
At times 0, 10, 20 and 30mins after the last lavage dose, 3
animals were sacrificed and the stomach, small intestine
caecum and colon examined for the presence of Evans blue
colouring.
A second group of mice were given the four 0.5mls of
lavage, and after 30mins, they were injected with lOOug of
pilocarpine. At times 0, 10, 20, 30, 40 and 80mins, after
the administration of pilocarpine, the volume and colour of
the fluid secreted were recorded. The animals (n=3) were
then sacrificed, and the stomach, small intestine, caecum
and colon examined for presence of blue colour.
The results are not presented here as the conclusions drawn
from them simply reinforce the findings described above.
30mins after the last dose of lavage fluid was given, there
was blue lavage fluid in the caecum and colon. The maximum
volume of intestinal contents was recovered 30mins after
the injection of pilocarpine (the maximum effect of
pilocarpine is known to occur within 30mins (Elson et al,
1984)). The fluid collected in the petri-dish was blue in
colour, but on sacrifice of the animals, a large amount of
blue fluid still remained in the gut.
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Comments
From the results obtained it appeared that the lavage
technique could not be maximized in any way. The lavage
fluid fed to the animals was not completely deposited,
therefore the fluid collected for analysis was not
representative of whole gut luminal contents. The
variation, in volume recoverable and IgA concentrations,
between animals and days was too great, and I therefore
considered the technique to be unreliable.
THE GUT WASHING TECHNIQUE
I developed a gut washing technique which encompassed the
positive aspects of the lavage technique, such as the
lavage solution, the use of protease inhibitors and the
actual processing of the samples. However, instead of
inducing the animals to defaecate, they were sacrificed and
the contents washed out.
Normal adult BDF-^ mice were fed the lavage solution, and
after 30 mins the animals were sacrificed, their intestines
from the duodenum up to and including the caecum removed
and washed out. The complete method is described in chapter
3. Again the volumes of gut washings were recorded and the




The results, shown in Table 5:2, are representative of the
volumes of gut washings collected.
The concentrations of IgA (ng/ml) (Table 5:3) were obtained
from two experiments, performed on normal mice. The
technigue was performed many times, and the results
presented here are representative of other experiments.
Volumes of gut washings obtained
Of the total 5mls of fluid, 2mls lavage fluid plus 3mls of
EDTA/soybean trypsin inhibitor passed through the gut, 90-
100% was collected for analysis (Table 5:2).
Concentration of total IqA in gut washings.
As hoped, there was no significant difference between the
two groups of animals (Table 5:3), although the range
within each group (trial 1- 85ng/ml-274ng/ml and trial 2-
50ng/ml-251ng/ml) was still quite extensive.
Comments
In conclusion, the gut washing technique is reliable,
reproducible and easy to perform.
The major disadvantage of this method, over the lavage
technique, is that temporal studies of the secretory immune
response in individual mice cannot be performed.
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The concentrations of IgA in the gut washings, were lower
than those obtained in the faecal fluid after whole gut
lavage (ng/ml rather than ug/ral). This is probably because
the gut lavage method produces a concentrate of gut luminal
contents, and when the amount of IgA is expressed per ml of
faecal fluid, a falsely high result is obtained.
A further observation using the gut washing technique was,
that if less than 3mls of volume were collected from an
animal, the concentration of total IgA was falsely high.
Samples of less than 3mls volume were thus eliminated from
future studies.
The range of results within a group of animals is rather
wide, but the statistical methods used take account of
this. Using large numbers of mice, and adequate controls
for each experiment should eliminate any problems regarding
statistical analysis.
An excellent advantage of using the gut washing technique
is that sections of the jejunum can be fixed and stained
for plasma cell counts. A record therefore of IgA
concentrations in the intestinal lumen and IgA+-plasma cell
counts in the same animal can be obtained. This enables
more involved studies of relative changes in the migration
of plasma cells to the lamina propria, and production
and/or secretion of immunoglobulin into the gut lumen.
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Volume (mis) |ig Total IgA/ml mg Protein/ml
(Range) (Range) (Range)
Experiment
1 (n=12) 0.8 ± 0.37 18.90 ± 13.70 12.49 ± 8.02
(0.2 - 1.4) (0.46 - 168.69) (0.75 - 92.22)
2 (n=12) 0.63 ± 0.16 58.38 ± 16.70 7.29 ± 2.67
(0.4 - 1.0) (6.73 - 213.38) (0.31 - 22.93)
3 (n=12) 1.23 + 0.54 1.38 ± 0.32 10.32 + 1.94
(0.3 - 1.8) (0.12 - 4.26) (2.10 - 22.08)
4 (n=6) 1.45 ± 0.6 17.14 + 3.1 ND
(0.3 - 2.1) (0.74 - 79.62)
Analysis of P = 0.001 P = 0.014 N.S.
variance
FIGURE 5:1 The lavage technique.
Volumes (itiean + SEM) , total IgA (mean+SEM) and protein
concentrations (mean+SEM) of lavage fluid collected on four















FIGURE 5:2 The gut washing technigue.

















































Mean + S.E.M. 162.40 ± 21.02
(50-251)
FIGURE 5:3 The gut washing technique.




MUCOSAL IMMUNOGLOBULIN CONCENTRATIONS THROUGHOUT A GVHR IN
ADULT MICE
INTRODUCTION
In comparison to the many investigations into the effects
of a GvHR on systemic B cell responses and immunoglobulin
production, the effect on secretory immunoglobulin
production has not yet been elucidated.
In 1976 Gold et al, studied plasma cell numbers in the
duodenum of neonatal mice with GvHR. Their findings showed,
that 3 weeks after the induction of a semi-allogeneic GvHR
in nonirradiated newborn (C57Bl/KAxBalb/c) mice, there
was a virtual absence, in the LP, of IgA and IgM plasma
cells, with no detectable IgG plasma cells.
Systemically it has been shown that the parent to hybrid
murine model of GvHR produces a brief, initial phase of
immunostimulation in which T helper cells are
alloactivated. B cell hyperplasia and hypergamma-
globulinaemia are common features. This is immediately
followed by immunosuppression. During the initial
immunostimulatory phase, activated T cells are known to be
present in the mucosa (chapter 2).
The aim of this study was to investigate, in detail, what
effect the presence of activated T cells, in the adult
mouse gut, would have on mucosal B cell properties as
reflected by plasma cell counts in the LP, and
immunoglobulin secretion into the gut lumen.
Having established the gut washing technique, I was able to
measure directly the concentrations of immunoglobulins in
the gut luminal contents throughout the GvHR, as well as
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determine the plasma cell counts in the small intestine LP.
General protocol
The same protocol was used throughout the- following
experiments.
A GvHR was induced in adult BDF-^ mice, aged 6-8 weeks, by
i.p. injection of 10® C57B1/6J donor spleen cells. Control
animals received medium alone.
At various time points thereafter, gut washings were
collected (as described in full in chapter 3) from both
control and GvHR groups.
Sections of mid-gut were collected for staining of IgA-,
IgM- and IgG-containing plasma cells (chapter 3).
Immunoglobulin concentrations were determined by ELISA
(chapter 3; Appendix A: 2, A:3).
8-10 animals/group were studied at each time point.
Due to the large numbers of animals reguired for such a
time course experiment, it was impossible to study daily
changes in immunoglobulin concentrations in gut washings in
one experiment. A series of experiments were therefore
performed to study selected time points.
The concentrations of total immunoglobulins in the gut
washings from experiment 1-5, are detailed in Table 6:1 and




In this first experiment, total IgA concentrations, and
IgA-containing plasma cells numbers in the LP were analysed
on days 7, 14 and 21.
These time points were chosen as being representative of
the phases of GvHR. The onset of splenic hypertrophy occurs
on day 7. By day 14 the GvHR is at the peak of severity,
and within the period of T cell alloactivation. By day 21
the GvHR has entered a period of reduced activity.
Results
A significant increase (P<0.01) in total IgA (ng/ml) in gut
washings was found on day 14 (Table 6:1-experiment 1),
accompanied by an increase (P<0.01) in IgA plasma cell
numbers (Table 6:2-experiment 1).
EXPERIMENT 2
After finding this striking rise in total IgA on day 14 of
the GvHR, a second experiment was performed in order to
duplicate this finding and study other time points.
Total IgA concentrations were analysed on days 4, 7, 10,
14, and 29 after the induction of a GvHR. Plasma cell
counts were not performed on this occasion.
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Results
Unfortunately, at no time point was there a significant
increase in total IgA concentrations (Table 6:1- experiment
2) .
EXPERIMENT 3
Despite there being no increase in total IgA concentrations
on day 14 in the latter experiment, the initial results of
experiment 1 revealed such a striking increase on day 14
that a 3rd experiment was set up to study more closely
around this time.
In this experiment both total IgA and IgM concentrations in
gut washings were studied. Simultaneously IgA, IgM and IgG
plasma cell numbers were counted. Days 10, 11, 12, 13, and
14 after the induction of the GvHR were investigated.
Results
A significant increase (PC0.05) in total IgA concentrations
(Table 6:1-experiment 3), concomitant with a significant
rise (P<0.05) in IgA plasma cell numbers (Table 6:2—
experiment 3) was observed on day 12 of the GvHR.
An increase in total IgM concentrations (Table 6:1-
experiment 3) on day 11 (P<0.01), day 12 (P<0.001), day 13
(P<0.01) and day 14 (P<0.05) was observed. IgM plasma cell
numbers (Table 6:2-experiment 3) were increased on days 12
(P< 0.05 ) and 14 (P<0.05) .
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No change in IgG plasma cell counts were observed.
Because IgG plasma cells were found in such low numbers,
and no changes in numbers were observed during the GvHR,
total IgG concentrations in gut washings were not analysed.




The study of total IgA and IgM concentrations (Table 6:1-
experiment 4) and IgA, IgM and IgG plasma cells numbers
(Table 6:2-experiment 4) on days 15 and 18 revealed no
significant difference between animals with GvHR and
controls.
EXPERIMENT 5
A second phase of immunostimulation has been reported in
this murine model of GvHR, the features of which are
suggestive of an autoimmune-type disease. The onset of this
phase is believed to occur many weeks after the onset of
GvHR.
My previous studies of the progression of the GvHR (chapter
4) revealed a dramatic increase in spleen index around day
32 (Fig 4:3), suggesting that at this time there is an
increase in systemic cell proliferation.
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A study of immunoglobulin concentrations and plasma cell
numbers was therefore performed on day 31.
Results
A striking increase in both total IgA concentrations
(P<0.05) and total IgM concentrations (P<0.01) (Table 6:1-
experiment 5) was observed at this time point.
No change was found in IgA plasma cell numbers (Table 6:2—
experiment 5), and unfortunately the staining procedure for
IgM plasma cells failed, and no results were obtained.
Comments
The results of this investigation show, that during the
semi-allogeneic GvHR in nonirradiated adult BDF^ mice,
there were increased plasma cell counts in the LP and
increased immunoglobulin concentrations in the gut lumen.
A transient increase in total IgA concentrations,
accompanied by an increase in IgA plasma cell numbers in
the LP, occurred on day 12 after the induction of a GvHR.
By day 13 both the immunoglobulin levels and plasma cell
numbers had returned to normal.
A prolonged increase in total IgM concentrations in gut
luminal contents was observed from day 11 up to and
including day 14. A peak of statistical significance was
reached on day 12, suggesting that this day was the peak of
the total IgM response. IgM plasma cell numbers were
increased on days 12 and 14.
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Both total IgA and IgM concentrations remained as controls
until the second striking increase found on day 31 of the
GvHR.
The increases in total immunoglobulin concentrations in the
gut followed a similar pattern as that of the systemic
GvHR, as monitored by the spleen index (Fig 4:3). It was
therefore possible that the effects observed at the gut
level were a direct result of serum leakage into the gut
lumen, at a time when the gut is undergoing many
morphological changes (chapter 4). Evidence against this is
that an increase in LP plasma cell counts of the IgA and
IgM isotypes but not IgG was observed. Secondly I performed
a small experiment (data not shown) in which Evans' blue
dye was injected intra-venously into mice on day 14 of the
GvHR and into age-matched controls. No detectable leakage
of Evans' blue dye, monitored spectrophotometrically, was
found in the gut washings of either control mice or mice
with GvHR.
The increase in IgA and IgM concentrations in the gut lumen
on day 31, was not accompanied by an increase in plasma
cell counts, and serum leakage may be relevant at this
time. Other considerations, such as an increase in
immunoglobulin production within each plasma cell, or
increased immunoglobulin concentrations in bile secretions,
must be taken into account.
In summary, during the initial phase of GvHR there was a
transient increase in levels of IgA in the gut lumen, on
day 12, and a prolonged increase in mucosal IgM. A similar
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increase in plasma cell counts was also observed.
This dichotomy in mucosal immunoglobulin production
suggests that the GvHR may be affecting mucosal B cells
early in their maturation pathway.
The second rise in both IgA and IgM concentrations,
occurring on day 31 of the GvHR, was discovered late in my
work. It is possible that this increase reflects the onset
of the chronic, immunostimulatory form of the reaction,
however further study is required.
The data presented in this chapter should however be
interpreted with great caution. A large degree of
variability in total IgA concentrations, was observed in
control animals, and the increase in IgA levels described
during the GvHR was not observed on every occasion. In
addition, some values for both IgA and IgM concentrations
were near the limit of resolution of the ELISA. It is
therefore possible that the gut washing technique is not
sufficiently powerful to detect meaningful differences
consistently.
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Total IgA (ng/ml) Total IgM (ng/ml)
Experiment CON GvHR CON GvHR
1 day 7 35.40 ± 8.17 20.66 ± 3.01
14 85.66 ± 27.48 419 ± 33"
21 43.25 ± 10.63 74 28 ± 22.95
2 day 4 36 80 ± 2 72 44 ± 505
7 66 66 ± 14 06 140 50 ± 47.13
10 40.12 ± 1225 34.62 ± 5.43
14 30.70 ± 2.05 41.14 ± 24.22
29 21.53 ± 1.48 33.62 ± 8.88
3 day 10 201.78 ± 2925 194.65 ± 60 04 14 95 ± 7.43 26.41 ± 1083
11 21725 ± 1939 228 25 ± 165 67 8.62 ± 1.48 43.06 ± 17.50"
12 123.71 ± 1053 272.16 ± 43.50' 4.48 ± 056 5882 ± 25.90'"
13 154 81 ± 22 42 172 ± 2799 8 92 ± 227 31.27 ± 1091"
14 107.11 ± 1765 146.29 ± 22 84 829 ± 2.06 21.31 ± 7.47*
4 day 15 150 72 ± 24 28 157.39 ± 19.07 9 00 ± 1.68 10 04 ± 4.80
18 150.72 ± 2428 170.16 ± 21.54 9.00 ± 1.68 8.02 ± 3.73
5 day 31 415.84 ±136.57 777.85 ± 84.51' 17.06 ±1124 262.66 ± 138.87*
' P <0.05
" P <0 01
*" P <0.001
TABLE 6;1 Total IgA and IgM concentrations in gut washings
collected at various times throughout the GvHR.
Figures represent the mean+SEM.
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lgA+ lgM+ lgG+
Experiment CON GvHR CON GvHR CON GvHR
1 day 7 187 ± 38 126+ 10
14 334 ± 52 574 + 46"
21 226 + 33 249 + 4
3 day 10 357 ± 37 368 + 7 224 + 12 220 + 16 33 ± 7 31 + 2
11 327 + 4 351 + 5 210 + 7 219 ± 18 31 + 3 27+5
12 300 + 25 421 + 2* 239 + 3 327 ± 13* 25 ± 2 32+ 3
13 309 + 16 350 + 16 269 + 28 310 + 10 19+4 21 + 3
14 248 + 11 247 ± 10 192 + 4 257 ± 13* 19+4 19+ 4
4 day 15 300 ± 28 303 + 36 213 ± 38 154 ± 9 21+6 22 ± 4
18 300 + 32 314 + 8 213 + 38 146 + 3 20+ 1 20+ 1
5 day 31 320 + 17 366 + 5 - - - -
' P < 0.05
" P < 0.01
TABLE 6:2 IgA-, IgM-, and IgG- containing plasma cell
counts in mid-gut sections taken at various times
throughout the GvHR.
Figures represent the means+SEM.
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CHAPTER SEVEN
IMMUNOGLOBULIN CONCENTRATIONS IN SALIVA, MILK AND SERUM
DURING A GVHR IN ADULT MICE
INTRODUCTION
In chapter 6 the striking, enhancing effect of the GvHR on
secretory immunoglobulin concentrations in the gut lumen
was defined. On day 12 of the GvHR there was an increase in
IgA plasma cell numbers in the intestinal LP, and an
increase in IgA in the gut lumen.
The hypothesis of this investigation was that during the
GvHR, the stimulation of IgA precursor B cells in PP may
produce an increase in IgA precursor cells migrating to
other sites of the common mucosal immune system; thus
producing an increase in IgA in saliva and milk.
For completion, serum IgA, IgM and IgG concentrations were
also studied throughout the GvHR; thus reflecting systemic
B cell stimulation.
A: THE EFFECT OF A GVHR ON IGA PRODUCTION IN SALIVA AND
MILK
There is much evidence to support the existence of a common
mucosal immune system in animals. The theory is that after
local sensitization of B cells in the GALT, the activated
cells, of which a large number will be IgA precursor B
cells, leave the gut and enter the MLN. Subseguently the
cells enter the circulation through the thoracic duct and
then home to the LP of the intestinal and respiratory
tracts and salivary, lacrimal, mammary and cervical
uterine glands. The IgA precursor B cells then
differentiate into IgA plasma cells and produce antibody
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(reviewed Mestecky and McGhee, 1987).
Total IgA concentrations in saliva during a GvHR.
Experimental protocol
A semi-allogeneic GvHR was induced in nonirradiated BDF^
mice by i.p. injection of 10® C57B1/6J donor spleen cells.
Controls received medium alone.
On days 11, 12, 13, 14 and 18 after the induction of GvHR,
6-8 mice/group were given pilocarpine i.p. and the saliva
collected (chapter 3). The technigue used to collect saliva
was guite easily performed although only small volumes
could be obtained.
Total IgA concentrations were determined by ELISA (chapter
3-Appendix A:2).
Results
The results, presented in Table 7:1, show that at no time
point after the induction of a GvHR, was there a
significant difference in total IgA concentrations (ng/ml)
as compared with controls.
Total IaA concentrations in milk during a GvHR.
Experimental protocol
The gestation period of the mouse is approximately 21 days
from the first sign of mating; determined by the appearance
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of a vaginal plug of semen, and commonly known as plugging.
A semi-allogeneic GvHR was induced in nonirradiated, female
BDF-l mice (as described above) 10 days after plugging, thus
the birth of the litter, and the release of milk coincided
with the peak of effect of the GvHR. The control group,
which consisted of females at the same stage of pregnancy,
were given medium alone. 4-5 animals/group were used.
The offspring of the BDF-|_ mothers, with an ensueing GvHR
during pregnancy, suffered no ill effects and thrived as
the offspring from the control mothers.
On days 1, 2, 3 and 4 post-parturition the mice were given
an i.p. injection of oxytocin and the milk was collected in
capillary tubes (chapter 3). This technigue proved guite
difficult and only small volumes of milk were collected
from each animal.
The above time points coincided with days 11, 12, 13 and 14
of the GvHR, and are shown in Table 7:2 as such.
Total IgA concentrations were determined by ELISA (chapter
3-Appendix A:2).
Results
The results, given in Table 7:2, show that there was no
significant difference in the total IgA concentrations




The results show quite clearly that there was no effect on
total IgA concentrations in saliva or milk during the GvHR.
However, the levels of IgA in saliva did appear to be
raised on days 13 and 14 of the GvHR, and although
statistical significance was not reached, the possibility
does exist that IgA concentrations are affected at these
points during the reaction. Plasma cell counts of salivary
and mammary glands were not studied, therefore it is not
known if an increased number of IgA precursor cells
migrated to these sites. The apparent unchanged
concentrations of IgA in saliva and milk suggest that the
GvHR does not induce increased cell migration and
immunoglobulin production in distant mucosal sites, but
rather the mucosal effect is confined to the gut.
B: SYSTEMIC IMMUNOGLOBULIN PRODUCTION DURING A GVHR
The immunostimulatory phase of the acute semi-allogeneic
GvHR in nonirradiated mice, has been shown to produce B
cell hyperplasia, increased plasma cell numbers in the
medullary areas of lymph nodes and hypergammaglobulinaemia
(chapter 2) .
The aim of this study was to determine the concentrations
of total IgA, IgG and IgM in the systemic circulation,
throughout the time course of the GvHR.
Experimental protocol
A semi-allogeneic GvHR was induced in nonirradiated BDF-|_
mice, aged 6-8 weeks, as described above. Control animals
received medium alone.
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On days 4, 7, 11, 12, 13, 20, 24, 27 and 32 after the
induction of the GvHR, serum was collected from both
control and GvHR groups, by total body exsanguination
(chapter 3).
Total IgA, IgM and IgG concentrations were determined by
ELISA (chapter 3-Appendix A:2, A:3 and A:4).
In order to allow the collection of serum on all the above
days in one experiment, only 4 animals/group were used. The
experiment was then repeated. The results of the two
experiments were almost identical, therefore the values for
each time point were grouped together to allow statistical
evaluation.
Total IgA concentrations in serum
The results are shown in Fig 7:1. The concentrations of IgA
(ug/ml) were significantly greater on days 4 (P<0.001), 7
(P<0.001) and 11 (PC0.001) of the GvHR.
The levels reached a peak on day 12 (P<0.001), had dropped
by day 13, although they still remained significantly
higher than controls (P<0.001).
By days 20, 24 and 27 the concentrations of IgA did not
differ significantly from controls.
A striking increase (5 fold greater than the control) was
observed on day 32 (PC0.001).
Total IqM concentrations in serum
The results are shown in Fig 7:2. Total IgM concentrations
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(ug/ral) were significantly greater than controls on day 4
(P<0.001), 7 (P<0.001) and 11 (P<0.001).
By day 12 the levels were rising further (P<0.001),
reaching a peak on day 13 (P<0.001).
By day 20 the levels had dropped but were still
significantly greater than controls (PC0.001). However, by
days 24 and 27, the concentrations were significantly lower
than controls (P<0.02 and P<0.05 respectively).
A significant increase (PC0.001) was observed on day 32,
but of a much lower magnitude than observed on day 13.
Total IgG concentrations in serum
The results are shown in Fig 7:3. There was no significant
difference in total IgG concentrations (mg/ml) on days 4,
7, 11 and 12 of the GvHR.
On day 13 a significant increase (PC0.001) in the levels of
IgG did occur, and this appeared to be the peak.
The concentrations remained higher than controls on day 20
(P<0.001) but appeared to be on the decline, and by days 24
and 27 no significant difference could be detected.
An increase, to a similar level as day 13, occurred on day
32 .
Comments
The GvHR in adult mice produced significant changes in the
systemic IgA, IgM and IgG concentrations, in a pattern very
similar to the changes in splenic cell proliferation, as
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monitored by the spleen index (Fig 4:3).
Concentrations of IgA and IgM were the first to become
elevated, this occurred only 4 days after the induction of
the GvHR. Levels of IgA reached a peak on day 12, and IgM
on day 13. Concentrations of IgG did not increase until day
13. These alterations are in accord with the effects of
immunostimulation described in the initial phase of the
GvHR (chapter 2).
Following this brief initial immunostimulatory phase, a
period of reduced activity has been shown to occur
(chapter 2). The results presented here confirm this, in
that the concentrations of systemic immunoglobulins
subseguently dropped to that of the control group.
Interestingly, the concentrations of IgM decreased to
levels significantly lower than controls.
A second striking increase, particularly of IgA, was
observed on day 32, again in conjunction with the dramatic
increase in spleen index. It is possible that at this point
the mice have developed the chronic form of GvHR.
In summary, while the GvHR does not appear to influence
immunoglobulin production at the distant mucosal sites of
the salivary and mammary glands, there are dramatic changes
systemically, both during the initial phase of GvHR and at




ng Total IgA/ml Range (ng/ml)
Day 11 CON 179.08 ± 21.21 111.90 - 315.45
GvHR 216.04 + 36.20 99.75 - 397.15
Day 12 CON 246.56 + 31.10 165.55 - 397.15
GvHR 246.56 ± 14.37 194.50 - 310.25
Day 13 CON 151.85 ± 23.23 104.46 - 308.20
GvHR 235.05 + 41.24 119.94 - 488.62
Day 14 CON 337.10 ± 32.92 190.98 - 578.91
GvHR 433.83 + 86.59 83.17 -1294.36
Day 18 CON 193.49 + 28.16 117.00 - 315.45
GvHR 205.82 + 34.88 115.53 - 322.80




ng Total IgA/ml Range (ng/ml)
Day 1 1 CON 403.20 + 45.99 286.00 - 578.51
GvHR 399.00 + 37.78 273.10 - 475.53
Day 12 CON 293.81 + 39.87 223.35 - 397.15
GvHR 271.00 + 21.41 208.40 - 301.25
Day 13 CON 263.74 + 28.64 194.52 - 336.00
GvHR 303.64 ± 64.39 213.30 - 488.62
Day 14 CON 231.03 ± 31.93 165.55 - 315.45
GvHR 294.51 ± 41.23 213.25 - 397.15
TABLE 7:2 Total IgA concentrations in milk during a GvHR.
Figures represent mean+SEM.
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FIGURE 7:1 Serum IgA concentrations during a GvHR.
Total IgA concentrations (mean±SEM) in serum are given for
both animals with GvHR (closed triangle) and age-matched
controls (open circle).
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FIGURE 7:3 Serum IgG concentrations during a GvHR.
Total IgG concentrations (meaniSEM) in serum are given for




THE EFFECT OF A GVHR ON IMMUNOGLOBULIN PRODUCTION AT THE
EXTREMES OF LIFE
INTRODUCTION
The stimulatory nature of the GvHR is well recognised in
the adult murine model (chapter 2), and the work of this
thesis has demonstrated the enhanced concentrations of
mucosal immunoglobulins in the gut lumen (chapter 6).
However, the effects on immunoglobulin production,
particularly in the gut, are brief.
The aim of this study was to investigate a murine model in
which the immunostimulatory influences of the GvHR would be
exaggerated. The immune systems of both neonatal and aged
mice are altered quite dramatically as compared to the
young adult (see below) and thus both neonates and aged
mice were studied.
A: MUCOSAL IMMUNOGLOBULIN PRODUCTION IN NEONATAL MICE.
In neonatal mice both humoral and cell mediated responses
are immature. There are very few detectable immunoglobulin
secreting cells (Ig-SC) in systemic and mucosal organs
until weaning. At weaning, and in the following 3 weeks,
the exposure of the animal to exogenous antigens,
particularly in the gut (Ferguson and Parrott, 1972),
stimulates an increase in numbers of Ig-SC in SP, bone
marrow, MLN, PP and the small intestinal LP. T cell numbers
are also known to increase, and the animal's immune
responses mature (Van Der Heijden et al, 1988).
A GvHR induced in neonatal mice is known to produce a
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destructive-type enteropathy (chapter 2) and, as discussed
in chapter 6, a deficiency in immunoglobulin-containing
cells in the duodenum of preweaned mice, 14 days after the
induction of a GvHR, has been described (Gold et al, 1976).
However, the increased stimulation of both B and T cells
around the time of weaning, coupled with the
immunostimulatory nature of the GvHR suggests that the
effects of GvHR on mucosal immunoglobulin levels may be
exacerbated in neonates.
Mucosal immunoglobulin production was investigated at and
around the time of weaning.
Experimental protocol
A semi-allogeneic GvHR was induced in nonirradiated
neonatal BDF-^ mice aged 7, 14 and 21 days. Mice were weaned
at 21 days of age.
The concentration of donor spleen cell inoculum given to
the recipients (chapter 3) was adjusted to take into
account the age of the animals. Age-matched controls were
given medium alone. 8-10 mice/group were used.
14 days after the induction of the GvHR, at ages 21, 28 and
35 days, body and spleen weights were recorded and gut
washings collected from both control and GvHR groups.
Collecting the gut washings on these days enabled the
study of the effect of a GvHR on IgA and IgM concentrations
before weaning (day 21) and 1 week (day 28) and 2 weeks
(day 35) after weaning.
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At this age (21-35 days), the mice were very small and
unable to tolerate the 4x0.5mls of lavage fluid fed before
the collection of the gut washings. In an initial pilot
study, feeding this amount of lavage fluid resulted in
stomach rupture and death. The mice were able to tolerate
2x0.5mls of lavage solution, after a 12hr fast, and on
examination of the gut, both the small and large intestine
contained fluid.
IgA and IgM immunoglobulin concentrations were determined
by ELISA (chapter 3-Appendix A:2 and A:3).
Body weights and Spleen Index of neonatal mice with GvHR.
The body weights of both control and GvHR groups and the
spleen index of the GvHR groups are given in Table 8:1.
Only those animals, age 14 days at the onset of GvHR had,
on sacrifice, a significantly lower body weight (PC0.01)
than age-matched controls. The spleen index indicates that
a GvHR was in progress.
Total IqA concentrations in gut washings
In both control and GvHR groups there was a substantial
rise in mucosal IgA concentrations (ng/ml) within the
period of weaning (Table 8:2).
There was no significant difference in the total IgA
concentrations in gut washings taken from GvHR mice, aged
7, 14 or 21 days at the induction of GvHR, as compared to
the controls (Table 8:2).
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Total IqM concentrations in gut washings.
As with IgA, the levels of IgM (ng/ml) in gut washings,
from both control and GvHR groups, increased quite
dramatically over the first 2 weeks after weaning (Table
8:2).
A significant increase (P<0.01) in IgM concentrations
(Table 8:2) was observed on day 14 of the GvHR, in mice
aged 7 days at the induction of the reaction. No
significant changes were observed in the other age groups.
Comments
The results confirm previous reports (Van Der Heijden et
al , 1988 ) that after weaning in normal mice the
concentrations of IgA and IgM in the gut increase
dramatically.
Despite the immunostimulatory nature of the GvHR there was
no accentuation of IgA response in the gut lumen of
neonatal mice. In mice aged 7 days at the onset of GvHR, an
increase in total IgM was detected 14 days later. In
contrast to the findings of Gold et al , ( 197 6 ), no
immunoglobulin deficiency was observed.
B: IMMUNOGLOBULIN PRODUCTION IN AGED MICE WITH CHRONIC
GVHR.
In normal, aged animals the immune system undergoes a
senescence that is characterised by a decreasing ability to
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produce antibodies and to mount a CMI response. In
contrast, an increase in autoantibody formation to
polyclonal B cell stimulators, auto-anti-idiotypic
antibodies, and a failure of tolerance induction have been
described (Habicht, 1987). There is evidence to suggest
that in aged mice the cells of the mucosal-associated lymph
nodes do not have the decreased immune function that is
observed in the systemic tissues (Szewczuk and Wade, 1983).
The semi-allogeneic GvHR in nonirradiated BDF-j_ mice can
progress to the chronic form; the characteristics of which
are immunostimulatory in nature, and the most striking
features are systemic polyclonal B cell stimulation,
hypergammaglobulinaemia and autoantibody production. In the
work from Gleichmann and co-workers, the features of the
chronic GvHR were observed from 24 weeks after the
induction of the GvHR (chapter 2).
The non-specific immunostimulatory effects of the GvHR are
very similar to those occurring during the aging process,
and as with the neonatal model, it was hypothesized that
the effects on mucosal immunoglobulin production occurring
during the GvHR would be exaggerated in aged mice. Systemic
and mucosal immunoglobulin concentrations both in normal
aged mice and in aged mice with chronic GvHR were studied.
The systemic immune response, both humoral and cell-
mediated, to an enterically presented antigen, BLG, was
also studied in these aged animals. This work is relevant




A semi-allogeneic GvHR was induced in adult BDFmice aged
6-8 weeks, by i.p. injection of 10® C57B1/6J spleen cells.
Control animals received medium alone.
18 months later, body and spleen weights were recorded and
gut washings and serum collected. Gut washings were
collected from 10 animals/group, and serum from 16
animals/group.
Immunoglobulin concentrations were determined by ELISA
(chapter 3 - Appendix A:2, A:3, A:4).
Body weights and relative spleen weights of aged mice
Throughout this experiment all the animals remained well.
A group of young, adult BDF^ mice (aged 6-8 weeks) were
sacrificed at the same time as the aged animals, and body
and spleen weights recorded.
The body weights (Table 8:3) of the animals had, as
expected, increased (P<0.01) with age. An interesting
observation was the significantly lower (P<0.01) relative
spleen weight (mgs spleen weight/lOg body weight) of the
aged animals compared to animals aged 6-8 weeks (Table
8:3) .
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Age and immunoglobulin concentrations in serum and gut
washings
A comparison between the total IgA and IgM concentrations
in gut washings and total IgA, IgM and IgG in serum from
normal mice aged 6-8 weeks old, and normal mice aged 18
months is presented in Table 8:4. The values for normal
mice aged 6-8 weeks are the means ± SEM of the results
presented in chapters 6 and 7.
The concentrations of IgA and IgM in gut washings had quite
obviously increased with age. The levels in aged mice were
similiar in magnitude to those detected in early life, at
the time of weaning (Table 8:2).
In serum (Table 8:4), both IgA and IgM concentrations were
greatly increased in the 18 month old mice. Interestingly,
the concentrations of IgG did not increase with age, and
remained in the same range as the 6-8 week old mice.
Body weights and Spleen Index of aged mice with chronic
GvHR.
Animals with chronic GvHR remained well throughout this
experiment.
There was no significant difference in body weights between
control and GvHR groups (Table 8:5). A spleen index of 1.52
(Table 8:5) indicated the late effects of the GvHR.
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Mucosal immunoglobulin concentrations during chronic GvHR.
There was no significant difference (Table 8:6) in either
IgA or IgM concentrations in gut washings of mice with
chronic GvHR when compared to age-matched controls.
Serum immunoglobulin concentrations during chronic GvHR
The concentrations of serum IgA, IgM and IgG in mice with
chronic GvHR are given in Table 8:7.
Mice with chronic GvHR had significantly higher (P<0.005)
concentrations of IgA (ug/ml), and IgG (mg/ml) (P<0.00001).
In contrast, serum IgM concentrations (ug/ml) were
significantly lower (P<0.05) than controls.
Comments
The concentrations of both systemic and mucosal IgA and IgM
increased with age. Interestingly, the concentrations of
IgG remained within the same range as normal 6-8 week old
mice. These results may reflect the dichotomy of effects of
age on systemic and mucosal immunity.
The chronic form of the murine GvHR resulted in striking
increases in the concentrations of IgA and IgG in serum,
with a simultaneous decrease in IgM. There was no change in
the immunoglobulin levels in the gut luminal contents.
Hypergammaglobulinaemia with a concomitant decrease in IgM
has been observed in the chronic form of GvHR, in both
experimental animals and BMT patients (chapter 2).
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In summary, the GvHR in neonates did not exacerbate the
production of IgA in the gut as had been hypothesized. 14
days after the induction of a GvHR in 7 day old mice an
increase in IgM was observed, however, this increase was
not observed in any other age group.
In chronic GvHR, no effect on the mucosal immunoglobulin
response was observed. Systemically, both IgA and IgG
levels were elevated, but IgM levels were much lower than
controls, reflecting possibly, polyclonal stimulation and
isotype-switching of activated B cells; both recognised
features of the chronic form of GvHR.
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Age at Onset Age on Body Weights (g) Spleen
of GvHR (days) testing (days) Control GvHR Index
7 21 8206 ± 0.65 7.828 ± 0.53 1.87
14 25 11.717 ± 027 10261 + 0.33* 1.79
21 35 18.546 ± 0.72 18.204 + 0.57 1.80
* P<0.01




Age at Onset Age on Total IgA
of GvHR (days) testing (days) ng/ml
Total IgM
ng/ml
CON 166.42 + 39.3 35.39 ± 3.03
7 21
GvHR 289.70 + 88.50 146.57 ± 20.69*
CON 406.62 + 90.74 200.56 ± 39.46
14 28
GvHR 393.27 ± 53.06 197.43 ± 50.51
CON 682.92 ±116.93 523.20 + 115.15
21 35
GvHR 753.49 ± 118.92 573.82 + 174.65
TABLE 8:2 Total IgA and IgM concentrations (mean+SEM) in
gut washings collected from neonatal mice 14 days after the
induction of a GvHR.
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Control Control
Age : 6-8 wks Age : 18 months
Body weights (g) 21.484 + 0.38 35.812 + 2.21*
Relative Spleen
Weight (mgs) 35.41 ± 1.46 18.54 ± 2.28*
P<0.01
TABLE 8:3 Body and spleen weights of aged BDF1 mice.
Figures represent mean+s.d.
Control
Age : 6-8 wks
Control

















Total IgA 243.55 + 26.80 710.21 ± 71.66
(Hg/ml)
Range 120 - 385 257 - 1531.49
Total IgM 145.22 ± 12.88 486.41 ± 52.57
(gg/ml)








TABLE 8:4 The effect of age on serum and mucosal
immunoglobulin concentrations.
Figures represent mean+SEM.
Body weights (g) Relative Spleen Spleen
Weight (mgs) Index
Control 35.812 ± 2.21 18.54 + 2.28 -
GvHR 31.199 ± 1.40 28.11 ± 2.80 1.52




Total IgA Total IgM
(ng/ml ) (ng/ml)
CON 1072.12 ± 327.19 30.38 ± 6.78
Range 322.59 - 3027.12 8.48 - 67.76
GvHR 1049.50 ± 267.50 35.31 ± 7.73
Range 452.98 - 2725.92 4.97 - 76.04
TABLE 8:6 Total IgA and IgM concentrations (meaniSEM) in
gut washings collected from aged mice with chronic GvHR.
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Total IgA Total IgM Total IgG
(ng/ml) (ng/ml) (mg/ml)
Control 710.21 ± 71.66 486.41 ± 52.57 5.41 ± 0.21
Range 257 - 1531 191 - 1226 3.58 - 7.33
GvHR 1177.37 ± 137.72** 318.37 ± 36.30* 8.59 ± 0.39***




TABLE 8:7 Serum IgA, IgM and IgG concentrations (mean+SEM)
in aged mice with chronic GvHR.
CHAPTER NINE
THE EFFECT OF A GVHR ON IMMUNOGLOBULIN-SECRETING CELLS IN
PEYER'S PATCHES, MESENTERIC LYMPH NODES AND SPLEEN
INTRODUCTION
The findings presented in chapters 6 and 7, have
highlighted the immunostimulatory effect of the GvHR on B
cells and on immunoglobulin production.
Increased concentrations of IgA, IgM and IgG were detected
in the circulation during the initial phase of GvHR. Quite
separately, increased counts of IgA and IgM plasma cells,
but not IgG, were observed in the LP. The transient
increase in IgA concentrations in the gut lumen, and the
prolonged increase in IgM suggests that the GvHR is
affecting the immunoregulation of mucosal B cells early in
their maturation pathway.
The source of mucosal immunoglobulin-secreting cells (Ig-
SC) is believed to be the PP. During the migration of
activated B cells from the PP to the LP, T cell dependent
immunoregulation ensures isotype-switching from sIgM+ B
cells to sIgA+ B cells, clonal proliferation and finally
terminal differentiation into IgA-secreting plasma cells
(reviewed in chapter 1).
On leaving the PP, B cells enter the MLN and from there
enter the circulation via the thoracic duct. The cells may
spend some time in the SP prior to homing to the gut and
other distant mucosal sites.
The aim of this investigation was to assess the effect of a
GvHR on the total cell counts and Ig-SC counts in the
mucosal-associated lymph nodes and spleen to gain some
preliminary information as to where in the maturation and
immunoregulatory pathway of mucosal B cells the GvHR was
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exerting an immunostimulatory effect.
General protocol
A semi-allogeneic GvHR was induced in adult BDF^ mice, age
O
6-8 weeks, by i.p. injection of 10 donor spleen cells.
Controls received medium alone.
On days 4, 7, 11, 13, 20, 24, 27 and 32 after the induction
of a GvHR, PP, MLN and SP were removed (chapter 3). 4
mice/group were used at each time point. The lymph nodes
were pooled, and a single cell suspension made (chapter 3).
The total cell count was recorded and each suspension
appropriately diluted and two aliguots containing 10® cells
taken for use in the ELISPOT assay (chapter 3). The
dilutions of coating and conjugated antibodies stated in
chapter 3 were determined by using SP cells from normal
nonimmunised BDF^ mice. The concentrations of detecting
antibody chosen, gave a count of IgA+~, IgM+- and IgG+-SFC
in the expected range (van der Heijden, Stok and Bianchi,
1987 ) .
In this experiment, the ELISPOT assay was performed "blind"
to the nature and origin of the samples. At the end of the
experiment the data were collected and analysed.
The results are expressed in Fig 9:2, 9:3, and 9:4 (a, b,
c) as numbers of Ig Spot-Forming Cells (SFC)/10® cells.
This corresponds to the numbers of Ig-SC, as described in
the text. The results given for those animals with GvHR,
represent the mean value for each time point studied. The
SEM is not given as the results are taken from pooled
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samples. The results for the control samples, taken
throughout the experiment, are grouped together and the
meaniSEM displayed on the figures.
Macroscopic examination of lymph nodes
The enlargement of the spleen during a GvHR is well
recognised. As well as splenomegaly, both PP and MLN were
enlarged throughout the initial stages of the GvHR and
consequently the MLN in mice with GvHR were easier to find
and remove than in control mice.
A: TOTAL CELL COUNTS OF PP. MLN AND SP THROUGHOUT THE GVHR
The total cell counts of PP, MLN and SP are given in
Fig 9:1 (a, b, and c).
The total cell counts in the lymph nodes dissected from
normal, control mice were in the same order of magnitude as
reported by van der Heijden et al, (1987).
Total cell count of PP
On day 7 of the GvHR there was a dramatic increase in the
total cell count of PP (Fig 9:1a), which subsequently
dropped to below control levels by day 11. On days 20 and
24 the total cell count was substantially lower than
controls.
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Total cell count of MLN
The total cell count of MLN (Fig 9:1b) was greater than
controls on day 7 of the GvHR, and, although in decline the
numbers remained high until day 13. A second small increase
was observed on day 24, but by day 27 the count had
returned to that of controls.
Total cell counts of SP
The total cell count of SP (Fig 9:1c) was greater than
controls from day 7 of the GvHR and remained high until
around day 24. On day 32 of the GvHR there was a dramatic
increase in the total cell count, greater than that
observed on day 7.
Comments
During the GvHR, the PP, MLN and SP were increased in size,
and at certain time points throughout the reaction
increased total cell counts were detected.
A substantial increase in total cell count was observed on
day 7 of the GvHR in PP, MLN and SP. While the total cell
count remained higher than controls in the SP throughout
the GvHR, the numbers in the MLN and PP returned to normal
by days 11-13. A striking increase in total cell count was
observed on day 32, but only in the SP.
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B: IMMUNOGLOBULIN-SECRETING CELLS IN PP. MLN AND SP
THROUGHOUT THE GVHR
Total IqG-secretinq cells in PP, MLN and SP throughout the
GvHR.
The numbers of IgG+-SC in the SP, MLN and PP of the control
mice were of a similar order of magnitude as described by
van der Heijden et al (1987), using a Plaque-forming-cell
(PFC) assay.
Total IqG-secretinq cells in PP
An increase in counts of IgG+SFC/106 cells was observed on
day 11 (Fig 9:2a) of the GvHR. The count returned to
control levels by days 20-24 and remained so until the end
of the study.
Total IqG-secretinq cells in MLN
A substantial increase in IgG SFC/10^ cells in the MLN (Fig
9:2b) was observed on day 11. The numbers dropped, but
still remained higher than controls until the end of the
study.
Total IoG-secretinq cells in SP
The numbers of IgG SFC/10^ cells in the SP (Fig 9:2c) were
increased on day 7 of the GvHR. After a drop on day 11, the
numbers remained higher than controls until a second
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increase on day 32.
Total IcrA-secretinq cells in PP, MLN and SP throughout the
GvHR.
The numbers of IgA+SFC/10^ cells in PP, MLN and SP taken
from the control animals (Fig 9:3a,b,c) were extremely low
compared to the findings of van der Heijden et al, (1987).
Using their PFC-assay they found 1730 IgA+-SC/106 PP cells,
1197 IgA+-SC/106 MLN cells and 419 IgA+-SC/106 SP cells. In
this particular experiment only 2-3 IgA+-SC/10^ were
detected; it would therefore appear that this ELISPOT assay
had not worked.
Total IgM-secretino cells in PP, MLN and SP throughout the
GvHR.
The numbers of IgM+ cells in the PP, MLN and SP taken from
control mice (Fig 9:4a,b,c) were also very low. van der
Heijden et al, ( 1987 ) found 584 IgM+-SC/106 PP cells, 142
IgM+-SC/106 MLN cells and 2686 IgM+-SC/106 SP cells.
In this experiment only 2-4 IgM+-SC/10^ cells were
detected. Again this comparison of data would suggest that
this ELISPOT assay did not work.
Despite the very low counts in the control group, the
numbers of IgM+-SC were higher during the GvHR.
In the PP and the MLN (Fig 9:4 a,b) an increase was
observed on day 7 of the GvHR. In the SP (Fig 9:4c) the
counts were higher than controls on days 4 and 7 and a
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substantial increase was observed on day 32 of the GvHR.
General Comments
The investigations described in this study have shown that
during the GvHR there is a substantial increase in the
total cell count of PP, MLN and SP on day 7. While the
total cell counts of the PP returned to control levels by
day 11 and the MLN by day 13, the SP cell count remained
high throughout the reaction. A dramatic increase was
observed in the SP on day 32.
The results for the SP cell count parallel the increase in
cell proliferation, as monitored by the SP index (Fig 4:3).
The transient increase in PP and MLN cell numbers only
occurs within the initial phase of the GvHR.
The initial pilot studies of the ELISPOT assays for the
detection of IgA+-SC and IgM+-SC gave good results with
clear, well defined spots and the same conditions were used
in the "blind" experiment. Unfortunately, on this occasion
the assay did not work and I did not have time to repeat
the experiment, or re-analyse the assay. Further work
optimising the assay is now underway in our laboratory.
Despite this, the numbers of IgM+-SC during GvHR were
raised in the PP, MLN and SP on day 7, followed by a
dramatic increase, in the SP only, on day 32.
The ELISPOT assay for the detection of IgG+-SC gave very
good results, and again during the GvHR there were
substantially increased numbers of IgG+-SC in PP, MLN and
SP. While the numbers in the PP and MLN were raised on day
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11, and thereafter in decline, the numbers in the SP were
raised on day 7 and remained higher than controls until the
second increase on day 32.
In summary, during the initial immunostimulatory phase of
the GvHR, the total numbers of cells in PP and MLN are
transiently increased whereas in the SP the numbers remain
high throughout the GvHR. The second increase in SP total
cell count, on day 32, may reflect the onset of the chronic
GvHR.
The effects appeared to be paralleled in the numbers of Ig-
SC in the PP, MLN and SP in that a transient increase in
IgG+-SC numbers was observed in the PP and MLN but a
prolonged increase was observed in the SP.
Unfortunately no conclusions can be drawn about the numbers
of IgA+- and IgM+-SC as the assay did not work on this
occasion. However, the increased numbers of IgM+-SC
detected in LN of mice with GvHR, and the lack of effect on






FIGURE 9:1 Total cell counts of PP (a), MLN (b), and SP
(c), of adult BDF1 mice throughout the GvHR.
The group mean of the control animals is represented by the
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FIGURE 9;2 Total IgG-secreting cells in PP (a), MLN (b),
and SP (c) of BDF1 mice throughout the GvHR.
The group mean of the control animals is represented by the
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FIGURE 9:3 Total IgA-secreting cells in PP
(c) of BDF1 mice throughout the GvHR.
( a ) , MLN (b),
and SP
The group mean of the control animals is represented by the
solid line and the SEM by the broken lines.
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FIGURE 9;4 Total IgM-secreting cells in PP (a), MLN (b),
and SP (c) of BDFl mice throughout the GvHR.
The group mean of the control animals is represented by the
solid line and the SEM by the broken lines.
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CHAPTER TEN
ORAL TOLERANCE INDUCTION TO ENTERICALLY PRESENTED ANTIGENS
IN BDF1 AND TRANSGENIC MICE
INTRODUCTION
The relationship between mucosal immunity and systemic
hyporesponsiveness (oral tolerance) is as yet uncertain,
and in chapter 11 the investigations into the murine
systemic and mucosal immune responses to the clinically
relevant dietary antigens, OVA and BLG, under normal
conditions and conditions of T cell activation are
described.
Prior to studying the secretory immune response to OVA and
BLG, it was first necessary to investigate oral tolerance
induction to these chosen antigens.
The phenomenon of oral tolerance is recognised as the
suppression of systemic humoral and cell mediated immune
responses to an enterically presented antigen, and is under
T cell regulation (chapter 1).
A substantial amount of work on the mechanisms of oral
tolerance to the dietary antigen OVA has been performed in
this laboratory (Strobel, 1983; Bruce, 1985; Lamont, 1986),
and therefore OVA was further used in these studies as a
dietary antigen of known properties.
A second antigen, BLG, a protein found in cow's milk, and
implicated in CMPI was also studied. This antigen was of
particular interest as I had the unigue resource of a
colony of transgenic mice, transfected with a cloned sheep
BLG gene, which expressed sheep BLG, in milk, during
lactation.
k
The aims of the investigations described in this chapter
were : -
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a. to establish the technique of oral tolerance using the
well studied antigen OVA.
b. to determine the dose of BLG required to induce oral
tolerance in adult mice and to investigate a possible low
dose priming effect, which has now been described with OVA
(Lamont, Mowat and Parrott, 1989); a wide range of doses of
BLG were studied. The antigen specificity of the reaction
was also determined.
In addition, since aged animals were available from the
experiments described in chapter 8, oral tolerance
induction in aged mice was studied.
c. Finally, the systemic immune response to BLG in F-^ mice,
having received BLG from the milk of transgenic mothers,
from the first day of life, was assessed.
A: ORAL TOLERANCE INDUCTION TO OVA
Previous work from this laboratory had shown that systemic
hyporesponsiveness to OVA could be induced when a dose of
25mgs OVA was fed to adult mice. Using the established
protocol I performed an oral tolerance experiment, using
OVA, to both learn the technique, and to determine the
systemic hyporesponsiveness of the adult BDF-^ mice which
were to be used in the studies described in chapter 11.
Experimental protocol of tolerance induction
The experimental design is described in Fig 10:1. This
basic protocol was used in all of the studies of oral
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tolerance. 7 days after feeding the desired amount of
antigen (chapter 3), the animals were challenged
systemically by i.d. injection of lOOug antigen in CFA
(chapter 3). 3 weeks post-immunisation animals were bled
via the retro-orbital plexus (chapter 3) and serum
antibodies detected by ELISA (chapter 3, Appendix A:5). The
DTH response was determined, by the 24hr footpad increment,
after antigen challenge (chapter 3).
8 BDF-^ mice, aged 6-8 weeks, were used per group. Serum was
collected from 6 mice/group, and the DTH response was
assessed in all 8 mice.
Values for the % suppression of the DTH response were
obtained as follows:-
% Suppression =
response in control group - response in tolerant group
xlOO
response in control group
Results
The results, presented in Table 10:1, show that feeding
25mgs of OVA prior to systemic challenge produces
significantly lower (P<0.01) levels of IgG anti-OVA
antibodies than in saline fed controls. Similarly the DTH
response was significantly lower (P<0.01; 85% suppression)
in mice fed OVA as compared with controls.
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B: ORAL TOLERANCE INDUCTION TO BLG IN ADULT BDFl MICE
Experimental protocol
The study was divided into 4 separate experiments, in which
a range of doses (lug-75mgs) of BLG were fed. The protocol
used was as described in Fig 10:1. 8 BDF-^ mice (age 6-8
wks)/group were studied, and the antibody and DTH responses
assessed as described above.
Results
Experiment 1
In this first experiment mice were fed lmg, lOmgs, 25mgs,
or 50mgs of BLG. The control group received saline alone.
While feeding lmg BLG gave a significantly higher footpad
increment (PC0.05) than controls, only in those mice fed 50
mgs BLG (Table 10:2), were both the IgG anti-BLG response
(P<0.05) and the DTH response (P<0.005; 133% suppression)
significantly lower than the saline fed controls.
Experiment 2
Mice were fed lOug, 50ug, lOOug or 250ug BLG, and control
mice received saline.
In those animals fed lOug BLG, a significantly lower DTH
response (P<0.05; 38% suppression) was observed. However no
significant alteration in either the antibody or DTH
-191-
response was observed in the other groups.
Experiment 3
Mice were fed 500ug, lmg, 25mgs or 50mgs of BLG. Controls
received a saline feed.
In those animals fed 25mgs or 50mgs of BLG, the antibody-
response was significantly lower than controls (P<0.01).
However, only those animals fed 50mgs of BLG had a
significantly lower DTH response (P<0.001; 140%
suppression) thus duplicating the findings of experiment 1.
Experiment 4
Mice were fed lug, 5ug, lOug or 75mgs of BLG. The controls
were fed saline.
Mice fed 75mgs of BLG had a significantly decreased
antibody response (P<0.01) as compared with controls. No
other concentrations of BLG induced oral tolerance.
Comments
The results described in Tables 10:2, :3, :4 and :5 show
that the dose of BLG reguired to induce systemic
hyporesponsiveness in both the antibody and DTH responses
was 50mgs. A suppressed antibody response was also observed
in mice fed 25mgs or 75mgs BLG. No low dose priming of the
antibody and DTH responses was found. The disparate
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effects to the DTH response after feeding lOug or lmg BLG
were only significant at the P<0.05 level, and were not
reproduced. The probable explanation is that these
anomalies occurred by chance when such a large number of
different experimental groups were being analysed. In
addition, it should be noted that the DTH responses to BLG
in some positive control groups were very low and this may
complicate the interpretation of the findings on oral
tolerance to BLG.
Antigen specificity of the induction of oral tolerance to
BLG
In previous studies of oral tolerance induction to OVA, the
antigen specificity of the response was determined by the
inability to induce systemic hyporesponsiveness to an
unrelated antigen, such as horse serum albumin (HSA) or
bovine serum albumin (BSA), by prior feeding with OVA.
To determine the antigen specificity of the tolerance
response to BLG, mice were challenged with OVA after prior
feeding with BLG.
Experimental protocol
The experimental protocol described in Fig 10:1 was used in
this experiment. The following 4 groups of 8 adult BDF^
mice were studied. Group A, controls, were fed saline and
challenged with BLG. Group B, were fed 50mgs BLG and
challenged with BLG. Group C, the OVA control group, were
fed saline and challenged with OVA, and Group D were fed
50mgs BLG and challenged with OVA. The antibody response,
both IgG anti-BLG and IgG anti-OVA, was assessed in all
groups, while the DTH response to BLG
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was assessed in Groups A and B, and the DTH response to OVA
assessed in Groups C and D.
Results
The results presented in Table 10:6 confirm that feeding
50mgs of BLG induces systemic tolerance for both IgG anti-
BLG (P<0.01) and the DTH response (PC0.001; 100%
suppression).
Feeding mice 50mgs BLG did not suppress either the humoral
or DTH responses to OVA, indicating that oral tolerance
induction to BLG is an antigen-specific phenomenon.
Oral tolerance induction in aged mice
Experimental protocol
The experimental protocol described in Fig 10:1 was used in
this experiment. The following groups of BDF-^ mice (8
animals/group) were studied. Group A (age 6-8wks) were fed
saline and immunised with BLG, Group B (age 6-8wks) were
fed BLG (50mgs) and immunised with BLG, Group C (age
18mths) were fed saline and immunised with BLG and Group D
(age 18mths) were fed BLG (50mgs) and immunised with BLG.
Results
The results are given in Table 10:7.
In mice age 6-8wks, prior feeding of BLG (50mgs),
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significantly suppressed both the IgG anti-BLG response
(P<0.05) and the DTH response (P<0.01; 112% suppression);
thus repeating the findings described above.
In contrast, feeding a tolerizing dose of BLG to aged mice
(age 18mths) did not induce oral tolerance for either the
humoral or cell mediated immune response. In fact the DTH
response of aged mice after immunisation, without prior
feeding (Group C), was significantly greater (P<0.05) than
that found in young adult mice (Group A).
C: THE TRANSGENIC MOUSE MODEL
A strain of transgenic mice, possessing the sheep BLG gene
and expressing BLG in milk during lactation, was donated by
J.P. Simons (Edinburgh Research Station, AFRC Institute of
Animal Physiology and Genetics Research, King's Buildings
Edinburgh).
The complete method of gene transfer used in producing the
transgenic mouse strain is described in Simons, McClenaghan
and Clark, ( 1987 ) .
Briefly, a clone of the gene encoding sheep BLG was
microinjected into pronucleus stage fertilized eggs
obtained from superovulated (C57B1/6xCBA)females after
mating with F-^ males. The injected eggs were cultured
overnight and cleaved embryos transferred into the oviducts
of pseudopregnant F-j_ females. Detection of the BLG gene in
the offspring was by Southern blot analysis of sections of
tail, at weaning.
Abundant BLG transcripts were detected only in the mammary
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gland, although after long exposures extremely low levels
of BLG could be detected in other sites (Simons et al,
1987).
A range of concentrations of sheep BLG from 3mg/ml to
23mg/ml could be found in the milk of lactating females
(Simons et al, 1987 ), and production of the gene product
was believed to be switched on, under hormonal control, as
early as day 11 of gestation.
I was given a group of 8 females, known to possess the
sheep BLG gene, but which had not yet expressed the
protein, and 8 females, born of transgenic mothers, but not
carrying the gene.
The transgenic mouse strain offered a possible animal model
for the study of both the systemic and mucosal immune
reactions of neonates to a novel, dietary antigen presented
in the mothers milk, and administered to an essentially
immature gut from the first day of life.
Previous work in this laboratory revealed that feeding a
weight related dose of OVA to mice in the first weeks of
life, or in the prenatal period, resulted in a primed
antibody and DTH response on subsequent challenge (Strobel
and Ferguson, 1984).
The investigations described in this section were a pilot
study designed to determine the systemic response in adult
mice having been fed a novel, dietary antigen, BLG, in the
first few weeks of life.
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CROSS-REACTIVITY BETWEEN OVINE AND BOVINE BLG
The BLG used in the studies of oral tolerance described
above was the commercially available bovine BLG and the
ELISA was designed to detect antibodies to bovine BLG.
Prior to studying the systemic antibody and DTH responses
in the transgenic mouse strain, it was first necessary to
determine the cross-reactivity of bovine and ovine (sheep)
BLG. Cross-reactivity between the two antigens would allow
the challenge of mice with the bovine BLG, and detection of
antibodies using the established ELISA.
The precipitin assay used to determine the cross-reactivity
between the two antigens is described in chapter 3. 2
precipitin plates were set up as follows (Fig 10:2):-
Plate 1: A positive control, set up to assess the viability
of the assay contained normal mouse serum (NMS) as the test
antigen (in wells 1 and 2), and rabbit anti-mouse Ig (Dako,
Immunoglobulins, Denmark) as the detecting antibody (well
3) .
Plate 2: contained a 1:5 dilution of defatted Dorset Horn
sheep milk (a kind gift from J.P. Simons), the test antigen
in well 1, a 3mg/ml concentration of bovine BLG (Sigma) in
well 2 and a neat solution of mouse serum containing IgG




The results (Fig 10:2), depicted diagrammatically, show
complete identity between bovine BLG and the BLG contained
in sheep milk.
SYSTEMIC RESPONSE TO BLG IN THE OFFSPRING OF TRANSGENIC
MICE
The following four groups were designed to assess the
systemic response to BLG after prior feeding of the antigen
(Group A a control, and Group B the test group).
In conjunction Groups C and D were designed to give some
initial information on the effect of possessing the sheep
BLG gene (although not having expressed the gene product)
on the systemic response to BLG.
Group A: Offspring, both female and male, of a cross
between nontransgenic females and CBA males (Animal Unit,
Western General Hospital, Edinburgh). The offspring did not
possess the sheep BLG gene, and were not exposed to sheep
BLG during lactation; thus acting as controls.
Group B: Offspring of a cross between transgenic females
and CBA males. All the offspring received sheep BLG during
lactation. Some of the offspring may have received the
sheep gene from the transgenic mothers, however this was
not assessed.
Group C: Offspring of a cross between transgenic females
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and CBA males. The offspring were then fostered onto normal
lactating C57B1/6J females (from Group D) within a few
hours after birth. Some of the offspring would possess the
sheep BLG gene, and the mice may have received sheep BLG,
from the mother's milk, prior to being fostered.
Group D; Offspring of a cross between normal C57B1/6J
females and CBA males, fostered onto the transgenic mothers
of group C. These animals would not possess the sheep gene,
but would receive sheep BLG from milk, during lactation.
Experimental protocol
On day 21 of life the offspring from all 4 groups were
weaned onto the standard small rodent diet (CRM(x)). 3
weeks post-weaning the mice were systemically challenged
with lOOug bovine BLG in CFA injected i.d. into the right
hind footpad. 3 weeks post-immunisation serum was collected
and the DTH response assessed.
Results
Antibody response
The antibody response observed in Group A (Fig 10:3) was
comparable to the response found in mice immunised with BLG
but without a prior feed (see Tables 10:2, :3, :4 and :5).
Although not statistically different from Group A, there
was a wide range (OD values 0.129 - 1.086) in the antibody
responses in Group B, suggesting that while some mice had a
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suppressed antibody response to BLG after feeding, others
did not.
The mice in Group C also had a wide range (OD values 0.419
- 1.134) of antibody response despite having only been in
contact with BLG in the first few hours before being
fostered.
The mice in Group D had a positive antibody response to
BLG, comparable to the control Group A, despite having been
fed sheep BLG. There was no statistical difference between
Groups C and D.
A statistical comparison between Groups B and D (both
groups having received sheep BLG in milk from transgenic
females) revealed that the antibody response in Group B was
significantly lower (P<0.05) than in Group D. The
difference between the groups was that mice in Group B were
born of transgenic mothers; therefore up to 50% of the
offspring would have received a copy of the sheep BLG gene
from the mothers.
DTH response
No statistical difference between the groups was observed,
indicating that the presence of BLG in the milk ingested in
the first weeks of life did not suppress the DTH response.
The milk is known to contain a wide spectrum of BLG




The results obtained from this investigation show that
normal mice fed sheep BLG from the milk of transgenic
females were not tolerant to this antigen on subseguent
systemic challenge, neither were they primed, as observed
by Strobel and Ferguson, (1984).
In those animals born of transgenic mothers, and possibly
possessing a copy of the gene, there was a wide variation
in the antibody response regardless of whether or not these
animals had been previously fed BLG; suggesting that
possession of the sheep gene may alter the outcome of the
antibody response.
Under certain conditions, the foetus and the newborn are
believed to express milk (Witch's milk). It is therefore
possible that those mice carrying the sheep BLG gene
expressed sheep BLG while in the uterus; thus influencing
the humoral and DTH responses in later life. In this
respect serum collected from nonimmunised, transgenic
females, after expression of the gene product, did not
contain detectable IgG anti-BLG antibodies (data not
shown).
The transgenic mouse colony was outbred, while all other
oral tolerance experiments have been carried out in inbred
strains. This alone may explain the wide variation in
results.
The transgenic mouse was initially expected to be a good,
practical model of studying tolerance induction to BLG in
neonates. However, these preliminary experiments have shown
-201-
that there are many considerations that have to be taken
into account.
In summary, the results from this chapter show that feeding
50mgs of BLG to adult BDF^ mice 7 days before immunisation
suppresses both the humoral and DTH responses to that
antigen. However, the DTH response in positive controls
fed saline and immunised with BLG, was low which may effect
the interpretation of oral tolerance to this antigen.
Feeding the same dose to aged BDF^ mice did not induce oral
tolerance.
The transgenic mice proved to be a useful model of antigen
delivery to neonatal mice, and the feeding of normal mice
on transgenic lactating females, did not produce systemic
hyporesponsiveness to BLG when challenged in adult life.
However, the initial evidence gained from this study,
suggests that possession of the sheep BLG gene, and the
possible expression of the gene product, influences the
systemic antibody response to BLG.
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EXPERIMENTAL PROTOCOL
Day 0 Antigen feed
Control mice receive Saline
Day 7 Systemic challenge
with 100 gg Antigen
Day 2 8 Bleed animals for antibody assay
Day 29/30 24 hr DTH response
FIGURE—10;1 Experimental protocol of oral tolerance
induction in mice.
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Group IgG anti-OVA DTH Response
FED / IMM OD 405 nm 24hr footpad increment (mm)
SAL / OVA 0.860 ± 0.05 0.26 ± 0.05
OVA/OVA 0.560 ± 0.09* 0.04 ± 0.02*
(85%)
* P<0.01
TABLE 10:1 Oral tolerance to OVA in adult BDF1 mice.
The figures represent the mean+SEM of both the IgG antibody
and DTH responses after prior feeding of 25mgs of OVA.
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Group IgG anti-BLG DTH Response
FED/IMM OD 405 nm 24hr footpad
increment (mm)
SAL/BLG 1.167 + 0.05 0.06 ± 0.02
1 mg BLG / BLG 1.146 ± 0.02 0.14 + 0.02*
10 mg BLG /BLG 1.070 ± 0.05 0.08 ± 0.01
25 mg BLG / BLG 0.906 ± 0.03 0.07 + 0.01




TABLE 10:2 Oral tolerance to BLG in adult BDF1 mice.
The figures represent the mean+SEM of both the IgG antibody










SAL/BLG 0.810 + 0.04 0.13 ± 0.01
10 pg BLG / BLG 0.890 ± 0.03 0.08 ± 0.01*
(38%)
50 pg BLG/BLG 0.814 ± 0.03 0.10 ± 0.02
100 pg BLG / BLG 0.900 ± 0.05 0.12 ± 0.03
250 pg BLG /BLG 0.949 ± 0.04 0.13 ± 0.02
P <0.05
TABLE 10;3 Oral tolerance to BLG in adult BDF1 mice.










SAL/BLG 1.016 + 0.05 0.05 ± 0.007
500 gg BLG / BLG 0.950 ± 0.05 0.06 ± 0.01
1 mg BLG / BLG 0.999 ± 0.05 0.07 + 0.02
25 mg BLG / BLG 0.703 ± 0.08* 0.06 + 0.02




TABLE 10:4 Oral tolerance to BLG in adult BDFl mice
The figures represent the mean+SEM of both the IgG antibodyand DTH responses after prior feeding of various doses of
BLG •
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Group IgG anti-BLG DTH Response
FED/IMM OD 405 nm 24hr footpad
increment (mm)
SAL/BLG 0.822 + 0.03 0.07 ± 0.01
1 gg BLG / BLG 0.766 ± 0.08 0.06 + 0.02
5 gg BLG / BLG 0.901 ± 0.04 0.06 ± 0.01
10 gg BLG / BLG 0.748 ± 0.11 0.08 ± 0.02
75 mgs BLG / BLG 0.342 + 0.05* 0.07 ± 0.01
* P<0.01
TABLE 10:5 Oral tolerance to BLG in adult BDFl mice.
The figures represent the mean+SEM of both the IgG antibody













A: Sal/BLG 0.350 ± 0.08 negative 0.08 ± 0.01 ND
B: BLG/BLG 0.120 ± 0.04* negative 0 ±0.01* *(100%) ND
C: Sal/OVA negative 0.710±0.10 ND 020 ± 0.03




TABLE 10:6 Antigen specificity of oral tolerance induction
to 50mgs of BLG.




Group IgG anti-BLG 24hr footpad
FED/IMM OD 405 nm increment (mm)
A 6-8 wk old
SAL7BLG
1.198 + 0.03 0.08 + 0.01
B 6-8 wk old
BLG/BLG
0.249 + 0.07* -0.01 ± 0.01**
(112%)
C 18 mth old
SAL7BLG
1.205 + 0.03 0.20 + 0.04*




TABLE 10:7 Oral tolerance to BLG in aged BDF1 mice.
The figures represent the mean+SEM of both the IgG antibody
and DTH responses after prior feeding of 50mgs of BLG.
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Plate 1
Wells 1,2 Normal mouse serum
Well 3 Rabbit anti-mouse
immunoglobulin
Plate 2
Well 1 Ovine BLG
Well 2 Bovine BLG
Well 3 Mouse serum containing
IgG anti-bovine BLG
antibodies
FIGURE 10:2 Diagrammatic representation of the cross-
reactivity between ovine and bovine BLG.
Plate 1 represents the control plate, and plate 2 depicts





















FIGURE 10;3 Serum IgG antibodies to Bovine BLG
transgenic mice.
The mean+SEM is given for each group. The description
each group is given in the text.






FIGURE 10:4 The DTH response to Bovine BLG in transgenic
mice.
Figures represent the mean+SEM of each group. The
description of each group is in the text.
-213-
CHAPTER ELEVEN
THE SYSTEMIC AND MUCOSAL IMMUNE RESPONSES TO ENTERICALLY
PRESENTED ANTIGENS; A STUDY OF THE RELATIONSHIP BETWEEN
ORAL TOLERANCE AND MUCOSAL IMMUNITY
INTRODUCTION
The presentation of antigen via the gut is generally-
considered to induce systemic hyporesponsiveness; thus
protecting the body from the potentially harmful effects of
a systemic immune reaction. There are conflicting reports,
however, as to whether systemic tolerance is accompanied by
a mucosal antibody response or not (chapter 1). While
Challacombe and Tomasi (1980), have demonstrated a salivary
IgA response occurring simultaneously with oral tolerance,
Elson and co-workers (1984ab) have shown, using the potent
immunogen CT together with KLH, that the intestinal IgA
response and systemic tolerance are reciprocally linked and
do not occur simultaneously. Thus the abrogation of oral
tolerance to KLH, by feeding with CT, was accompanied by a
mucosal IgA anti-KLH response, detectable in the gut lumen.
Other studies of oral tolerance abrogation, such as by
depletion of suppressor T cells, have demonstrated an
antigen-specific active DTH response in the intestinal
mucosa after feeding of OVA (Mowat and Ferguson, 1981b;
Mowat, 1986), however humoral immunity was not assessed.
Previous work from our laboratory has shown that feeding
OVA during the initial phase of a GvHR prevents oral
tolerance induction and enhances antigen presentation
(Strobel, Mowat and Ferguson, 1985). In addition, the
findings of this work, i.e. the immunostimulatory effects
of the GvHR on immunoglobulin production, both in the
mucosa (chapter 6) and in the circulation (chapter 7) and
the evolving DTH response in the mucosa (chapter 4),
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suggest that the GvHR may be a possible model for studying
the relationship between mucosal IgA production and oral
tolerance after feeding a dietary antigen.
The aim of the investigations described in this chapter was
to assess the mucosal IgA antibody response to dietary
antigens (OVA and BLG) fed during a GvHR, and to determine
if the immunostimulatory nature of the GvHR causes an
immunopotentiation of the IgA antibody response in a
similar manner as that described with CT. Further to this,
the co-existence of systemic hyporesponsiveness and mucosal
immunity was investigated.
THE MUCOSAL IGA RESPONSE TO DIETARY ANTIGENS FED DURING A
GVHR
The mucosal IgA antibody response to OVA and BLG was
studied in gut washings collected from mice fed antigen at
various times throughout the GvHR, and comparisons were
made to the IgA antibody response when CT was fed with the
antigen and when antigen was fed alone.
General protocol
The basic experimental design of the investigation was as
follows:-
Three groups of adult BDF-^ mice (n=8-10) were studied. The
details of the timings of antigen feeds are given with the
descriptions of each experiment.
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Group A: A semi-allogeneic GvHR was induced in
nonirradiated BDF^ mice (chapter 3) on day 0 of the
investigation, and the animals were fed OVA or BLG at a
dose known to induce tolerance.
Group B: Adult, normal BDF-^ mice were fed antigen (OVA or
BLG) concomitant with an immunogenic dose of CT (lOug)
(Elson and Ealding, 1984ab; Lycke and Holmgren, 1986). This
group acted as the positive control as CT is known to have
an immunopotentiating effect on the mucosal IgA antibody
response, both to itself and unrelated antigens fed at the
same time (chapter 1).
Group C: Adult, normal BDF^ mice were fed antigen (OVA or
BLG) alone.
Gut washings were taken (chapter 3) 7 days after the last
feed of antigen. Total IgA concentrations and IgA
antibodies to OVA and BLG were determined by ELISA (chapter
3; appendix A:2 and A:6).
Presentation of results for the levels of IcrA antibodies to
OVA and BLG in gut washings.
For each experiment the OD 405nm values (meaniSEM) for IgA
antibodies to either OVA or BLG are given. In addition, the
Units of IgA antibodies/ug total IgA are also submitted.
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Determination of Units of IqA antibodies.
The standard curves for the OD 405nm values of IgA anti-OVA
(Fig 11:1) and IgA anti-BLG (Fig 11:2) were produced by-
incubating doubling dilutions of serum, collected from mice
immunised with either OVA or BLG (chapter 3), in the
respective ELISAs.
Units were assigned to the dilutions of positive serum, as
illustrated on the graphs, with the lowest OD 405nm value
still on the linear part of the curve given a Unit value of
1. For IgA anti-OVA this was a 1:64 dilution and for IgA
anti-BLG a 1:512 dilution. The Unit values were doubled as
the concentration of positive serum doubled (see Figs 11:1
and 11:2).
Using a Casio fx-180P scientific calculator, each standard
curve was assessed by linear regression analysis and the
Unit value corresponding to the OD 405nm value of each
sample read off the standard curve. The Units of IgA
antibody were then expressed per ug total IgA, and the
mean+SEM calculated for each group.
A: IqA anti-OVA antibody response in gut washings after 2
feeds of OVA.
Experimental design
On day 0, a GvHR was induced in 8-10 BDF^ mice (Group A).
On days 3 and 11 of the experiment (corresponding to days 3
and 11 of the GvHR) animals in Groups A and C received
25mgs OVA i.g., and mice in Group B received 25mgs of OVA
-217-
plus lOug CT. Gut washings were collected on day 19.
Results
The results are given in Table 11:1.
There was no significant difference in total IgA
concentrations (ng/ml) between the three groups.
IgA anti-OVA antibodies were detected in the gut washings
collected from mice with GvHR (Group A) and in comparable
levels to those found in mice which had been fed CT with
OVA (Group B). No IgA anti-OVA antibodies were found in
mice fed OVA alone (Group C).
B: iqA anti-OVA antibody response in gut washings after 4
feeds of OVA.
Experimental protocol
On day 0 a GvHR was induced in 8-10 BDF^ mice (Group A). On
days 6, 7, 12 and 13, Groups A and C received 25mgs OVA
i.g. Animals in Group B received 25mgs OVA plus lOug CT.
Gut washings were collected on day 20.
Results
The results are given in Table 11:2.
The concentrations of total IgA (ng/ml), although lower
than had been found in the previous experiment (Table
11:1), were not significantly different between groups.
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The OD 405nm values of IgA anti-OVA in Groups A and B were
higher than had been observed in the previous experiment
(Table 11:1) reflecting the increase in antigen load.
IgA anti-OVA antibodies were detectable in mice fed OVA
alone (Group C), and in levels within the same range as
detected in the gut washings of Groups A and B.
Comments
The results showed that feeding 2 doses of OVA during the
initial phase of the GvHR produced detectable levels of
IgA anti-OVA antibodies in the gut washings, whereas
feeding 2 doses of OVA to normal mice did not produce an
IgA antibody response. The levels of antibodies detected in
animals with GvHR were in the same range as those found in
normal mice fed OVA plus CT. Further investigation,
however, revealed that feeding 4 doses of OVA produced an
IgA anti-OVA response in all three groups, which suggests
that the induction of an IgA antibody response is dependent
on the number of times the gut encounters the antigen. The
enhanced antigen presentation that occurs during the
initial phase of GvHR would therefore account for the IgA
antibody response after only 2 doses of antigen.
C: IgA anti-BLG antibody response in gut washings after 3
feeds of BLG.
Experimental protocol
On day 0 a GvHR was induced in 8-10 BDF]_ mice (Group A) . On
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days 3, 11 and 19, animals in Groups A and C received 50mgs
BLG i.g., and mice in Group B received 50mgs BLG plus lOug
CT. Gut washings were collected on day 26.
Results
The results are given in Table 11:3.
The concentrations of total IgA (ng/ml) were significantly
increased in both Group A (P<0.005) and Group B (P<0.05) as
compared to the controls (Group C), and there was no
significant difference between Groups A and B.
All three groups had detectable levels of IgA anti-BLG
antibodies in the gut washings. Statistical analysis of the
OD 405nm values showed that there was no significant
difference in antibody levels between groups. However, when
the results were expressed as Units IgA anti-BLG/ug total
IgA, the levels were significantly greater in animals fed
CT plus BLG (Group B) as compared to both the GvHR group
(Group A; P<0.05) and the controls (Group C; P<0.05). There
was no significant difference between Groups A and C.
D: IqA anti-BLG antibody response in gut washings after 5
feeds of BLG.
Experimental protocol
On day 0 a GvHR was induced in 8-10 BDFj_ mice (Group A) . On
days 6, 7, 12, 13, and 24 the animals in Groups A and C
received 50mgs BLG i.g., and animals in Group B received
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50mgs BLG plus lOug CT. Gut washings were collected on day
31.
At this point the increased concentrations of total IgA and
IgM in gut washings collected on day 31 of the GvHR had
been discovered (chapter 6) and so total IgM and IgM anti-
BLG antibodies were analysed as well as IgA in this
particular experiment.
Results
Total IcrA and IaA anti-BLG antibody levels in gut washings.
There was no significant difference in total IgA
concentrations (ng/ml) in the gut washings collected from
Groups A, B and C (Table 11:4).
Mice fed 5 doses of BLG plus CT (Group B) had significantly
higher levels of IgA anti-BLG antibodies than both Group A
(PC0.005) and Group C (P<0.005). Interestingly, mice fed
BLG alone (Group C) had significantly greater antibody
levels (PC0.05) than mice fed during a GvHR (Group A).
Total IqM and IaM anti-BLG antibodies in gut washings after
5 feeds of BLG.
The concentrations (ng/ml) of total IgM (Table 11:5) were
significantly increased in mice with GvHR (Group A; P<0.05)
as compared to both Groups B and C.




An IgA anti-BLG response was observed in all three groups
after feeding either 3 or 5 doses of BLG.
Feeding 5 doses of CT and BLG (Group B) gave a greater IgA
anti-BLG response (OD 405nm) than after 3 feeds, which
indicates that with increased feeds of CT the levels of
antibodies to the unrelated antigen (BLG) are also
increased. Similarly, feeding 5 doses of BLG alone produced
a greater IgA antibody response (OD 405nm) than feeding 3
doses, although the response was not as great as that
observed when CT was fed concomitantly. In contrast this
effect was not observed in mice fed during a GvHR which
suggests that antibody production at this phase of the GvHR
may be depressed.
However, when the results were expressed as Units of IgA
antibodies, the levels of IgA anti-BLG antibodies/ug total
IgA were lower in both mice fed during a GvHR and fed alone
(Groups A and C), when 5 doses of antigen were given (Table
11:4) as compared to 3 doses (Table 11:3).
An interesting observation was the complete absence of
detectable IgM antibodies in all three groups, even in the
mice with GvHR (Group A) which had significantly increased
concentrations of total IgM.
In conclusion, the GvHR appeared to potentiate the IgA
anti-OVA response after 2 feeds, however this effect was
not found when mice were fed more than 2 doses of antigen.
The interesting finding of this investigation was the
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production of small amounts of IgA antibodies to fed
antigens in the gut washings of normal mice. Oral tolerance
induction was therefore studied in these animals to
determine if both a mucosal immune response and oral
tolerance did co-exist. Oral tolerance experiments were
also performed on mice fed antigen plus CT, as in this
situation oral tolerance to the unrelated antigen is known
to be abrogated.
ORAL TOLERANCE INDUCTION AFTER MULTIPLE FEEDS OF DIETARY
ANTIGEN
Oral tolerance induction after 4 feeds of OVA
Experimental protocol
Three groups of adult BDFi mice were used (n=16). The
animals were fed at intervals corresponding to those
described in the studies of the mucosal IgA response. On
days 0, 1, 6 and 7, Group A (controls) received 0.2mls of
saline, Group B received lOug CT plus 25mgs OVA and Group C
received 25mgs OVA. 7 days after the last feed of antigen,
8 mice from each group were sacrificed, gut washings
collected and analysed. The remaining 8 mice/group were
immunised with lOOug OVA/CFA. 3 weeks post-immunisation




IaA anti-OVA antibody response in gut washings
An IgA anti-OVA antibody response was detected in animals
fed OVA alone or concomitantly with CT. The results were
similar to those described in Table 11:2, and are thus not
presented here.
Oral tolerance to OVA
The results are presented in Table 11:6.
Mice fed 4 doses of OVA alone (Group C) had both a
significantly suppressed systemic IgG anti-OVA antibody
response (P<0.05) and DTH response (P<0.01; 80%
suppression) as compared to the saline fed controls.
Mice fed CT with OVA did not have a suppressed serum IgG
anti-OVA antibody response although the DTH response was
significantly lower than the saline fed controls (PC0.01;
55% suppression).
Oral tolerance induction after 5 feeds of BLG
Experimental protocol
Three groups of BDF^ mice (n=16) were used. The groups were
the same as described above. On days 0, 1, 6, 7 and 17,
Group A were fed 0.2mls of saline, Group B received 50mgs
BLG plus lOug CT, and Group C received 50mgs BLG alone. 7
days after the last feed, 8 mice/group were sacrificed and
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the gut washings analysed. The remaining 8 mice/group were
immunised with lOOug BLG/CFA. 3 weeks post-immunisation,
serum was collected and the antibody and DTH responses
assessed (chapter 10).
Results
IoA anti-BLG antibodies in gut washings
IgA antibodies to BLG were found in Groups B and C in
levels similar to those presented in Table 11:4.
Oral tolerance induction to BLG
Mice fed 5 doses of BLG alone (Group C) (Table 11:7) had
significantly suppressed serum IgG anti-BLG antibodies
(P<0.05) as compared to the saline fed controls (Group A),
however the DTH response was not suppressed. As described
in Chapter 10, the DTH response to BLG in positive control
mice was lower than expected which may complicate the
analyses of the data. Mice fed CT with the BLG (Group B)
did not have a suppressed systemic response to BLG.
Comments
Feeding 4 doses of OVA alone produced the following
response:-
i) a mucosal IgA anti-OVA antibody response
ii) systemic hyporesponsiveness.
In contrast, mice receiving 4 doses OVA plus CT had:-
i) a mucosal IgA anti-OVA antibody response
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ii) no suppression of the systemic IgG anti-OVA response
iii) suppression of the DTH response.
Animals fed 5 doses of BLG alone produced:-
i) a small but detectable mucosal IgA anti-BLG antibody
response
ii) a suppressed systemic IgG antibody response
iii) no suppression of the DTH response.
Feeding 5 doses of CT with the BLG:-
i) completely abrogated the induction of oral tolerance
ii) induced a high mucosal IgA anti-BLG antibody response.
General comments
The results presented in this chapter demonstrate that an
IgA antibody response to enterically presented dietary
antigens (OVA and BLG) can be detected in the gut lumen.
The initial experiments showed that feeding 2 doses of OVA,
on days 3 and 11 after the induction of GvHR, produced an
IgA antibody response not found in animals without GvHR.
However, when the number of doses given was increased to 4,
an IgA anti-OVA antibody response was observed in mice
without GvHR, and in both cases the results were comparable
to those found when CT was fed concomitantly. These results
suggest that repeated feeding of antigen is reguired to
induce an IgA response, and that the enhanced antigen
presentation that is known to occur during the initial
phase of a GvHR, is responsible for the IgA response after
only 2 doses of OVA.
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Feeding CT with OVA or BLG produced an IgA antibody-
response to the dietary antigen and the OD 405nm readings
of IgA anti-BLG increased with the number of feeds given.
This effect was observed to a lesser extent when antigen
was fed alone, but not at all when a GvHR was in progress.
In fact, after 5 doses of BLG the Units of IgA anti-BLG/ug
total IgA were lower in both normals and mice with GvHR
than after 3 doses.
Expression of the IgA antibody results per total IgA may be
a more accurate indicator of the proportion of antibodies
to the total IgA produced, however this figure is very much
dependent on other endogenous factors which may be
stimulating IgA production at the time of the
investigation. Similarly, technical aspects such as fluid
secretion into the gut lumen and the volume of gut
washings collected may influence the total IgA
concentrations. Therefore, expressing the IgA antibody
results as both OD values and Units of IgA anti-BLG/ug
total IgA is valuable in describing the results.
The study of the systemic response to multiple feeds of OVA
and BLG in normal animals revealed that oral tolerance and
a mucosal IgA response co-existed after 4 feeds of OVA.
However, when 5 feeds of BLG were given, an IgA anti-BLG
response and a suppressed systemic IgG anti-BLG response
were detected, but the DTH response was not suppressed.
Oral tolerance to 5 doses BLG was completely abrogated when
CT was given as well, and a very high IgA anti-BLG response
was observed, which suggests that when a high IgA antibody
response is "switched on" oral tolerance is abrogated, but
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small levels of "background" IgA antibodies can be produced
simultaneously with systemic hyporesponsiveness.
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FIGURE 11:1 IgA anti-OVA antibody ELISA standard curve.
Both the OD 405nm values (solid line) and the best fitting
line (broken line), as determined by linear regression
analysis, are shown.
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FIGURE 11;2 IgA anti-BLG antibody ELISA standard curve.
Both the OD 405nm values (solid line) and the best fitting
line (broken line), as determined by linear regression
analysis, are shown.
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Total IgA IgA antl-OVA Units IgA anti OVA/
Group ng/ml OD 405 nm pg Total IgA
A 164.80 ± 12.22 0.251 ± 0.04 10.59 ± 2.49
B 248.77 ± 67.19 0.290 ± 0.03 10.45 ± 2.34




ND - Not Detectable
TABLE—11:1 Total IgA and IgA anti-OVA antibody responses in
gut washings after 2 feeds of OVA.
Group A: mice fed OVA during a GvHR.
Group B: control mice fed CT and OVA.






Units IgA antl OVA/
pg Total IgA
A 89.04 ± 7.99 0.497 ± 0.120 29.20 ± 3.59
B 99.11 ± 13.33 0.333 ± 0.196 33.26 ± 16.90




TABLE 11:2 Total IgA and IgA anti-OVA antibody responses in
gut washings after 4 feeds of OVA.
mice fed OVA during a GvHR.
control mice fed CT and OVA.




Total IgA IgA anti-BLG Units IgA anti-BLG/
Group ng/ml OD 405 nm pg Total IgA
A 202.01 ± 47.50 0.168 ± 0.03 7.01 ± 2.48
B 143.50 ± 49.17 0.294 ± 0.09 30.64 ± 8.54
C 54.73 ± 6.27 0.105 ± 0.02 18.97 ± 4.34
Analysis of
variance
P = 0.046 NS P=0.046
TABLE 11:3 Total IgA and IgA anti-BLG antibody responses in
gut washings after 3 feeds of BLG.
Group A: mice fed BLG during a GvHR.
Group B: control mice fed CT and BLG.
Group C: control mice fed BLG alone.
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Total IgA IgA anti-BLG Units IgA anti-BLG/
Group ng/ml OD 405 nm pg Total IgA
A 498.23 ± 115.27 0.165 ± 0.04 2.78 ± 0.50
B 515.22 ± 149.44 0.949 ± 0.09 47.60 ± 9.99
C 465.17 ± 127.66 0.305 ± 0.06 7.79 ± 2.04
Analysis of NS P = 0.0001 P=0.0001
variance
TABLE 11:4 Total IgA and IgA anti-BLG antibody responses in
gut washings after 5 feeds of BLG.
Group A: mice fed BLG during a GvHR.
Group B: control mice fed CT and BLG.







A 32.81 ±10.58 ND
B 3.87 ± 0.76 ND




ND - Not Detectable
TABLE 11:5 Total IgM and IgM anti-BLG antibody responses in
gut washings after 5 feeds of BLG.
Group A: mice fed BLG during a GvHR.
Group B: control mice fed CT and BLG.









SAL / OVA 0.710 ± 0.108 0.20 + 0.03
10 pg CT
25 mgs OVA I
fOVA 0.748 ± 0.08 0.09 ± 0.01" (55%)
25 mgs OVA/OVA 0.459 ± 0.07* 0.04 ± 0.003** (80%)
* P <0.05
** P<0.01
TABLE 11:6 Oral tolerance to OVA after 4 feeds of OVA.
Systemic IgG anti-OVA antibody response (mean+SEM) and DTH
response (mean + SEM) in mice fed OVA alone and in mice fed
CT and OVA.
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Group IgG anti-BLG DTH Response
FED/IMM OD 405 nm 24hr footpad
increment (mm)
SAL/BLG 1.337 + 0.04 0.10 ± 0.02
10pgCT /
/BLG 1.392 ± 0.07 0.06 + 0.02
50 mgs BLG'
50 mgs BLG/BLG 0.858 ± 0.09* 0.09 ± 0.06
* P <0.05
TABLE 11;7 Oral tolerance to BLG after 5 feeds of BLG.
Systemic IgG anti-BLG antibody response (mean+SEM) and DTH






The semi-allogeneic GvHR is known to produce an
immunostimulation of the immune response, and
alloactivation of T cells is a recognised feature. A major
site affected by the presence of activated T DTH effector
cells is the gut. The murine GvHR is thus an excellent
model for the study of mucosal immune responses both of the
humoral and cell mediated type.
The aim of this thesis was to define the effects of the
GvHR on the architecture of the small intestine and the
mucosal humoral response.
The progression of both systemic and intestinal reactions
was studied, and subsequent to developing a method for
collecting gut washings, a definitive study of mucosal
immunoglobulin concentrations was performed in adult,
neonatal and aged mice with GvHR.
Striking effects on the levels of IgA and IgM were found
and in order to investigate possible mechanisms to explain
this feature, studies on the dissemination of the response
to distant mucosal sites were performed. In addition, the
effect of the GvHR on Ig-SC numbers in the SP, MLN and PP
was analysed.
Finally, oral tolerance to BLG, both in normal mice and in
a transgenic mouse model was examined and the possible
relationship between mucosal immunity and systemic
hyporesponsiveness investigated.
The results obtained were discussed in each separate
chapter, and in this discussion I shall bring together
-238-
these results in order to delineate the possible mechanisms
underlying the effects of the GvHR on the mucosal immune
response.
THE ONSET AND PROGRESSION OF A SEMI-ALLOGENEIC GVHR IN
NONIRRADIATED F1 MICE
In most animal models of GvHR the onset of the reaction is
recognised by a proliferation of cells in the organised
lymphoid tissue, particularly the SP; splenomegaly being a
measure of the progression of the reaction (Simonsen,
1962). In the semi.-allogeneic GvHR in nonirradiated F ^
hosts, donor cell proliferation is not necessarily
reguired, however upon stimulation by alloantigens,
nondividing donor cells are believed to release soluble
factors that induce host cells to proliferate (Scollay,
Hofman and Globerson, 1974).
The results presented in chapter 9 demonstrate that the
induction of a GvHR in BDF-^ mice produced an increase in
the total cell count of PP, MLN and SP on day 7 of the
GvHR, indicating cell proliferation and the onset of the
reaction. Similarly, a significant infiltration of IEL into
the small intestinal epithelium was found by day 7 of the
GvHR (chapter 4) indicating that the intestinal reaction
was underway.
The progression of the systemic GvHR was monitored by the
spleen index. Gleichmann et al (1984), delineated two
phases which occur during the acute semi-allogeneic GvHR in
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nonirradiated mice. Initially there is a brief phase of
alloactivation of T helper cells (lasting approximately 14
days), resulting in DTH reactivity and T cell-dependent B
cell stimulation. This is followed by alloactivation of T
suppressor/cytotoxic cells and reduced activity. In this
particular model of GvHR, a chronic immunostimulatory form
may follow. A consistent finding of my work was an elevated
SI between days 7 and 11 (chapter 4), followed by a phase
of low SI. However, on day 32 of the reaction a striking
increase in SI was observed. This increase was reflected in
total cell counts in the SP, but not in the mucosal-
associated lymph nodes.
These investigations confirm that the induction of a semi-
allogeneic GvHR in BDF-^ mice, induces an increase in cell
numbers in the PP, MLN and SP during the initial
immunostimulatory phase of the acute reaction. A second
increase in cell numbers occurs on day 32, in the SP only,
and I suggest that this reflects the onset of the chronic
form of the GvHR. Interestingly, 18 months after the
induction of the GvHR (chapter 8) the SI was still
elevated.
THE INTESTINAL GVHR
Previous investigations have described the effects of
intestinal GvHR, both at single time points and throughout
the reaction, using a variety of animal strain
combinations, and within a wide range of ages. Effects on
the structure of the gut have been noted in irradiated
-240-
hosts (Piguet, 1985; Mowat et al, 1988), nonirradiated,
neonatal mice (MacDonald and Ferguson, 1977; Mowat and
Ferguson, 1982; Felstein and Mowat, 1988) and
nonirradiated, adult mice (Mowat et al, 1988; Mowat, 1989).
From these reports two distinct forms of enteropathy, a
proliferative and a destructive form, have been described.
The investigations described in chapter 4 show that while
both recognised forms of enteropathy can be determined in a
semi-allogeneic GvHR in nonirradiated adult BDF]_ mice, the
reaction actually manifests in an evolution of
architectural alterations.
The mice remained healthy throughout the time of study, up
to 5 weeks post-GvHR induction, with no significant weight
loss and no deaths. The absence of any clinical signs of
GvHR, especially during the phase of a destructive
enteropathy (between days 19 and 27) is in contrast to the
significant weight loss, ruffled fur, abnormal gait and
hunched posture and mortality observed by other workers
(Mowat, 1989; Mowat and Felstein, 1989).
An important factor in the severity of the systemic GvHR is
the cleanliness of the animal house in which the
experiments are performed, as bacterial products can
influence the level of systemic anti-host immune
responsiveness, without affecting the gut (chapter 2). The
BDF^ mice I used were an inbred strain, bred in the Animal
Unit at the Western General Hospital, Edinburgh. The male
parents (DBA/2) were obtained from a stock colony, while
the female parents (C57B1/6J) were obtained from commercial
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animal breeders (chapter 3). The BDF-|_ mice used in each
experiment were therefore born and raised in the environs
of the Animal Unit. In contrast, the BDF-]_ mice used by
Mowat and co-workers (Mowat, 1989; Mowat and Felstein,
1989) were purchased from commercial breeders and brought
into a new environment. The GvHR was thus studied in
animals which were possibly reacting to novel bacterial
antigens; which may explain the exaggerated systemic
manifestations.
The intestinal GvHR was assessed by measuring villus and
crypt lengths and IEL counts; parameters known to signal a
local DTH reaction (Mowat and Ferguson, 1982). At least 7
phases of change to both the mucosal architecture and
cellular infiltration were determined, and assessed in
conjunction with the progression of the systemic reaction
(Fig 4:12).
The infiltration of increased numbers of IEL into the
epithelium during the initial phase of the GvHR, is a well
recognised feature of the proliferative phase of the
intestinal reaction (Mowat and Ferguson, 1982; Mowat and
Felstein, 1989 ) .
A significant reduction in the numbers of IEL/100
epithelial cells was subsequently observed between days 19
and 24. A decreased IEL count has been previously
described, but only in irradiated hosts (Mowat et al,
1988). In both animal models (i.e. nonirradiated and
irradiated hosts), the decreased IEL count coincided with a
period of significantly reduced villus length. Studies are
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now in progress in our laboratory, to determine, by image-
analysis, the relationship between the fall in IEL counts
and the absolute numbers of IEL, and the relationship
between the fall in IEL counts and reduction in villus
epithelial cell populations, in terms of time.
A spectrum of alterations to the mucosal architecture was
observed throughout the GvHR.
During the initial phase of the reaction, the prominent
feature was crypt hyperplasia. A reduced villus length was
observed on day 11 of the GvHR, however, the villi
maintained their long, finger-like structure.
Between days 19 and 27 of the GvHR, a phase of intestinal
damage occurred which resulted in flattening of the villi.
At the onset of this villus atrophy, the crypts were of
normal length, however, by day 24 the crypts were
hyperplastic. By day 27, a severe destruction of the
mucosal structure was observed and both the villi and
crypts were atrophic.
Villus atrophy and crypt hyperplasia are recognised
features of the destructive-type lesion observed in
neonatal mice with GvHR (MacDonald and Ferguson, 1977;
Felstein and Mowat, 1988), and in irradiated mice with GvHR
(Mowat et al, 1988). Similarly, villus atrophy and crypt
hypoplasia have been described in irradiated mice with GvHR
(Mowat et al, 1988), and in a protein-deprived murine model
(Lamont, 1986).
Under normal conditions, a steady state is maintained
within the villus/crypt unit. The enterocytes move up the
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villi in continuous sheets from their origin in the crypts,
where a self-renewing population of stem cells balances the
loss of enterocytes from the villus tip. Consequently, any
effect on the crypt cell kinetics will eventually manifest
in alterations to the villus length and to the maturity of
the enterocyte.
The GvHR is believed to directly affect the cell kinetics
within the crypt (reviewed Mowat and Felstein, 1989).
The results presented here emphasize, that in any form of
intestinal damage, it is important that the changes to the
villus and crypt lengths are not considered as separate,
singular events, but rather as a spectrum or evolution of
alterations resulting from changes in the dynamic
equilibrium of the complete villus/crypt unit.
The mechanisms underlying the intestinal GvHR are not yet
fully understood. However, as reviewed in chapter 2, the
evidence so far suggests that both the proliferative and
the destructive forms of enteropathy are the result of a
"bystander phenomenon" which is class II MHC-restricted,
and most probably the result of a local DTH response rather
than classical CTL activity. In addition, there is
gathering evidence to substantiate the original hypothesis
of Ferguson and co-workers that enteropathic lymphokines
play a major role in the intestinal GvHR (Ferguson and
Parrott, 1973; MacDonald and Ferguson, 1976; 1977).
Mucosal lymphocytes isolated from mice with acute GvHR are
able to produce IFN-gamma, IL-2 and IL-3 (Guy-Grand and
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Vassalli, 1986) and IFN-gamma and IFN-beta have been
demonstrated, by immunofluorescence, in the spleens of
irradiated mice with GvHR (Cleveland, Annable and Klimpel,
1988). Similarly, increased levels of serum TNF have been
demonstrated in mice with acute GvHR (Bayston, Faulkner and
Cohen, 1988).
More importantly, treatment of mice with antibodies against
IFN-gamma prevents the proliferative intestinal
manifestations in nonirradiated hosts (Mowat, 1989), while
treatment with antibodies to TNF-alpha prevents the
destructive lesion found in irradiated hosts (Piguet et al,
1987 ) .
The role of IFN-gamma in the intestinal GvHR is pertinent
when one considers the effects of this cytokine on cells
involved in the inflammatory response. IFN-gamma has been
shown to induce the migration of lymphocytes out of
circulation, into the site of inflammation, during a DTH
response (Isselkutz et al, 1988). In addition, IFN-gamma is
believed to be a potent inducer of both class II (la)
expression on gut epithelial cells (Cerf-Bensussan et al,
1984; MacDonald et al, 1988) and macrophage activation
(Schultz and Kleinschmidt, 1983); all of which are features
of the intestinal GvHR (Bland, 1988; Barclay and Mason,
1982) .
Continuous treatment of mice with anti-IFN-gamma during a
GvHR prevents the increase in IEL count normally observed
at the onset of the intestinal reaction (Mowat, 1989). If
the infiltration of IEL into the gut epithelium is a direct
result of locally released IFN-gamma then it is possible
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that the decrease in IEL counts observed on day 13 is
indicative of a cessation of IFN-gamma release. This
coincides with the entry of the systemic GvHR into a phase
of reduced activity (Gleichmann et al , 1984 ). In
consequence, it is possible that the destructive-type
lesion observed between days 19 and 24, is not a direct
result of IFN-gamma release, but perhaps a secondary effect
due to the IFN-gaznma-induced activation of macrophages, and
the enhanced class II (la) expression on the enterocytes.
Mowat (1989), did show that continuous treatment of mice
with anti-IFN-gamma prevented the destructive enteropathy,
however, the anti-IFN-gamma was administered from 1 day
prior to the induction of the GvHR, until the end of the
study. The results therefore demonstrate that IFN-gamma is
involved in the manifestation of the destructive lesion,
however, they do not dissociate between the presence of
IFN-gamma and the function of cells activated by IFN-gamma.
Piguet et al (1987), described the elimination of the
destructive lesion in irradiated mice after the continuous
injection of anti-TNF-alpha. TNF-alpha is produced mainly
from activated macrophages, it is therefore interesting to
consider the possibility that the destructive lesion,
observed between days 19 and 24, is a result of the action
of TNF-alpha released from macrophages, previously
activated by IFN-gamma.
On day 27 of the GvHR, a rise in IEL count and an elevated
SI was observed. The presence of villus atrophy and crypt
atrophy at this point is very interesting. Lee et al
(1984), described a synergistic effect of IFN-gamma and
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human lymphotoxin on neoplastic cells, which resulted in an
inhibition of cell proliferation. It is therefore possible
that the combined release of IFN-gamma and TNF-alpha during
the GvHR may result in the arrest of crypt cell
proliferation, the end result being crypt atrophy and
villus atrophy.
MUCOSAL IMMUNOGLOBULIN PRODUCTION DURING A GVHR
Having established a gut washing technigue for the
collection of gut luminal contents (chapter 5), I was able
to define the effects of the GvHR on mucosal immunoglobulin
concentrations (chapter 6).
A pattern of increased immunoglobulin production, similar
to the pattern of systemic progression of the GvHR
occurred, in that increased levels of IgA and IgM were
found in gut washings taken during the initial
immunostimulatory phase of the GvHR, and at the onset of
the chronic GvHR. Of great interest was the striking
isotype variation in duration and magnitude of the
response. While total IgM levels were elevated from day 11
up to and including day 14 of the reaction, total IgA
levels were raised on day 12 only. This effect was
reflected in the plasma cell counts in the LP. IgG
concentrations were not analysed in the gut washings as
very few IgG+ plasma cells were found in the LP of either
normal or GvHR mice.
In the immunoregulatory pathway of mucosal B cells, there
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are two stages at which T cells (or their soluble
mediators) are believed to play a specific role. The first
is at isotype-switching from sIgM+ B cells to sIgA+ B cells
within the PP, and the second at terminal differentiation
within the mucosal sites (chapter 1).
The finding of a transient increase in IgA accompanied by
an increase in IgM lasting 4 days, initially suggested that
the GvHR was affecting mucosal B cells early in their
maturation pathway. The possibility existed that activation
of non-specific T helper cells at the onset of GvHR was
driving B cells, within the PP, into proliferation without
a switch in surface isotype expression. The predominant
isotype would therefore be sIgM+. Migration of this
population of sIgM+ B cells into the LP would, upon
receiving a signal inducing terminal differentiation,
result in increased IgM levels, in gut washings, over a
longer period of time.
The studies described in chapter 7 and 9 refute this
hypothesis and, although no direct studies on cell
migration were performed, oppose the original idea that
migration of committed plasmablasts into the LP was
occurring. Prior to entering the LP, a population of
mucosa-seeking plasmablasts would be expected in the SP.
Therefore, had the GvHR influenced the migration of
plasmablasts into the LP, one would have expected a large
number of cells to have migrated from the SP into the LP.
However, as early as day 4 after the induction of GvHR,
large numbers of IgM+-SC were detectable in the SP (chapter
9), and yet no increase in IgM+ plasma cells was observed
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in the LP, until day 11. Similarly, a significant increase
in SP IgG+-SC numbers was observed on day 7, and at no time
was there an increase in IgG+ plasma cells in the LP. In
addition, no increase in IgA concentrations were observed
in either milk or saliva (chapter 7), which again suggests
that there was no general migration of plasmablasts to
distant mucosal sites. Hence, it is most likely that the
GvHR exerts its effect at the later stage of terminal
differentiation.
Support for GvHR-induced terminal differentiation of B
cells was given by Lindholm et al ( 1973). The authors
demonstrated that axillary LN, taken from nonirradiated
mice with GvHR, contained large numbers of plasma cells in
the medullary areas, a development not found in control
mice.
The role of T helper cells in the terminal differentiation
of sIgA+ B cells into IgA synthesizing cells has been well
described (Elson et al , 1979 ; Kawanishi, Saltzman and
Strober, 1983b; Kawanishi and Strober, 1983). Systemically
it is now well appreciated that B cell differentiation is
regulated, in part, by lymphokines released from activated
T cells (Kishimoto and Hirano, 1988). The lymphokines
involved in this process are IL-4 (B cell activation), IL-5
(B cell proliferation) and IL-6 (B cell differentiation).
These lymphokines are now being studied with regard to
their influence on B cells within the GALT, however their
roles in mucosal B cell differentiation are not yet
completely understood.
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The LP contains T cells predominantly of the helper
phenotype and LP T cell help for Ig synthesis has been
demonstrated (Elson et al, 1983). The majority of published
work, however, on T cell regulation of IgA synthesis has
been acguired from in vitro studies using PP derived cells,
and although it is not entirely representative of the
effector site of the LP, the results do give information on
the effect of soluble mediators on mucosal B cells.
The information gained from this thesis suggests that
during the GvHR, activated T helper cells present in the
gut, induce LP plasmablasts to differentiate into Ig
synthesizing plasma cells which release Ig into the gut
lumen, and as with the local DTH response, it is possible
that soluble mediators play a major role.
Several studies have shown that murine IL-5 can selectively
enhance IgA synthesis in vitro (Murray et al, 1987; Bond et
al, 1987; Kunimoto, Harriman and Strober, 1988; Harriman et
al, 1988; Beagley et al, 1988; Maghazachi and Phillips-
Quagliata, 1988; Matsumoto et al, 1989).
IL-5, produced by murine PP T cells, added to LPS-driven B
cell cultures has been shown to enhance IgA production; an
effect further enhanced by the addition of IL-4, although
IL-4 itself, has no effect on IgA production (Murray et al,
1987 ). IL-5 is believed to affect PP B cells at the stage
of terminal differentiation, and not isotype-switching
(Harriman et al, 1988 ), although a role for IL-4 in
isotype-switching has been suggested (Kunimoto et al ,
1988) .
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A perhaps more pertinent study by Beagley et al (1988), has
shown that rIL-5 can induce PP B cells to enter into high
rate IgA synthesis with no requirement for exogenous LPS.
Interestingly, the increase in IgA synthesis observed by
Beagley et al (1988), was not accompanied by an increase in
absolute numbers of IgA+-SC which infers that the effect of
rIL-5 is to increase IgA production by each plasma cell.
It is now recognised that IL-6 can induce a significant
increase in IgA secretion in PP B cell cultures, to greater
levels than observed with IL-5 (Beagley et al, 1989 ). As
with IL-5, IL-6 exerts its influence on sIgA+ B cells, and
is thus not involved in isotype-switching. Similarly cell
proliferation does not necessarily occur, thus an increase
in IgA synthesis per plasma cell is observed (Beagley et
al, 1989; McGhee et al, 1989).
The information on the role of lymphokines in IgM synthesis
at the gut level is not as extensive as that of IgA,
however, IL-5 has been shown to induce polyclonal IgM
secretion from SP B cells in the absence of a stimulating
antigen (Murakimi et al, 1988). Similarly IL-6 is able to
induce terminal differentiation and high rate IgM synthesis
from B lymphoblastoid cell lines (Kishimoto and Hirano,
1988) .
The intriguing question is that if both IL-5 and IL-6 are
equally capable of inducing terminal differentiation of
both IgA+ and IgM+ B cells, why then was the increase in
IgA levels in the gut, transient?
The interesting possibility is that IgA production or
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secretion is in some way down-regulated. Aicher et al
(1989), have recently demonstrated an IEL population in
Balb/c mice which express both mRNA for IL-5, and an IgA
FcalphaR. Binding of IgA to this receptor resulted in the
down-regulation of IL-5 production which in turn down-
regulated the synthesis of IgA. In this respect, it is
interesting to note that at the time of the transient
production of IgA, during the GvHR, there were a large
number of IEL present in the epithelium.
As discussed previously, the increased IEL infiltration
observed at certain points during the GvHR, may indicate
the release of IFN-gamma. At both points of increased IEL
counts, i.e. during the acute immunostimulatory phase and
at the onset of the chronic form, increased levels of
immunoglobulins were observed. IFN-gamma has been shown to
enhance the expression of secretory component in a human
colonic adenocarcinoma cell line (HT-29) (Sollid et al,
1987; Kvale, Brandtzaeg and Lovhaug, 1988), which although
not directly transposable to the situation of the murine
GvHR, does offer the interesting possibility of a direct
relationship between the effects of the DTH response and
increased Ig levels in the gut lumen.
SYSTEMIC IMMUNOGLOBULIN PRODUCTION DURING A GVHR
One of the many effects of the systemic, immunostimulatory
semi-allogeneic GvHR in nonirradiated F^ mice is B cell
hyperplasia and B cell activation; a phenomenon triggered
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by the alloactivation of T helper cells (Gleichmann et al,
1984). Increased levels of host serum Igs have been
described in mice during the initial phase of the acute
reaction (Lindholm et al, 1973), and in BMT patients with
acute GvHD (Ringden et al, 1987). However, the majority of
research, on B cell responses during the GvHR, has
concentrated on antibody and autoantibody formation in the
chronic reaction (van Rappard van der Veen et al, 1984;
Gleichmann et al, 1982; Gleichmann et al, 1984).
The results from chapters 7 and 8 demonstrate, in detail,
the effects of both the acute and chronic forms of the
semi-allogeneic GvHR on IgG, IgM and IgA levels in serum.
The initial brief phase of immunostimulation occurring
during the acute reaction produced elevated levels of IgM
and IgA. While IgA levels remained at a consistently high
level until day 12, IgM concentrations were higher than
controls from day 4 until day 11, with a second burst of
production on days 12 and 13. In contrast, serum IgG levels
did not become elevated until day 13. By day 24 of the
GvHR, the levels of all three isotypes were similar to
controls, or in the case of IgM, significantly lower than
the controls. This drop in Ig concentrations coincided with
a reduction in activity of the GvHR.
A significant rise in Ig levels was observed on day 32, but
only in IgA and IgG concentrations; coinciding with the
onset of the chronic GvHR. Indeed, when serum Ig were
measured 18 months after the induction of the GvHR (chapter
8), when the chronic GvHR is well established, both IgG and
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IgA levels were very much higher than age-matched controls,
while IgM was significantly lower than controls.
In the initial days of a chronic GvHR in BDF^ mice injected
with DBA/2 parental spleen cells, an increase in SP IgM+-
and IgG+-SC numbers has been described, and although the
IgM+-SC numbers returned to normal the IgG+-SC numbers
remained elevated (Van Rappard van der Veen et al, 1984). A
similar pattern was observed in the initial, acute reaction
studied in chapter 9.
The T cell-B cell collaborations occurring during the
initial immunostimulatory phase of the systemic GvHR are
believed to be between host B cells and alloactivated donor
T cells (Gleichmann et al, 1984). Hence, activated B cells
undergo polyclonal stimulation under the influence of
alloreactive T helper cells and their soluble mediators.
Terminal differentiation occurs and Igs are secreted.
The majority of circulating B cells express slgM, and a
population of activated B cells committed to IgG production
would not be expected in nonimmunised mice; hence the
initial increase in IgM. The elevated levels of circulating
IgA suggest that pre-committed IgA+ activated B cells, some
of which may be mucosa-seeking, exist in the circulation.
The second burst of IgM production and the onset of
elevated IgG levels occurred after the increase in total
cell count in the SP (chapter 9). Previous studies have
suggested that after the initial random, polyclonal
stimulation of IgM, the subsequent increase in circulating
Igs is not random, but due to the activation of
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autoreactive B cells by " self-antigens" of a particular
linear structure (van Rappard van der Veen et al, 1984;
Gleichmann et al , 1984 ). Thus in the murine model of
chronic GvHR, autoantibodies to double-stranded DNA and
RBC are detectable. In this respect, what is interesting
about the relationship between the increased production of
IgM and IgG is its similarity to that found in the primary
and secondary antibody responses.
At the onset of the chronic GvHR, and in the established
chronic reaction, levels of IgG and IgA were elevated,
however, IgM production was significantly depressed.
Hypergammaglobulinaemia is a recognised feature of chronic
GvHR, and is due to isotype-switching of B cells from IgM
to IgG expression by the continuous presentation and
binding of "self-antigens" (Gleichmann et al, 1984). The
results from chapter 8 demonstrate that not only is there
an isotype-switch from sIgM+ to sIgG+, but also to sIgA+
expression. The switch from IgM to IgA occurs only
systemically, as no such change was observed in the gut
washings of these animals (chapter 8).
As already stated, the majority of published work describes
the effect of the chronic stimulatory GvHR on antibody
production. It would therefore be of great interest to
determine the antigen specificities of the Igs produced,
both systemically and in the mucosa, during the acute and
chronic forms of this murine model of GvHR.
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MUCOSAL AND SYSTEMIC IMMUNE RESPONSES TO ENTERICALLY
PRESENTED ANTIGENS
The final investigation of this work was to study the
mucosal humoral immune response to enterically presented
antigens, and to determine the relationship between oral
tolerance and mucosal immunity.
The initial investigations into the mucosal antibody
response to OVA and BLG (chapter 11), demonstrated that
unlike the dose-dependent immunopotentiating effect of
feeding CT concomitantly with antigen, on the mucosal IgA
anti-OVA and IgA anti-BLG responses, feeding antigen during
the GvHR did not enhance IgA antibody production.
An interesting observation was that feeding 2 doses of OVA
during the initial phase of the GvHR, produced an IgA anti-
OVA response; an effect not observed in normal mice.
Enhanced presentation of OVA has been described in mice fed
OVA during the initial phase of the GvHR (Strobel et al,
1985), which may account for the increased IgA antibody
response. Indeed, when 3 or more doses of antigen were fed
to normal mice, a small but detectable IgA antibody
response was observed in the gut, which suggests that the
amount of antigen encountered by the GALT is important in
the IgA response.
However, when 5 doses of antigen were fed to mice on days
6, 7, 12, 13 and 24 of the GvHR, the IgA antibody response,
as measured by OD values, was lower than that found in
normal mice. This seemingly suppressed mucosal, humoral
response is most probably not due to the numbers of feeds
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encountered by the gut, but the stage in the GvHR when the
antigen was administered.
Investigations into the humoral response to systemically
presented antigen, have demonstrated that a potentiated
antibody response occurs when the T-independent antigen
SIII is administered immediately after the induction of the
GvHR. However, when the antigen was given at a later stage
of the GvHR (day 6), a suppression of the antibody response
was observed (Byfield et al, 1973).
A similar finding was described by Treiber and Lapp (1976),
in which systemic sensitization of mice with SRBC in CFA on
days 13, 20 and 24 of the GvHR, produced no detectable
humoral response, although a DTH response was stimulated.
Once again the effects of the GvHR fall into a biphasic
pattern of immunostimulation followed by reduced activity*
This interesting dichotomous effect on the humoral and DTH
responses was suggested by Treiber and Lapp (1976), to
indicate the possible existence of two distinct T helper
cells and/or soluble mediators, and during the GvHR, the T
helper cells involved in the humoral response were more
easily suppressed than those involved in the DTH response.
The complicated effects of feeding and immunising mice
during the GvHR, and the lack of immunopotentiation on the
IgA response, demonstrated that the GvHR model was not a
suitable model for studying the relationship between
mucosal and systemic immunity, as had been hypothesized.
This study was therefore confined to normal mice.
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The finding of small, but detectable levels of IgA antibody
in the gut washings simultaneous with oral tolerance, after
intra-gastric presentation of antigen, reinforces the
findings of Challacombe and Tomasi (1980). The existence of
antigen-specific T helper cell activity for IgA, and
antigen-specific T suppressor cell activity for IgG in the
PP (Richman et al, 1981), or the possible existence of a
contrasuppressor cell network (Green et al, 1981; Ernst et
al, 1988 ) may be important in the co-existence of oral
tolerance and mucosal immunity.
Repeated feeding of antigen did not enhance the mucosal IgA
antibody response as observed when CT was fed
concomitantly, which suggests that under normal conditions
of dietary antigen presentation, the simultaneous
suppression of the systemic response and isotype-specific
help for the IgA response is under strict regulatory
control. Once again, the interesting possibility exists
that FcalphaR+ IEL within the epithelium (Aicher et al,
1989) may play an important role in the immunoregulation of
the mucosal IgA antibody response.
When 5 doses of BLG were fed simultaneously with CT, oral
tolerance to BLG was completely abrogated and a very high
IgA anti-BLG response detected in the gut. This is in
keeping with the findings of Elson and Ealding (1984ab),
however, it would appear from my results that CT up-
regulates the production of IgA rather than "switches on"
its production, as suggested by Elson and Ealding (1984b).
The mode of action of CT on the immunoregulatory network is
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as yet not fully understood. In vitro studies have shown
that CT can enhance the production of IL-1 from APC and the
proliferation of both Con A-stimulated SP T cells and LPS-
stimulated SP B cells, although this effect is dependent on
the concentration of CT present, and the length of
incubation (Lycke et al, 1989).
It is possible therefore, that, in direct contrast to other
dietary antigens presented via the gut, CT is able to exert
an immunostimulatory effect on the mucosal immune response
by down-regulation of the suppressor network. Lange,
Lindholm and Holmgren (1978), found that SP cells taken
from donor mice injected intra-venously with CT 1-3 days
earlier, gave a significantly stronger GvHR when injected
into nonirradiated F-^ recipients. The authors suggested
that parenterally administered CT inhibits a cell
population in the SP which normally exerts a suppressive,
regulatory influence on the developing GvHR.
CT enters the gut by binding to the monosialoganglioside
GM-l receptor present on the enterocyte, and subsequently
interacts with the adenylate cyclase complex on the basal
membrane (reviewed by Stephen and Pietrowski, 1981).
Increased levels of cyclic adenosine monophosphate (cAMP)
may thus affect cell populations within the LP or PP.
Indeed, T suppressor/cytotoxic cells have been found to be
more susceptible to inhibition by cAMP than T helper cells
and B cells (Tsuro et al, 1982; Gilbert and Hoffman, 1985).
Entry of CT, via the villus enterocyte, may thus inhibit
the suggested down-regulatory influence of IEL on IgA
synthesis. This interesting hypothesis requires
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investigation.
In conclusion, a small mucosal IgA antibody response does
co-exist with systemic hyporesponsiveness, although the IgA
antibody response is under strict regulation. Feeding CT
concomitantly with OVA or BLG abrogates oral tolerance
and up-regulates the mucosal IgA antibody response to the
unrelated antigen.
An important model for future studies of oral tolerance and
mucosal immunity may be the transgenic mouse model
described in chapter 10.
The investigations demonstrated that normal mice fostered
onto transgenic females, which secrete sheep BLG in their
milk, were not tolerant to BLG on subsequent systemic
challenge.
Previous reports have shown that when OVA is fed to mice
within the first week of life, systemic priming for both
the humoral and CMI responses occurs. The initial priming
of the humoral response can be partially suppressed if the
mice are fed OVA 2 weeks after the initial dose, and
completely suppressed if fed 4 weeks after the initial
dose. Retolerization of the CMI response is not
accomplished before 14 weeks after the initial encounter
with OVA (Strobel, 1983; Strobel and Ferguson, 1984).
A more detailed analysis of the systemic response to BLG,
fed during the neonatal period to normal mice, would be
achieved if the neonates were fostered onto transgenic
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females at various times throughout the preweaning period.
The transgenic female would therefore be an excellent
delivery system of native BLG, presented in the environment
of maternal milk, to immunologically immature mice.
An important consideration however, which must be taken
into account in future studies, is the concentration of
sheep BLG present in the milk of lactating transgenic
females; a range of BLG concentrations between 3mg/ml and
23mg/ml was described by Simons et al, (1987). Antigen
concentration has been shown to be important to the
immunological outcome after enteric presentation, as low
doses of OVA do not induce oral tolerance but do induce an
antigen-specific local DTH response (Lamont et al, 1989).
The study of oral tolerance in mice born of transgenic
mothers, was complicated by the possible possession of a
copy of the sheep BLG gene and expression of the gene
product. With the correct genetic analysis of the
offspring, it would be possible to determine the effects of
possessing and expressing the gene on the eventual immune
response of the animal. Indeed, the transgenic mouse model
may prove important to the elucidation of the cellular
basis of tolerance to "self antigens"; a phenomenon not
yet fully understood.
CONCLUDING REMARKS
Throughout this discussion, I have concentrated on the
possible role of lymphokines in the intestinal GvHR, both
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with regard to the changes in mucosal architecture and
immunoglobulin concentrations in the gut lumen.
Recently, it has been demonstrated that mouse CD4+ T helper
cell clones and cell lines can be divided into two subsets,
designated TH1 and TH2/ based on their lymphokine profiles
(Mosmann et al, 1986; Mosmann and Coffman, 1987).
Tri cells produce IL-2, IFN-gamma and lymphotoxin in
response to activation by foreign antigen, alloantigen or
Con A. Th2 cells produce IL-4, IL-5 and possibly IL-6 in
response to stimuli (Mosmann and Coffman, 1989).
Murine TH1 cells are capable of producing an antigen-
specific and MHC-restricted DTH response (Cher and Mosmann,
1987 ), and although it is unclear if they are responsible
for the initial activation signal of the DTH reaction, they
are involved in the effector stage. The effector stage
results in the recruitment and activation of monocytes and
granulocytes that mediate the subseguent stages of the
reaction. IFN-gamma has been shown to play a major role in
the TH1-mediated DTH reaction (Mosmann and Coffman, 1989).
Murine TH2 cells are generally agreed to be excellent
helpers in both antigen specific and polyclonal B cell
responses. However, unlike TH^ cells, Th2 cells are found
as precursors that require priming before they can be
induced to secrete their lymphokines, and consequently it
is several days before TH2 cells develop their effector
functions (Swain et al, 1988). Unlike resting B cells,
large B cells do not require contact with the T^2 cells and
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thus can proliferate and differentiate in response to the
lymphokines alone (Mosmann and Coffman, 1989).
A study of CD4+ T cells from mucosal sites has shown that
a large number of the cells are IL-5-secreting cells and
thus akin to cells.
During the immunostimulatory phase of the semi-allogeneic
GvHR, it is possible that alloactivation of both TH1- and
TH2-type cells occurs. The release of lymphokines such as
IFN-gamma, may thus induce the infiltration of IEL into the
epithelium and the proliferative form of enteropathy. The
increase in total IgA and IgM concentrations in the gut
lumen, and the increase in plasma cell counts, may indicate
the effect of lymphokines such as IL-4, IL-5 and IL-6,
released from activated TH2 cells.
The GvHR subsequently enters a period of reduced activity ,
during which T suppressor/cytotoxic cells are activated
(Gleichmann et al, 1984). In the class II MHC-restricted
semi-allogeneic GvHR, both the proliferative and
destructive forms of intestinal GvHR can occur in the
absence of CTL activity (Borland et al, 1983; Felstein and
Mowat, 1988), and I suggest that the changes in the mucosal
architecture observed during this phase are due to the IFN-
gama-induced activation of effector cells such as
macrophages, and the subsequent release of cytostatic
cytokines such as TNF-alpha.
As the GvHR enters the chronic form of T helper cell
activation, it is possible that the combination of TNF-
alpha and IFN-gamma released from activated T^q cells
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produces the villus and crypt atrophy.
The increased levels of total IgA and IgM observed at this
time, without a concomitant increase in plasma cell counts,
may reflect the activation of cells, or perhaps an IFN-
gamma-induced increase in the expression of the secretory
component on villus enterocytes.
Treiber and Lapp (1976), suggested that T helper cells,
involved in the humoral response, were suppressed in the
later stages of the GvHR. However, Gleichmann et al (1984),
have suggested that T cell help is present for B cells
during the systemic, chronic reaction. The inability of
mice with GvHR to produce a humoral response to exogenous
antigen, lies in the physical dissociation of the antigens
seen by T cells and those seen by B cells. Hence, only
autoreactive B cell clones are activated.
The concept of two T helper cell subsets, TH^ an<3 th2 '
their lymphokine profiles, and their separate regulatory
functions within the immune system, will not only influence
the direction of research in experimental gut injury, but
will clearly be relevant to future theories on the
pathogenesis of diseases of the immune system.
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